Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Head and Neck Cancer

  Free Subscription


Articles published in Head Neck

Retrieve available abstracts of 841 articles:
HTML format



Single Articles


    July 2021
  1. STOKES WA, Molina E, McDermott JD, Morgan RL, et al
    Survival impact of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in head and neck cancer.
    Head Neck. 2021 Jul 21. doi: 10.1002/hed.26809.
    PubMed     Abstract available


  2. SCHLIJPER R, Bos S, Hamilton SN, Tran E, et al
    Ninety-day mortality after radiotherapy for head and neck cancer: A population-based comparison between rural and urban patients.
    Head Neck. 2021 Jul 21. doi: 10.1002/hed.26819.
    PubMed     Abstract available


  3. KIM MJ, Back K, Choe JH, Kim JH, et al
    Feasibility of lateral sentinel lymph node biopsy in medullary thyroid cancer: A surrogate tool for determining prophylactic lateral neck dissection-A pilot study.
    Head Neck. 2021 Jul 20. doi: 10.1002/hed.26808.
    PubMed     Abstract available


  4. DIAO K, Nguyen TP, Moreno AC, Reddy JP, et al
    Stereotactic body ablative radiotherapy for reirradiation of small volume head and neck cancers is associated with prolonged survival: A large, single-institution, modern cohort study.
    Head Neck. 2021 Jul 16. doi: 10.1002/hed.26820.
    PubMed     Abstract available


  5. THANKAPPAN K, Subramanian S, Balasubramanian D, Kuriakose MA, et al
    Cost-effectiveness of oral cancer screening approaches by visual examination: A systematic review.
    Head Neck. 2021 Jul 14. doi: 10.1002/hed.26816.
    PubMed     Abstract available


  6. DING Z, Li Y, Pan X, Xuan M, et al
    Sentinel lymph node biopsy versus elective neck dissection in squamous cell carcinoma of the oral cavity with a clinically N0 neck: A systematic review and meta-analysis of prospective studies.
    Head Neck. 2021 Jul 10. doi: 10.1002/hed.26803.
    PubMed     Abstract available


  7. REID P, Staudacher AH, Marcu LG, Olver I, et al
    Characteristic differences in radiation-induced DNA damage response in human papillomavirus-negative and human papillomavirus-positive head and neck cancers with accumulation of fractional radiation dose.
    Head Neck. 2021 Jul 8. doi: 10.1002/hed.26802.
    PubMed     Abstract available


  8. BADDOUR K, Fadel M, Zhao M, Corcoran M, et al
    The cost of cure: Examining objective and subjective financial toxicity in head and neck cancer survivors.
    Head Neck. 2021 Jul 8. doi: 10.1002/hed.26801.
    PubMed     Abstract available


  9. CHILLAKURU Y, Benito DA, Strum D, Mehta V, et al
    Transoral robotic surgery versus nonrobotic resection of oropharyngeal squamous cell carcinoma.
    Head Neck. 2021;43:2259-2273.
    PubMed     Abstract available


  10. PFISTER NT, Beitler JJ, Stokes WA
    Contralateral nodal spread in human papillomavirus-associated oropharyngeal cancer: Can more details help guide contralateral neck coverage?
    Head Neck. 2021;43:2253.
    PubMed    


  11. HUSAIN S, Lohia S, Petkov V, Blackwell T, et al
    Disparities and guideline adherence for HPV testing among patients with oropharyngeal squamous cell carcinoma, NCDB, and SEER.
    Head Neck. 2021;43:2110-2123.
    PubMed     Abstract available


  12. HENN TE, Anderson AN, Hollett YR, Sutton TL, et al
    Circulating hybrid cells predict presence of occult nodal metastases in oral cavity carcinoma.
    Head Neck. 2021;43:2193-2201.
    PubMed     Abstract available


  13. CHEN L, Lin G, Qian J, Chen Z, et al
    A dynamic prognostic nomogram to predict the benefit from surgical treatment modality for patients with laryngeal squamous cell carcinoma.
    Head Neck. 2021;43:2148-2158.
    PubMed     Abstract available


  14. SMITH DK, Freundlich RE, Shinn JR, Wood CB, et al
    An improved predictive model for postoperative pulmonary complications after free flap reconstructions in the head and neck.
    Head Neck. 2021;43:2178-2184.
    PubMed     Abstract available


  15. TOMBLINSON CM, Fletcher GP, Hu LS, Mi L, et al
    Determination of posterolateral oropharyngeal wall thickness and the potential implications for transoral surgical margins in tonsil cancer.
    Head Neck. 2021;43:2185-2192.
    PubMed     Abstract available


  16. PANNU JS, Simpson MC, Adjei Boakye E, Massa ST, et al
    Survival outcomes for head and neck patients with Medicaid: A health insurance paradox.
    Head Neck. 2021;43:2136-2147.
    PubMed     Abstract available


  17. SAIYED FK, Guo T, Johnson F, Myers JN, et al
    Characterizing distant metastases and survival in oropharyngeal squamous cell carcinoma.
    Head Neck. 2021;43:2101-2109.
    PubMed     Abstract available


  18. WESTERGAARD-NIELSEN M, Moller S, Godballe C, Grau Eriksen J, et al
    Prognostic scoring models in parotid gland carcinoma.
    Head Neck. 2021;43:2081-2090.
    PubMed     Abstract available


  19. UDOVICICH C, Daniell J, Wiesenfeld D, Bressel M, et al
    Contralateral neck failure in oral tongue cancer: Outcomes from two centers using predefined treatment criteria.
    Head Neck. 2021;43:2024-2031.
    PubMed     Abstract available


  20. CHARTERS E, Wu R, Milross C, Bogaardt H, et al
    Swallowing and communication outcomes following primary transoral robotic surgery.
    Head Neck. 2021;43:2013-2023.
    PubMed     Abstract available


  21. LASKAR SG, Pai P, Sinha S, Budrukkar A, et al
    Intensity-modulated radiation therapy for nasal cavity and paranasal sinus tumors: Experience from a single institute.
    Head Neck. 2021;43:2045-2057.
    PubMed     Abstract available


  22. HAZIM AZ, Reed CT, Price KA, Foote RL, et al
    Survival outcomes in locally advanced cutaneous squamous cell carcinoma presenting with clinical perineural invasion alone.
    Head Neck. 2021;43:1995-2001.
    PubMed     Abstract available


    June 2021
  23. GAO J, Tseng CC, Barinsky GL, Povolotskiy R, et al
    Exploratory analysis on the association of mental health disorders with in-hospital postoperative complications and mortality in head and neck cancer surgery.
    Head Neck. 2021 Jun 28. doi: 10.1002/hed.26791.
    PubMed     Abstract available


  24. BURBURE N, Handorf E, Ridge JA, Bauman J, et al
    Prognostic significance of human papillomavirus status and treatment modality in hypopharyngeal cancer.
    Head Neck. 2021 Jun 24. doi: 10.1002/hed.26793.
    PubMed     Abstract available


  25. FATEHI KS, Malik A
    Elective neck dissection and its extent in salivary gland cancers: A dilemma.
    Head Neck. 2021 Jun 18. doi: 10.1002/hed.26777.
    PubMed    


  26. WESTERGAARD-NIELSEN M, Godballe C, Eriksen JG, Larsen SR, et al
    Reply to Letter to the Editor regarding "Elective neck dissection and its extent in Salivary gland cancers: A Dilemma".
    Head Neck. 2021 Jun 18. doi: 10.1002/hed.26778.
    PubMed    


  27. RICH BJ, Schumacher LD, Sargi ZB, Masforroll M, et al
    Opioid use patterns in patients with head and neck cancer receiving radiation therapy: A single-institution retrospective analysis characterizing patients who did not require opioid therapy.
    Head Neck. 2021 Jun 18. doi: 10.1002/hed.26785.
    PubMed     Abstract available


  28. WEIZMAN B, Golan N, Ronen O
    Effect of socioeconomic status on survival in patients with head and neck cancer.
    Head Neck. 2021 Jun 16. doi: 10.1002/hed.26788.
    PubMed     Abstract available


  29. BERGAMINI C, Ferris RL, Xie J, Mariani G, et al
    Bleeding complications in patients with squamous cell carcinoma of the head and neck.
    Head Neck. 2021 Jun 12. doi: 10.1002/hed.26772.
    PubMed     Abstract available


  30. CAVALHEIRO BG, de Matos LL, Leite AKN, Kulcsar MAV, et al
    Survival in differentiated thyroid carcinoma: A comparison between the 7th and 8th editions of the AJCC/UICC TNM staging system and the ATA initial risk stratification system.
    Head Neck. 2021 Jun 1. doi: 10.1002/hed.26773.
    PubMed     Abstract available


  31. WESTERGAARD-NIELSEN M, Godballe C, Grau Eriksen J, Larsen SR, et al
    Surgical treatment of the neck in patients with salivary gland carcinoma.
    Head Neck. 2021;43:1898-1911.
    PubMed     Abstract available


  32. SHEPPARD SC, Borner U, Wartenberg M, Giger R, et al
    Diagnostic use of fine-needle aspiration cytology and core-needle biopsy in head and neck sarcomas.
    Head Neck. 2021;43:1939-1948.
    PubMed     Abstract available


  33. SABIQ F, Huang K, Patel A, Banerjee R, et al
    Novel imaging classification system of nodal disease in human papillomavirus-mediated oropharyngeal squamous cell carcinoma prognostic of patient outcomes.
    Head Neck. 2021;43:1854-1863.
    PubMed     Abstract available


  34. HENNOCQ Q, Saintigny P, Quilhot P, Bertolus C, et al
    Association between sex and survival in patients with head and neck spindle cell carcinoma.
    Head Neck. 2021;43:1864-1871.
    PubMed     Abstract available


  35. YANG J, Wei R, Song X, Sun X, et al
    Risk of second primary malignancy after minor salivary gland cancer: A Surveillance, Epidemiology, and End Results database analysis.
    Head Neck. 2021;43:1769-1779.
    PubMed     Abstract available


  36. SAMPLE RA, Wood CB, Mazul AL, Barrett TF, et al
    Low-risk human papilloma virus positive oropharyngeal cancer with one positive lymph node: Equivalent outcomes in patients treated with surgery and radiation therapy versus surgery alone.
    Head Neck. 2021;43:1759-1768.
    PubMed     Abstract available


  37. LUGINBUHL A, Kahue CN, Stewart M, Curry JM, et al
    Head and neck surgery global outreach: Ethics, planning, and impact.
    Head Neck. 2021;43:1780-1787.
    PubMed     Abstract available


  38. WANG X, Zheng X, Zhu J, Li Z, et al
    Radioactive iodine therapy may not improve disease-specific survival in follicular variant papillary thyroid cancer without distant metastasis: A propensity score-matched analysis.
    Head Neck. 2021;43:1730-1738.
    PubMed     Abstract available


  39. LANISNIK B, Levart P, Cizmarevic B, Svagan M, et al
    Surgeon-performed ultrasound with fine-needle aspiration biopsy for the diagnosis of parotid gland tumors.
    Head Neck. 2021;43:1739-1746.
    PubMed     Abstract available


  40. YAVUZ H, Vural O
    Tracheoesophageal puncture closure with annular mucosal flap.
    Head Neck. 2021;43:1705-1710.
    PubMed     Abstract available


    May 2021
  41. FAGAN JJ, Otiti J, Onakoya PA, Diom E, et al
    AfHNS fellowship: A model to improve access to head and neck cancer care in Africa and developing countries.
    Head Neck. 2021 May 29. doi: 10.1002/hed.26770.
    PubMed     Abstract available


  42. YANG S, Yuan ZJ, Zhu YH, Chen X, et al
    lncRNA PVT1 promotes cetuximab resistance of head and neck squamous cell carcinoma cells by inhibiting miR-124-3p.
    Head Neck. 2021 May 25. doi: 10.1002/hed.26742.
    PubMed     Abstract available


  43. CIVANTOS AM, Prasad A, Carey RM, Bur AM, et al
    Palliative care in metastatic head and neck cancer.
    Head Neck. 2021 May 21. doi: 10.1002/hed.26761.
    PubMed     Abstract available


  44. GOSHTASBI K, Abiri A, Lehrich BM, Haidar YM, et al
    The influence of facility volume on patient treatments and survival outcomes in nasopharyngeal carcinoma.
    Head Neck. 2021 May 17. doi: 10.1002/hed.26739.
    PubMed     Abstract available


  45. PANG J, Faraji F, Risa E, Mell LK, et al
    High rates of postoperative radiotherapy delay in head and neck cancer before and after Medicaid expansion.
    Head Neck. 2021 May 17. doi: 10.1002/hed.26736.
    PubMed     Abstract available


  46. HOESSEINI A, van Leeuwen N, Offerman MPJ, Zhang J, et al
    Predicting survival in head and neck cancer: External validation and update of the prognostic model OncologIQ in 2189 patients.
    Head Neck. 2021 May 7. doi: 10.1002/hed.26716.
    PubMed     Abstract available


  47. RIJO-CEDENO J, Mucientes J, Seijas Marcos S, Romero J, et al
    Adding value to tumor staging in head and neck cancer: The role of metabolic parameters as prognostic factors.
    Head Neck. 2021 May 6. doi: 10.1002/hed.26725.
    PubMed     Abstract available


  48. VERMAIRE JA, Terhaard CHJ, Verdonck-de Leeuw IM, Raaijmakers CPJ, et al
    Reliability of the 100 mL water swallow test in patients with head and neck cancer and healthy subjects.
    Head Neck. 2021 May 6. doi: 10.1002/hed.26723.
    PubMed     Abstract available


  49. LIAO W, He J, Gou Q, Duan B, et al
    Local treatment of metastases plus systemic chemotherapy on overall survival of patients with metastatic nasopharyngeal carcinoma.
    Head Neck. 2021 May 3. doi: 10.1002/hed.26706.
    PubMed     Abstract available


  50. DE VIRGILIO A, Kim SH, Wang CC, Holsinger FC, et al
    Anatomical-based classification for transoral base of tongue resection.
    Head Neck. 2021;43:1604-1609.
    PubMed     Abstract available


  51. OTTENSTEIN L, Cornett H, Switchenko JM, Nathan M, et al
    Characterizing postoperative physiologic swallow function following transoral robotic surgery for early stage tonsil, base of tongue, and unknown primary human papillomavirus-associated squamous cell carcinoma.
    Head Neck. 2021;43:1629-1640.
    PubMed     Abstract available


  52. DE VIRGILIO A, Costantino A, Ferreli F, Malvezzi L, et al
    High-definition three-dimensional exoscope for head and neck reconstruction: Prospective analysis of 27 consecutive patients.
    Head Neck. 2021;43:1574-1580.
    PubMed     Abstract available


  53. SUNG YE, Kim MS, Lee YS
    Proposal of a scoring system for predicting pathological risk based on a semiautomated analysis of whole slide images in oral squamous cell carcinoma.
    Head Neck. 2021;43:1581-1591.
    PubMed     Abstract available


  54. LIM Y, Tang KD, Karpe AV, Beale DJ, et al
    Chemoradiation therapy changes oral microbiome and metabolomic profiles in patients with oral cavity cancer and oropharyngeal cancer.
    Head Neck. 2021;43:1521-1534.
    PubMed     Abstract available


  55. TAM S, Gajera M, Luo X, Glisson BS, et al
    Cytotoxic and targeted systemic therapy in patients with advanced cutaneous squamous cell carcinoma in the head and neck.
    Head Neck. 2021;43:1592-1603.
    PubMed     Abstract available


  56. YOUNG A, Bigcas JL, Yang A, Reeve N, et al
    Transoral robotic submandibular gland transposition to reconstruct radical tonsillar resection defects.
    Head Neck. 2021;43:1695-1698.
    PubMed     Abstract available


  57. GUALTIERI T, Verzeletti V, Ferrari M, Perotti P, et al
    A new landmark for lingual artery identification during transoral surgery: Anatomic-radiologic study.
    Head Neck. 2021;43:1487-1498.
    PubMed     Abstract available


  58. SMITH AW, Gallitto M, Lehrer EJ, Wasserman I, et al
    Redefining risk of contralateral cervical nodal disease in early stage oropharyngeal cancer in the human papillomavirus era.
    Head Neck. 2021;43:1409-1414.
    PubMed     Abstract available


  59. MOLTENI G, Gazzini L, Sacchetto A, Nocini R, et al
    Role of the temporoparietal fascia free flap in salvage total laryngectomy.
    Head Neck. 2021;43:1692-1694.
    PubMed     Abstract available


  60. LIU HY, Daniels CP, Trada Y, Bernard A, et al
    The importance of smoking status at diagnosis in human papillomavirus-associated oropharyngeal cancer.
    Head Neck. 2021;43:1440-1450.
    PubMed     Abstract available


  61. NOCON CC, Kuchta K, Bhayani MK
    Prognostic value of lymph node ratio versus American Joint Committee on Cancer N classification for surgically resected human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    Head Neck. 2021;43:1476-1486.
    PubMed     Abstract available


    April 2021
  62. XU H, Lu L, Lu T, Xu Y, et al
    Identifying the optimal candidates for locoregional radiation therapy in patients with de novo metastatic nasopharyngeal carcinoma.
    Head Neck. 2021 Apr 27. doi: 10.1002/hed.26726.
    PubMed     Abstract available


  63. HIGHLAND J, Aylward A, Do O, Monroe M, et al
    Trust in physicians among patients with head and neck cancer before and after treatment.
    Head Neck. 2021 Apr 26. doi: 10.1002/hed.26721.
    PubMed     Abstract available


  64. SEKI-SODA M, Sano T, Ogawa M, Yokoo S, et al
    CD15(+) tumor infiltrating granulocytic cells can predict recurrence and their depletion is accompanied by good responses to S-1 with oral cancer.
    Head Neck. 2021 Apr 24. doi: 10.1002/hed.26712.
    PubMed     Abstract available


  65. NUYTS S, Bollen H, Eisbruch A, Corry J, et al
    Unilateral versus bilateral nodal irradiation: Current evidence in the treatment of squamous cell carcinoma of the head and neck.
    Head Neck. 2021 Apr 19. doi: 10.1002/hed.26713.
    PubMed     Abstract available


  66. MESSING BP, Ward EC, Lazarus C, Ryniak K, et al
    Longitudinal comparisons of a whole-mouth taste test to clinician-rated and patient-reported outcomes of dysgeusia postradiotherapy in patients with head and neck cancer and associations with oral intake.
    Head Neck. 2021 Apr 15. doi: 10.1002/hed.26690.
    PubMed     Abstract available


  67. WANG SM, Yin SC, Su XZ, Xu Q, et al
    Magnitude of radial forearm free flaps and factors associated with loss of volume in oral cancer reconstructive surgery: A prospective study.
    Head Neck. 2021 Apr 13. doi: 10.1002/hed.26704.
    PubMed     Abstract available


  68. WIBONELE BK, Smith BD, Altonji S, Kaplan S, et al
    Head and neck cancer research collaborations between the United States and low- and middle-income countries: A 10-year publication analysis.
    Head Neck. 2021 Apr 5. doi: 10.1002/hed.26703.
    PubMed     Abstract available


  69. YANG N, Mercier E, Guertin L, Bissada E, et al
    Development, translation, and preliminary validation of the neck dissection assessment tool.
    Head Neck. 2021 Apr 2. doi: 10.1002/hed.26696.
    PubMed     Abstract available


  70. SMITS HJG, Assili S, Kauw F, Philippens MEP, et al
    Prognostic imaging variables for recurrent laryngeal and hypopharyngeal carcinoma treated with primary chemoradiotherapy: A systematic and meta-analysis.
    Head Neck. 2021 Apr 2. doi: 10.1002/hed.26698.
    PubMed     Abstract available


  71. ZAKERI K, Wang H, Kang JJ, Lee A, et al
    Outcomes and prognostic factors of major salivary gland tumors treated with proton beam radiation therapy.
    Head Neck. 2021;43:1056-1062.
    PubMed     Abstract available


  72. SCHVARTSMAN G, Bell D, Rubin ML, Tetzlaff M, et al
    The tumor immune contexture of salivary duct carcinoma.
    Head Neck. 2021;43:1213-1219.
    PubMed     Abstract available


  73. XING MH, Mundi N, Govindan A, Khorsandi A, et al
    Unusual location of a second branchial cleft cyst presenting in the suprasternal notch.
    Head Neck. 2021;43:E27-E29.
    PubMed     Abstract available


  74. BALASUBRAMANIAN D, Subramaniam N, Missale F, Marchi F, et al
    Predictive nomograms for oral tongue squamous cell carcinoma applying the American Joint Committee on Cancer/Union Internationale Contre le Cancer 8th edition staging system.
    Head Neck. 2021;43:1043-1055.
    PubMed     Abstract available


  75. DONG P, Wang L, Qu Y, Huang R, et al
    Low- and high-dose radioiodine ablation for low-/intermediate-risk differentiated thyroid cancer in China: Large randomized clinical trial.
    Head Neck. 2021;43:1311-1320.
    PubMed     Abstract available


  76. MASHRAH MA, Aldhohrah T, Abdelrehem A, Koraitim M, et al
    What is the best method for prevention of postparotidectomy Frey syndrome? Network meta-analysis.
    Head Neck. 2021;43:1345-1358.
    PubMed     Abstract available


  77. STACK BC JR, Twining C, Rastatter J, Angelos P, et al
    Consensus statement by the American Association of Clinical Endocrinology (AACE) and the American Head and Neck Society Endocrine Surgery Section (AHNS-ES) on Pediatric Benign and Malignant Thyroid Surgery.
    Head Neck. 2021;43:1027-1042.
    PubMed     Abstract available


  78. ATALLAH I, Castellanos PF
    Transoral closure of the supraglottic larynx for intractable aspiration.
    Head Neck. 2021;43:1370-1375.
    PubMed     Abstract available


  79. SINHA S, Agarwal JP, Mahajan A, Chaturvedi P, et al
    Implications of limited exolaryngeal disease and cricoarytenoid joint involvement in organ conservation protocols for laryngopharyngeal cancers: Results from a prospective study.
    Head Neck. 2021;43:1289-1299.
    PubMed     Abstract available


  80. MCKENZIE RM, Parhar HS, Ng TL, Prisman E, et al
    Muscle invasion in oropharyngeal carcinoma undergoing transoral robotic surgery.
    Head Neck. 2021;43:1194-1201.
    PubMed     Abstract available


  81. CAREY RM, Shimunov D, Weinstein GS, Cannady SB, et al
    Increased rate of recurrence and high rate of salvage in patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma with adverse features treated with primary surgery without recommended adjuvant therapy.
    Head Neck. 2021;43:1128-1141.
    PubMed     Abstract available


  82. LIU WC, Liu HE, Kao YW, Qin L, et al
    Definitive intensity-modulated radiotherapy or surgery for early oral cavity squamous cell carcinoma: Propensity-score-matched, nationwide, population-based cohort study.
    Head Neck. 2021;43:1142-1152.
    PubMed     Abstract available


  83. SUN M, Wang K, Qu Y, Zhang J, et al
    Proposal of a TNM classification-based staging system for esthesioneuroblastoma: More precise prediction of prognosis.
    Head Neck. 2021;43:1097-1104.
    PubMed     Abstract available


  84. KUMAR A, Laskar SG, Thiagarajan S
    Is Transoral Robotic Surgery (TORS) for oropharyngeal squamous cell carcinoma being done more often than actually indicated?
    Head Neck. 2021;43:1376-1377.
    PubMed    


  85. BATES JE, Amdur RJ
    In reply to Kumar et al, Is TORS for oropharyngeal squamous cell carcinoma being done more often than actually indicated?
    Head Neck. 2021;43:1378-1379.
    PubMed    


  86. ROOKER SA, Van Abel KM, Yin LX, Nagelschneider AA, et al
    Risk factors for subsequent recurrence after surgical treatment of recurrent pleomorphic adenoma of the parotid gland.
    Head Neck. 2021;43:1088-1096.
    PubMed     Abstract available


  87. SARI SY, Yilmaz MT, Elmali A, Yedekci FY, et al
    Parotid gland stem cells: Mini yet mighty.
    Head Neck. 2021;43:1122-1127.
    PubMed     Abstract available


    March 2021
  88. GUAN H, He Y, Su Y, Wei Z, et al
    Assessment of different induction chemotherapy regimens in locally advanced nasopharyngeal carcinoma: A meta-analysis.
    Head Neck. 2021 Mar 31. doi: 10.1002/hed.26699.
    PubMed     Abstract available


  89. LI W, Lu H, Wang H, Hu L, et al
    Establishment and validation of a novel nomogram to predict overall survival in nasopharyngeal carcinoma with lymph node metastasis.
    Head Neck. 2021 Mar 29. doi: 10.1002/hed.26687.
    PubMed     Abstract available


  90. NG WT, Tsang RKY, Beitler JJ, de Bree R, et al
    Contemporary management of the neck in nasopharyngeal carcinoma.
    Head Neck. 2021 Mar 29. doi: 10.1002/hed.26685.
    PubMed     Abstract available


  91. EBERSOLE B, McCarroll L, Ridge JA, Liu JC, et al
    Identification and management of late dysfunction in survivors of head and neck cancer: Implementation and outcomes of an interdisciplinary quality of life (IQOL) clinic.
    Head Neck. 2021 Mar 21. doi: 10.1002/hed.26681.
    PubMed     Abstract available


  92. STADLER TM, Morand GB, Rupp NJ, Hullner MW, et al
    FDG-PET-CT/MRI in head and neck squamous cell carcinoma: Impact on pretherapeutic N classification, detection of distant metastases, and second primary tumors.
    Head Neck. 2021 Mar 17. doi: 10.1002/hed.26668.
    PubMed     Abstract available


  93. SHAH R, Gosavi V, Mahajan A, Sonawane S, et al
    Preoperative prediction of parathyroid carcinoma in an Asian Indian cohort.
    Head Neck. 2021 Mar 10. doi: 10.1002/hed.26677.
    PubMed     Abstract available


  94. PATEL U, Mittal N, Rane SU, Patil A, et al
    Correlation of transcriptionally active human papillomavirus status with the clinical and molecular profiles of head and neck squamous cell carcinomas.
    Head Neck. 2021 Mar 10. doi: 10.1002/hed.26676.
    PubMed     Abstract available


  95. SAKA-HERRAN C, Jane-Salas E, Estrugo-Devesa A, Lopez-Lopez J, et al
    Head and neck cancer and non-steroidal anti-inflammatory drugs: Systematic review and meta-analysis.
    Head Neck. 2021 Mar 8. doi: 10.1002/hed.26663.
    PubMed     Abstract available


  96. SANSA A, Venegas MDP, Valero C, Pardo L, et al
    The aspartate aminotransaminase/alanine aminotransaminase (De Ritis) ratio predicts sensitivity to radiotherapy in head and neck carcinoma patients.
    Head Neck. 2021 Mar 6. doi: 10.1002/hed.26673.
    PubMed     Abstract available


  97. FASSAS S, Cummings E, Sykes KJ, Bur AM, et al
    Telemedicine for head and neck cancer surveillance in the COVID-19 era: Promise and pitfalls.
    Head Neck. 2021 Mar 4. doi: 10.1002/hed.26659.
    PubMed     Abstract available


  98. WARREN EAK, Anil J, Castro PD, Kemnade J, et al
    Human epidermal growth factor receptor 2 expression in head and neck squamous cell carcinoma: Variation within and across primary tumor sites, and implications for antigen-specific immunotherapy.
    Head Neck. 2021 Mar 4. doi: 10.1002/hed.26662.
    PubMed     Abstract available


  99. BUGTER O, van Iwaarden DLP, van Leeuwen N, Nieboer D, et al
    A cause-specific Cox model for second primary tumors in patients with head and neck cancer: A RONCDOC study.
    Head Neck. 2021 Mar 3. doi: 10.1002/hed.26666.
    PubMed     Abstract available


  100. KIONG KL, Diaz EM, Gross ND, Diaz EM Jr, et al
    The impact of COVID-19 on head and neck cancer diagnosis and disease extent.
    Head Neck. 2021 Mar 2. doi: 10.1002/hed.26665.
    PubMed     Abstract available


  101. DICKSTEIN DR, Egerman M, Monrose E, Varma A, et al
    Treatment tolerability and outcomes in elderly patients with head and neck cancer.
    Head Neck. 2021;43:858-873.
    PubMed     Abstract available


  102. TODSEN T, Bennedbaek FN, Kiss K, Hegedus L, et al
    Ultrasound-guided fine-needle aspiration biopsy of thyroid nodules.
    Head Neck. 2021;43:1009-1013.
    PubMed     Abstract available


  103. DAVIES L
    Why are there different conclusions about thyroid cancer mortality?
    Head Neck. 2021;43:984-986.
    PubMed    


  104. LABARGE B, Walter V, Bann DV, Goldenberg D, et al
    In-depth analysis of thyroid cancer mortality.
    Head Neck. 2021;43:977-983.
    PubMed     Abstract available


  105. LYU X, Liu S, Zheng L, Huang M, et al
    New approach to an overlooked flap: Technique to augment venous drainage of the infrahyoid myocutaneous flap.
    Head Neck. 2021;43:942-948.
    PubMed     Abstract available


  106. COLAIANNI CA, Feng AL, Richmon JD
    Partial parotidectomy via periauricular incision: Retrospective cohort study and comparative analysis to alternative incisional approaches.
    Head Neck. 2021;43:825-832.
    PubMed     Abstract available


  107. GUNTINAS-LICHIUS O, Thielker J, Robbins KT, Olsen KD, et al
    Prognostic role of intraparotid lymph node metastasis in primary parotid cancer: Systematic review.
    Head Neck. 2021;43:997-1008.
    PubMed     Abstract available


  108. DOESCHER J, Minkenberg P, Laban S, Kostezka U, et al
    Immune checkpoint expression in HNSCC patients before and after definitive chemoradiotherapy.
    Head Neck. 2021;43:778-787.
    PubMed     Abstract available


  109. SWARTZ JE, Wegner I, Noorlag R, van Kempen PMW, et al
    HIF-1a expression and differential effects on survival in patients with oral cavity, larynx, and oropharynx squamous cell carcinomas.
    Head Neck. 2021;43:745-756.
    PubMed     Abstract available


  110. SULLIVAN CB, Al-Qurayshi Z, Chang K, Pagedar NA, et al
    Analysis of palliative care treatment among head and neck patients with cancer: National perspective.
    Head Neck. 2021;43:805-815.
    PubMed     Abstract available


    February 2021
  111. LI M, Zhang B, Chen Q, Zhang L, et al
    Concurrent chemoradiotherapy with additional chemotherapy for nasopharyngeal carcinoma: A pooled analysis of propensity score-matching studies.
    Head Neck. 2021 Feb 28. doi: 10.1002/hed.26664.
    PubMed     Abstract available


  112. STEPAN KO, Mazul AL, Skillington SA, Paniello RC, et al
    The prognostic significance of race in nasopharyngeal carcinoma by histological subtype.
    Head Neck. 2021 Feb 23. doi: 10.1002/hed.26639.
    PubMed     Abstract available


  113. YANG K, Li M, Zhu J, Zeng L, et al
    Nomograms for predicting survival outcomes in intensity-modulated radiotherapy era of nasopharyngeal carcinoma: A study based on Epstein-Barr virus DNA biological responses.
    Head Neck. 2021 Feb 19. doi: 10.1002/hed.26654.
    PubMed     Abstract available


  114. VAN DER LANS RJL, Engel MSD, Rijken JA, Hensen EF, et al
    Neuroendocrine neoplasms of the middle ear: Unpredictable tumor behavior and tendency for recurrence.
    Head Neck. 2021 Feb 19. doi: 10.1002/hed.26658.
    PubMed     Abstract available


  115. RAMSEY T, Lee B, Curran K, Desai V, et al
    Associations of insurance, urbanity, and comorbidity with types of palliative care received by patients with head and neck cancer.
    Head Neck. 2021 Feb 18. doi: 10.1002/hed.26648.
    PubMed     Abstract available


  116. RANGABASHYAM M, Koh SQ, Sultana R, Tan NC, et al
    Factors associated with returning to work in head and neck cancer survivors in Singapore: A preliminary exploratory mixed-methods approach study.
    Head Neck. 2021 Feb 18. doi: 10.1002/hed.26644.
    PubMed     Abstract available


  117. FUNG SYH, Chan KCA, Wong EWY, Ng CWK, et al
    Droplet digital PCR of tumor suppressor gene methylation in serial oral rinses of patients with head and neck squamous cell carcinoma.
    Head Neck. 2021 Feb 17. doi: 10.1002/hed.26647.
    PubMed     Abstract available


  118. SABOUR S, Ghajari H
    Diagnostic value of exosomal circMYC in radioresistant nasopharyngeal carcinoma: Methodological issues.
    Head Neck. 2021 Feb 17. doi: 10.1002/hed.26645.
    PubMed    


  119. ELSHARAWI R, Antonucci E, Sukari A, Cramer JD, et al
    Quality metrics for head and neck cancer treated with definitive radiotherapy and/or chemotherapy.
    Head Neck. 2021 Feb 17. doi: 10.1002/hed.26640.
    PubMed     Abstract available


  120. GUO J, Gui R
    Reply: Diagnostic value of exosomal circMYC in radioresistant nasopharyngeal carcinoma: Methodological issues (HED-20-22881).
    Head Neck. 2021 Feb 17. doi: 10.1002/hed.26652.
    PubMed    


  121. USHINSKY A, Guevara CJ, Kim SK
    Intranodal lymphangiography with thoracic duct embolization for the treatment of chyle leaks after head and neck cancer surgery.
    Head Neck. 2021 Feb 15. doi: 10.1002/hed.26646.
    PubMed     Abstract available


  122. GRECO E, Ringash J, Tomlinson G, Huang SH, et al
    Presence and duration of feeding tube in a 5-year cohort of patients with head and neck cancer treated with curative intensity-modulated radiation therapy.
    Head Neck. 2021 Feb 13. doi: 10.1002/hed.26638.
    PubMed     Abstract available


  123. BURGIN SJM, Spector ME, Pearson AT, Bellile E, et al
    Long-term neck and shoulder function among survivors of oropharyngeal squamous cell carcinoma treated with chemoradiation as assessed with the neck dissection impairment index.
    Head Neck. 2021 Feb 12. doi: 10.1002/hed.26636.
    PubMed     Abstract available


  124. POON DMC, Kam MKM, Johnson D, Mo F, et al
    Durability of the parotid-sparing effect of intensity-modulated radiotherapy (IMRT) in early stage nasopharyngeal carcinoma: A 15-year follow-up of a randomized prospective study of IMRT versus two-dimensional radiotherapy.
    Head Neck. 2021 Feb 11. doi: 10.1002/hed.26634.
    PubMed     Abstract available


  125. ANG MK, Montoya JE, Tharavichitkul E, Lim C, et al
    A phase II study of nimotuzumab (TheraCim-hR3) concurrent with cisplatin/radiotherapy in patients with locally advanced head and neck squamous cell carcinoma.
    Head Neck. 2021 Feb 5. doi: 10.1002/hed.26635.
    PubMed     Abstract available


  126. XIE G, Zhu A, Gu X
    Mitogen-activated protein kinase inhibition-induced modulation of epidermal growth factor receptor signaling in human head and neck squamous cell carcinoma.
    Head Neck. 2021 Feb 3. doi: 10.1002/hed.26633.
    PubMed     Abstract available


  127. WAI KC, Xu MJ, Lee RH, El-Sayed IH, et al
    Head and neck surgery during the coronavirus-19 pandemic: The University of California San Francisco experience.
    Head Neck. 2021;43:622-629.
    PubMed     Abstract available


  128. ALVES LDB, Menezes ACS, Pereira DL, Santos MTC, et al
    Benefits of intraoral stents in patients with head and neck cancer undergoing radiotherapy: Systematic review.
    Head Neck. 2021 Feb 1. doi: 10.1002/hed.26620.
    PubMed     Abstract available


  129. HOLCOMB AJ, Richmon JD
    Transoral robotic salvage oropharyngectomy with submental artery island flap reconstruction.
    Head Neck. 2021;43:E13-E19.
    PubMed     Abstract available


  130. DE VIRGILIO A, Costantino A, Canzano F, Accorona R, et al
    Regional disease control in sinonasal mucosal melanoma: Systematic review and meta-analysis.
    Head Neck. 2021;43:705-715.
    PubMed     Abstract available


  131. REED R, Strumpf A, Martz TG, Kavanagh KJ, et al
    2015 American Thyroid Association guidelines and thyroid-stimulating hormone suppression after thyroid lobectomy.
    Head Neck. 2021;43:639-644.
    PubMed     Abstract available


  132. LUK PP, Ebrahimi A, Veness MJ, McDowell L, et al
    Prognostic value of the 8th edition American Joint Commission Cancer nodal staging system for patients with head and neck cutaneous squamous cell carcinoma: A multi-institutional study.
    Head Neck. 2021;43:558-567.
    PubMed     Abstract available


  133. LAO WP, Lagabon KJ, Arom GA, Walker PC, et al
    Combined endoscopic and transoral resection of a high-staged juvenile nasopharyngeal angiofibroma: A pictorial essay.
    Head Neck. 2021;43:719-724.
    PubMed     Abstract available


  134. BINZ GHA, Soyka MB, Holzmann D, Meerwein CM, et al
    Need for long-term follow-up in sinonasal inverted papilloma: A Single-institution experience.
    Head Neck. 2021;43:630-638.
    PubMed     Abstract available


  135. SMITHERS FAE, Haymerle G, Palme CE, Low TH, et al
    A prospective study of intraoperative assessment of mucosal squamous cell carcinoma margins in the head and neck.
    Head Neck. 2021;43:590-600.
    PubMed     Abstract available


  136. HUM L, Bethmann D, Feng Z, Chang SC, et al
    Cumulative suppressive index as a predictor of relapse free survival and overall survival in Human Papilloma Virus-negative oral squamous cell carcinomas with negative resection margins.
    Head Neck. 2021;43:568-576.
    PubMed     Abstract available


  137. PINATTI LM, Sinha HN, Brummel CV, Goudsmit CM, et al
    Association of human papillomavirus integration with better patient outcomes in oropharyngeal squamous cell carcinoma.
    Head Neck. 2021;43:544-557.
    PubMed     Abstract available


  138. HUANG SH, de Almeida JR, Watson E, Glogauer M, et al
    Short-term and long-term unstimulated saliva flow following unilateral vs bilateral radiotherapy for oropharyngeal carcinoma.
    Head Neck. 2021;43:456-466.
    PubMed     Abstract available


  139. SU WW, Lee YH, Yen AM, Chen SL, et al
    Impact of treatment delay on survival of oral/oropharyngeal cancers: Results of a nationwide screening program.
    Head Neck. 2021;43:473-484.
    PubMed     Abstract available


  140. YIN LX, Van Abel KM, Rooker SA, Nagelschneider AA, et al
    Risk factors for carcinoma ex pleomorphic adenoma in patients presenting with recurrence after resection of pleomorphic adenoma.
    Head Neck. 2021;43:419-427.
    PubMed     Abstract available


  141. BOS P, van den Brekel MWM, Gouw ZAR, Al-Mamgani A, et al
    Clinical variables and magnetic resonance imaging-based radiomics predict human papillomavirus status of oropharyngeal cancer.
    Head Neck. 2021;43:485-495.
    PubMed     Abstract available


  142. KIKUCHI M, Yamashita D, Hara S, Takebayashi S, et al
    Clinical significance of tumor-associated immune cells in patients with oral squamous cell carcinoma.
    Head Neck. 2021;43:534-543.
    PubMed     Abstract available


  143. ARUN I, Maity N, Hameed S, Jain PV, et al
    Lymph node characteristics and their prognostic significance in oral squamous cell carcinoma.
    Head Neck. 2021;43:520-533.
    PubMed     Abstract available


  144. BASIM P, Argun D, Ozdenkaya Y
    Self-reported medication adherence in differentiated thyroid cancer survivors: Role of illness perception and medication beliefs.
    Head Neck. 2021;43:428-437.
    PubMed     Abstract available


    January 2021
  145. GISSI DB, Morandi L, Colella G, De Luca R, et al
    Clinical validation of 13-gene DNA methylation analysis in oral brushing samples for detection of oral carcinoma: An Italian multicenter study.
    Head Neck. 2021 Jan 28. doi: 10.1002/hed.26624.
    PubMed     Abstract available


  146. HOPKINS-ROSSABI T, Armeson KE, Zecker SG, Martin-Harris B, et al
    Respiratory-swallow coordination and swallowing impairment in head and neck cancer.
    Head Neck. 2021 Jan 25. doi: 10.1002/hed.26609.
    PubMed     Abstract available


  147. IQBAL MS, Kelly C, Kovarik J, McQueen A, et al
    Rapid recurrence in postoperative head and neck cancer: Underappreciated or overcalled problem?
    Head Neck. 2021 Jan 25. doi: 10.1002/hed.26615.
    PubMed    


  148. POLCE S, Gogineni E, Antone J, Ghaly M, et al
    Dental radiation dosimetric maps from intensity-modulated radiation therapy planning for head and neck cancers.
    Head Neck. 2021 Jan 15. doi: 10.1002/hed.26611.
    PubMed     Abstract available


  149. WEI ZG, Hu XL, He Y, Guan H, et al
    Clinical and survival analysis of nasopharyngeal carcinoma with consistently negative Epstein-Barr virus DNA.
    Head Neck. 2021 Jan 9. doi: 10.1002/hed.26608.
    PubMed     Abstract available


  150. MAYS AC, Yarlagadda B, Achim V, Jackson R, et al
    Examining the relationship of immunotherapy and wound complications following flap reconstruction in patients with head and neck cancer.
    Head Neck. 2021 Jan 8. doi: 10.1002/hed.26601.
    PubMed     Abstract available


  151. INGARFIELD K, McMahon AD, Hurley K, Toms S, et al
    Inequality in survival of people with head and neck cancer: Head and Neck 5000 cohort study.
    Head Neck. 2021 Jan 8. doi: 10.1002/hed.26589.
    PubMed     Abstract available


  152. BROEMER L, Friedrich M, Wichmann G, Muller J, et al
    Exploratory study of functional and psychological factors associated with employment status in patients with head and neck cancer.
    Head Neck. 2021 Jan 1. doi: 10.1002/hed.26595.
    PubMed     Abstract available


  153. JOZAGHI Y, Zafereo M, Williams MD, Gule-Monroe MK, et al
    Neoadjuvant selpercatinib for advanced medullary thyroid cancer.
    Head Neck. 2021;43:E7-E12.
    PubMed     Abstract available


  154. WANG Y, Zhou S, Liu X, Rui S, et al
    Transoral endoscopic thyroidectomy vestibular approach vs conventional open thyroidectomy: Meta-analysis.
    Head Neck. 2021;43:345-353.
    PubMed     Abstract available


  155. HAYDEN RE, Chang BA, Mullin DP, Patel AK, et al
    Bipedicled submental musculofascial "hammock" flap for salvage laryngectomy closure reinforcement.
    Head Neck. 2021;43:198-202.
    PubMed     Abstract available


  156. PATEL KB, Martin D, Zhao S, Kumar B, et al
    Impact of age and comorbidity on survival among patients with oral cavity squamous cell carcinoma.
    Head Neck. 2021;43:268-277.
    PubMed     Abstract available


  157. SHARBEL DD, Abkemeier M, Sullivan J, Zimmerman Z, et al
    Transcervical arterial ligation for prevention of postoperative hemorrhage in transoral oropharyngectomy: Systematic review and meta-analysis.
    Head Neck. 2021;43:334-344.
    PubMed     Abstract available


  158. MOORE EJ, Van Abel KM, Routman DM, Lohse CM, et al
    Human papillomavirus oropharynx carcinoma: Aggressive de-escalation of adjuvant therapy.
    Head Neck. 2021;43:229-237.
    PubMed     Abstract available


  159. CLARK CM, Newark AC, Fokar A, Maxwell JH, et al
    Aspirin use predicts prolonged survival in patients with oropharyngeal cancer: Nationwide Veterans Affairs database study.
    Head Neck. 2021;43:247-254.
    PubMed     Abstract available


  160. FUNG AS, Afzal AR, Banerjee R, Debenham B, et al
    A real-world comparison of cisplatin vs cetuximab used concurrently with radiation in the treatment of locally advanced oropharyngeal carcinoma.
    Head Neck. 2021;43:153-163.
    PubMed     Abstract available


  161. PANUGANTI BA, Stuart E, Weissbrod P
    Changes in treatment trends in the early glottic cancer population after the Affordable Care Act.
    Head Neck. 2021;43:137-144.
    PubMed     Abstract available


  162. CHWEYA CM, Low CM, Van Gompel JJ, Van Abel KM, et al
    Population-based analysis on the effect of nodal and distant metastases in sinonasal adenocarcinoma.
    Head Neck. 2021;43:128-136.
    PubMed     Abstract available


  163. GRANT-FREEMANTLE MC, Lane O'Neill B, Clover AJP
    The effectiveness of radiotherapy in the treatment of head and neck mucosal melanoma: Systematic review and meta-analysis.
    Head Neck. 2021;43:323-333.
    PubMed     Abstract available


  164. LIU SW, Woody NM, Wei W, Appachi S, et al
    Evaluating compliance with process-related quality metrics and survival in oral cavity squamous cell carcinoma: Multi-institutional oral cavity collaboration study.
    Head Neck. 2021;43:60-69.
    PubMed     Abstract available


  165. ZEVALLOS JP, Kramer JR, Sandulache VC, Massa ST, et al
    National trends in oropharyngeal cancer incidence and survival within the Veterans Affairs Health Care System.
    Head Neck. 2021;43:108-115.
    PubMed     Abstract available


  166. YAN F, Desiato VM, Nguyen SA, Lentsch EJ, et al
    Impact of greater auricular nerve sacrifice during parotidectomy on quality of life.
    Head Neck. 2021;43:70-78.
    PubMed     Abstract available


    December 2020
  167. PANDIT PN, Patil RA, Palwe VS, Tambade SH, et al
    Patterns of blood pressure changes in patients with head and neck cancer receiving radiotherapy or chemo-radiotherapy at a tertiary cancer centre.
    Head Neck. 2020 Dec 29. doi: 10.1002/hed.26590.
    PubMed     Abstract available


  168. FANG R, Peng L, Chen L, Liao J, et al
    The survival benefit of lymph node dissection in resected T1-2, cN0 supraglottic cancer: A population-based propensity score matching analysis.
    Head Neck. 2020 Dec 29. doi: 10.1002/hed.26596.
    PubMed     Abstract available


  169. STARR N, Oyler DR, Schadler A, Aouad RK, et al
    Chronic opioid use after laryngeal cancer treatment.
    Head Neck. 2020 Dec 28. doi: 10.1002/hed.26591.
    PubMed     Abstract available


  170. RAO VUS, Subash A, R Bhargavi V, Sinha P, et al
    Selective embolization of lingual artery in transoral robotic surgery for the management of recurrent base of tongue carcinomas.
    Head Neck. 2020 Dec 24. doi: 10.1002/hed.26585.
    PubMed     Abstract available


  171. KISHIKAWA T, Suzuki M, Takemoto N, Fukusumi T, et al
    Response Evaluation Criteria in Solid Tumors (RECIST) and PET Response Criteria in Solid Tumors (PERCIST) for response evaluation of the neck after chemoradiotherapy in head and neck squamous cell carcinoma.
    Head Neck. 2020 Dec 23. doi: 10.1002/hed.26583.
    PubMed     Abstract available


  172. GARCIA-ANAYA MJ, Ordonez R, Toledo MD, Correa RC, et al
    Importance of dose in palliative treatment for incurable head and neck cancer with radiotherapy.
    Head Neck. 2020 Dec 15. doi: 10.1002/hed.26555.
    PubMed     Abstract available


  173. ANDERSON EM, Luu M, Balzer BL, Scher KS, et al
    Variations in the association of grade with survival across the head and neck cancer landscape.
    Head Neck. 2020 Dec 10. doi: 10.1002/hed.26566.
    PubMed     Abstract available


  174. CHEN G, Jiang H, Jiang D, Wu Q, et al
    Pretreatment serum vitamin level predicts severity of radiation-induced oral mucositis in patients with nasopharyngeal carcinoma.
    Head Neck. 2020 Dec 10. doi: 10.1002/hed.26576.
    PubMed     Abstract available


  175. SANDLER ML, Xing MH, Levy JC, Chai RL, et al
    Metastatic thyroid carcinoma to the parapharyngeal and retropharyngeal spaces: Systematic review with seven newly reported cases describing an uncommon presentation of a common disease.
    Head Neck. 2020 Dec 9. doi: 10.1002/hed.26572.
    PubMed     Abstract available


  176. CARNABY GD, Chhabria K
    Preliminary development and validation of a measure of fear of swallowing and swallowing-related movement injury in head and neck cancer: Swallowing Kinesiophobia Scale.
    Head Neck. 2020 Dec 2. doi: 10.1002/hed.26573.
    PubMed     Abstract available


  177. WORKMAN AD, Soylu S, Kamani D, Nourmahnad A, et al
    Limitations of preoperative cytology for medullary thyroid cancer: Proposal for improved preoperative diagnosis for optimal initial medullary thyroid carcinoma specific surgery.
    Head Neck. 2020 Dec 2. doi: 10.1002/hed.26550.
    PubMed     Abstract available


    November 2020
  178. YI X, Chen W, Li C, Chen X, et al
    Circular RNA circ_0004507 contributes to laryngeal cancer progression and cisplatin resistance by sponging miR-873 to upregulate multidrug resistance 1 and multidrug resistance protein 1.
    Head Neck. 2020 Nov 28. doi: 10.1002/hed.26549.
    PubMed     Abstract available


  179. ZHANG Z, Xia F, Wang W, Jiang B, et al
    Ambulatory thyroidectomy is safe and beneficial in papillary thyroid carcinoma: Randomized controlled trial.
    Head Neck. 2020 Nov 28. doi: 10.1002/hed.26557.
    PubMed     Abstract available


  180. RITTER A, Badir S, Mansour M, Segal Z, et al
    Solid organ transplantation worsens the prognosis of patients with cutaneous squamous cell carcinoma of the head and neck region-Comparison between solid organ transplant recipients and immunocompetent patients.
    Head Neck. 2020 Nov 27. doi: 10.1002/hed.26546.
    PubMed     Abstract available


  181. AKALI NR, Buggaveeti R, Sukumaran SV, Balasubramanian D, et al
    Prior chemoradiotherapy and pathological perineural invasion predict the survival outcomes of salvage surgery in head and neck squamous cell carcinoma.
    Head Neck. 2020 Nov 21. doi: 10.1002/hed.26547.
    PubMed     Abstract available


  182. JURICA JM, Rubio F, Hernandez DJ, Sandulache VC, et al
    Institutional financial toxicity of failure to adhere to treatment guidelines for head and neck squamous cell carcinoma.
    Head Neck. 2020 Nov 9. doi: 10.1002/hed.26539.
    PubMed     Abstract available


  183. CARRON J, Torricelli C, Silva JK, Queiroz GSR, et al
    microRNAs deregulation in head and neck squamous cell carcinoma.
    Head Neck. 2020 Nov 6. doi: 10.1002/hed.26533.
    PubMed     Abstract available


  184. ADEOYE J, Wan CCJ, Thomson P
    Mock clinical testing in the validation of fluid-phase biomarkers for head and neck carcinoma diagnosis: A Scoping review.
    Head Neck. 2020 Nov 5. doi: 10.1002/hed.26526.
    PubMed     Abstract available


  185. YUAN X, Zhang L, Huang Y, Liu D, et al
    Induction of interleukin-6 by irradiation and its role in epithelial mesenchymal transition and radioresistance of nasopharyngeal carcinoma cells.
    Head Neck. 2020 Nov 5. doi: 10.1002/hed.26531.
    PubMed     Abstract available


  186. HU CY, Wang WM, Chu XH, Ren ZH, et al
    Global, regional, and national burden of nasopharyngeal carcinoma from 1990 to 2017-Results from the Global Burden of Disease Study 2017.
    Head Neck. 2020;42:3243-3252.
    PubMed     Abstract available


  187. GEORGE A, Bagadia RK, Joshna BM, Subash A, et al
    Soft tissue deposits: Surrogate marker for distant metastasis?
    Head Neck. 2020;42:3465-3466.
    PubMed    


    October 2020
  188. MOSES LE, Oliver JR, Rotsides JM, Shao Q, et al
    Nodal disease burden and outcome of medullary thyroid carcinoma.
    Head Neck. 2020 Oct 27. doi: 10.1002/hed.26511.
    PubMed     Abstract available


  189. CAVALIERI S, De Cecco L, Brakenhoff RH, Serafini MS, et al
    Development of a multiomics database for personalized prognostic forecasting in head and neck cancer: The Big Data to Decide EU Project.
    Head Neck. 2020 Oct 27. doi: 10.1002/hed.26515.
    PubMed     Abstract available


  190. LIU W, Qdaisat A, Zhou S, Fuller CD, et al
    Hypomagnesemia and incidence of osteoradionecrosis in patients with head and neck cancers.
    Head Neck. 2020 Oct 23. doi: 10.1002/hed.26510.
    PubMed     Abstract available


  191. MULDER FJ, Pierssens DDCG, Baijens LWJ, Kremer B, et al
    Evidence for different molecular parameters in head and neck squamous cell carcinoma of nonsmokers and nondrinkers: Systematic review and meta-analysis on HPV, p16, and TP53.
    Head Neck. 2020 Oct 23. doi: 10.1002/hed.26513.
    PubMed     Abstract available


  192. MARGALIT DN, Sacco AG, Cooper JS, Ridge JA, et al
    Systematic review of postoperative therapy for resected squamous cell carcinoma of the head and neck: Executive summary of the American Radium Society appropriate use criteria.
    Head Neck. 2020 Oct 23. doi: 10.1002/hed.26490.
    PubMed     Abstract available


  193. KONO M, Wakisaka R, Kumai T, Hayashi R, et al
    Effects of early nutritional intervention by a nutritional support team for patients with head and neck cancer undergoing chemoradiotherapy or radiotherapy.
    Head Neck. 2020 Oct 5. doi: 10.1002/hed.26502.
    PubMed     Abstract available


  194. GADKAREE SK, McCarty JC, Feng AL, Siu JM, et al
    Role of physician density in predicting stage and survival for head and neck squamous cell carcinoma.
    Head Neck. 2020 Oct 4. doi: 10.1002/hed.26495.
    PubMed     Abstract available


  195. WANG Z, Yuan H, Huang J, Hu D, et al
    Prognostic value of immune-related genes and immune cell infiltration analysis in the tumor microenvironment of head and neck squamous cell carcinoma.
    Head Neck. 2020 Oct 3. doi: 10.1002/hed.26474.
    PubMed     Abstract available


  196. OKANO W, Hayashi R, Matsuura K, Shinozaki T, et al
    Extent of salvage neck dissection following chemoradiation for locally advanced head and neck cancer.
    Head Neck. 2020 Oct 1. doi: 10.1002/hed.26494.
    PubMed     Abstract available


  197. KARATAS OF, Capik O, Barlak N, Aydin Karatas E, et al
    Comprehensive in silico analysis for identification of novel candidate target genes, including DHX36, OPA1, and SENP2, located on chromosome 3q in head and neck cancers.
    Head Neck. 2020 Oct 1. doi: 10.1002/hed.26493.
    PubMed     Abstract available


  198. JEANS C, Ward EC, Brown B, Vertigan AE, et al
    Association between external and internal lymphedema and chronic dysphagia following head and neck cancer treatment.
    Head Neck. 2020 Oct 1. doi: 10.1002/hed.26484.
    PubMed     Abstract available


  199. SYKES KJ, Morrow E, Smith JB, Holcomb AJ, et al
    What is the hold up?-Mixed-methods analysis of postoperative radiotherapy delay in head and neck cancer.
    Head Neck. 2020;42:2948-2957.
    PubMed     Abstract available


    September 2020
  200. SVAJDOVA M, Dubinsky P, Kazda T
    Radical external beam re-irradiation in the treatment of recurrent head and neck cancer: Critical review.
    Head Neck. 2020 Sep 30. doi: 10.1002/hed.26485.
    PubMed     Abstract available


  201. BRENNAN MT, Treister NS, Sollecito TP, Schmidt BL, et al
    Epidemiologic factors in patients with advanced head and neck cancer treated with radiation therapy.
    Head Neck. 2020 Sep 29. doi: 10.1002/hed.26468.
    PubMed     Abstract available


  202. LEE DY, Abraham J, Ross E, Ridge JA, et al
    Rapid recurrence in head and neck cancer: Underappreciated problem with poor outcome.
    Head Neck. 2020 Sep 29. doi: 10.1002/hed.26479.
    PubMed     Abstract available


  203. LIU YP, Wang SL, Zou X, You R, et al
    Transcervical endoscopic retropharyngeal lymph node (RPLN) dissection in nasopharyngeal carcinoma with RPLN recurrence.
    Head Neck. 2020 Sep 28. doi: 10.1002/hed.26459.
    PubMed     Abstract available


  204. MHASKAR R, Caputo MP, Mifsud MJ
    Reply to Letter to the Editor regarding "Diabetes mellitus in major head and neck cancer surgery: Systematic review and meta-analysis".
    Head Neck. 2020 Sep 23. doi: 10.1002/hed.26446.
    PubMed    


  205. HUANG GJ, Kong XY
    Diabetes mellitus in major head and neck cancer surgery.
    Head Neck. 2020 Sep 23. doi: 10.1002/hed.26451.
    PubMed    


  206. KRIPLANI A, Lavery JA, Mishra A, Korenstein D, et al
    Trends in chronic opioid therapy among survivors of head and neck cancer.
    Head Neck. 2020 Sep 22. doi: 10.1002/hed.26478.
    PubMed     Abstract available


  207. LIAO AH, Lin WT, Chen HK, Shih CP, et al
    Synergistic effects of combined treatment with ultrasound-mediated cisplatin-loaded microbubbles and atorvastatin on head and neck cancer.
    Head Neck. 2020 Sep 21. doi: 10.1002/hed.26445.
    PubMed     Abstract available


  208. LUO Y, Ma J, Liu F, Guo J, et al
    Diagnostic value of exosomal circMYC in radioresistant nasopharyngeal carcinoma.
    Head Neck. 2020 Sep 18. doi: 10.1002/hed.26441.
    PubMed     Abstract available


  209. ZOLKIND P, Lee JJ, Jackson RS, Pipkorn P, et al
    Untreated head and neck cancer: Natural history and associated factors.
    Head Neck. 2020 Sep 11. doi: 10.1002/hed.26460.
    PubMed     Abstract available


  210. RIJO-CEDENO J, Mucientes J, Alvarez O, Royuela A, et al
    Metabolic tumor volume and total lesion glycolysis as prognostic factors in head and neck cancer: Systematic review and meta-analysis.
    Head Neck. 2020 Sep 11. doi: 10.1002/hed.26461.
    PubMed     Abstract available


  211. TAE K
    Reply to Letter to the Editor: Transoral robotic selective neck dissection for papillary thyroid carcinoma: Is it appropriate?
    Head Neck. 2020 Sep 5. doi: 10.1002/hed.26449.
    PubMed    


  212. PICCIN O, D'Alessio P, Cavicchi O
    Transoral robotic selective neck dissection for papillary thyroid carcinoma: Is it appropriate?
    Head Neck. 2020 Sep 5. doi: 10.1002/hed.26447.
    PubMed    


  213. HUANG GJ, Yang BB
    Identification of genes associated with cancer stem cell characteristics in head and neck squamous cell carcinoma.
    Head Neck. 2020 Sep 1. doi: 10.1002/hed.26388.
    PubMed    


  214. ZHU X
    Reply to Letter to the Editor regarding "Identification of genes associated with cancer stem cell characteristics in head and neck squamous cell carcinoma through co-expression network analysis".
    Head Neck. 2020 Sep 1. doi: 10.1002/hed.26390.
    PubMed    


  215. PANUGANTI A, Kaul P, Singh MP, Garg PK, et al
    Patient participation in decision making-undisputed fact.
    Head Neck. 2020;42:2242-2243.
    PubMed    


  216. BAGADIA RK, Kudpaje AS, Rao VUS
    From compartmental to anatomically based circumferential resection-Is the reversal of trend justified?
    Head Neck. 2020;42:2764-2765.
    PubMed    


  217. CALABRESE L, Pietrobon G, Fazio E, Accorona R, et al
    Reply to "From compartmental to anatomically-based circumferential resection-Is the trend reversal of justified?"
    Head Neck. 2020;42:2766-2767.
    PubMed    


    August 2020
  218. LOPEZ EM, Tanner AM, Du E, Patel SN, et al
    Decline in circulating viral and human tumor markers after resection of head and neck carcinoma.
    Head Neck. 2020 Aug 28. doi: 10.1002/hed.26444.
    PubMed     Abstract available


  219. SU L, Lin Q, Li R, Hua Y, et al
    Prognostic value of nutritional impairment on treatment-related toxicity and survival in patients with nasopharyngeal carcinoma taking normal nutrition before radiotherapy.
    Head Neck. 2020 Aug 27. doi: 10.1002/hed.26426.
    PubMed     Abstract available


  220. CRAWFORD KL, Jafari A, Qualliotine JR, Stuart E, et al
    Elective neck dissection for T3/T4 cN0 sinonasal squamous cell carcinoma.
    Head Neck. 2020 Aug 24. doi: 10.1002/hed.26418.
    PubMed     Abstract available


  221. ZHI-JUN X, Yue-Xiao L, Bo-Yu G, Ya-Tin J, et al
    Are contralateral submental artery perforator flaps feasible for the reconstruction of postoperative defects of oral cancer?
    Head Neck. 2020 Aug 22. doi: 10.1002/hed.26422.
    PubMed     Abstract available


  222. DOUGLAS CM, Jethwa AR, Hasan W, Liu A, et al
    Long-term survival of head and neck squamous cell carcinoma after bone marrow transplant.
    Head Neck. 2020 Aug 21. doi: 10.1002/hed.26402.
    PubMed     Abstract available


  223. STANISZ I, Janik S, Grasl MC, Erovic BM, et al
    Panendoscopy during follow-up in laryngeal carcinoma patients after radiotherapy.
    Head Neck. 2020 Aug 21. doi: 10.1002/hed.26433.
    PubMed     Abstract available


  224. ARBAB M, Chen YH, Criscitiello S, Glass J, et al
    Patient reported outcomes in patients with head and neck cancer treated with concurrent chemoradiation with weekly versus bolus cisplatin.
    Head Neck. 2020 Aug 19. doi: 10.1002/hed.26432.
    PubMed     Abstract available


  225. MALIK A, Nair S
    Reply to Letter to the Editor regarding "Soft tissue deposits in oral cancers".
    Head Neck. 2020 Aug 13. doi: 10.1002/hed.26412.
    PubMed    


  226. NABUURS CH, Kievit W, Labbe N, Leemans CR, et al
    Evaluation of the modified Pittsburgh classification for predicting the disease-free survival outcome of squamous cell carcinoma of the external auditory canal.
    Head Neck. 2020 Aug 13. doi: 10.1002/hed.26424.
    PubMed     Abstract available


  227. SMITH DK, Cmelak A, Niermann K, Ghiam M, et al
    Preventive use of gabapentin to decrease pain and systemic symptoms in patients with head and neck cancer undergoing chemoradiation.
    Head Neck. 2020 Aug 7. doi: 10.1002/hed.26407.
    PubMed     Abstract available


  228. URABE M, Ueno M, Udagawa H
    Incidental identification of cervical nodal metastases from papillary thyroid carcinoma: Experiences related to esophageal cancer surgery.
    Head Neck. 2020 Aug 6. doi: 10.1002/hed.26392.
    PubMed    


  229. SHAH J
    Reply to the Letter to the Editor regarding "Significance and management of incidentally diagnosed metastatic papillary thyroid carcinoma in cervical lymph nodes in neck dissection specimens".
    Head Neck. 2020 Aug 6. doi: 10.1002/hed.26391.
    PubMed    


  230. DU C, Tao Y
    Response to comments HN-20-1003 "Induction chemotherapy followed by radiotherapy for N3 head and neck squamous cell carcinoma: useful treatment option with a caveat".
    Head Neck. 2020 Aug 6. doi: 10.1002/hed.26408.
    PubMed    


  231. CHAKRABORTY A, Thiagarajan S
    Induction chemotherapy followed by radiotherapy for N3 head and neck squamous cell carcinoma-Useful treatment option with a caveat.
    Head Neck. 2020 Aug 6. doi: 10.1002/hed.26413.
    PubMed    


  232. KRAFT S, Gadkaree SK, Deschler DG, Lin DT, et al
    Programmed cell death ligand-1 and cytotoxic T cell infiltrates in metastatic cutaneous squamous cell carcinoma of the head and neck.
    Head Neck. 2020 Aug 1. doi: 10.1002/hed.26370.
    PubMed     Abstract available


  233. BONOMO P, Talamonti C, Caini S
    Reply to Yamazaki et al (HED-19-525.R1).
    Head Neck. 2020;42:2219-2220.
    PubMed    


  234. YAMAZAKI H, Suzuki G, Takenaka T, Yoshida K, et al
    Is there clinical meaningful threshold in dose volume analysis between grade 0-2 and 3-4 radiation dermatitis?
    Head Neck. 2020;42:2217-2218.
    PubMed    


  235. SABOUR S
    Cytology in parotid Warthin's tumors: Methodological issues on diagnostic value to avoid misinterpretation.
    Head Neck. 2020;42:2213-2214.
    PubMed    


  236. BORSETTO D, Fussey JM, Cazzador D, Smith J, et al
    The diagnostic value of cytology in parotid Warthin's tumors: International multicenter series.
    Head Neck. 2020;42:2215-2216.
    PubMed    


    July 2020
  237. JEANS C, Brown B, Ward EC, Vertigan AE, et al
    Comparing the prevalence, location, and severity of head and neck lymphedema after postoperative radiotherapy for oral cavity cancers and definitive chemoradiotherapy for oropharyngeal, laryngeal, and hypopharyngeal cancers.
    Head Neck. 2020 Jul 31. doi: 10.1002/hed.26394.
    PubMed     Abstract available


  238. KARAN N, Siddiqui S, Sharma KS, Pantvaidya GH, et al
    Evaluation and validation of Physiological and Operative Severity Score for the enumeration of mortality and morbidity and Portsmouth-POSSUM scores in predicting morbidity and mortality in patients undergoing head and neck cancer surgeries.
    Head Neck. 2020 Jul 27. doi: 10.1002/hed.26354.
    PubMed     Abstract available


  239. GOGINENI E, Rana Z, Vempati P, Karten J, et al
    Stereotactic body radiotherapy as primary treatment for elderly and medically inoperable patients with head and neck cancer.
    Head Neck. 2020 Jul 21. doi: 10.1002/hed.26342.
    PubMed     Abstract available


  240. DEUTSCH FT, Khoury SJ, Sunwoo JB, Elliott MS, et al
    Application of salivary noncoding microRNAs for the diagnosis of oral cancers.
    Head Neck. 2020 Jul 20. doi: 10.1002/hed.26348.
    PubMed     Abstract available


  241. LINDEGAARD AM, von Buchwald C, Rasmussen JH, Specht L, et al
    Outcome in patients with isolated regional recurrence after primary radiotherapy for head and neck cancer.
    Head Neck. 2020 Jul 18. doi: 10.1002/hed.26361.
    PubMed     Abstract available


  242. UEKI Y, Takahashi T, Ota H, Shodo R, et al
    Role of programmed death-ligand 1 in predicting the treatment outcome of salvage chemotherapy after nivolumab in recurrent/metastatic head and neck squamous cell carcinoma.
    Head Neck. 2020 Jul 16. doi: 10.1002/hed.26374.
    PubMed     Abstract available


  243. DAGAN O, Moore A, Nachlon Y, Alkan U, et al
    Induction chemotherapy for locally advanced laryngeal and hypopharyngeal cancer: Single institution experience.
    Head Neck. 2020 Jul 16. doi: 10.1002/hed.26353.
    PubMed     Abstract available


  244. CAPUTO MP, Shabani S, Mhaskar R, McMullen C, et al
    Diabetes mellitus in major head and neck cancer surgery: Systematic review and meta-analysis.
    Head Neck. 2020 Jul 11. doi: 10.1002/hed.26349.
    PubMed     Abstract available


  245. LE ROUX MK, Graillon N, Guyot L, Taieb D, et al
    Salivary side effects after radioiodine treatment for differentiated papillary thyroid carcinoma: Long-term study.
    Head Neck. 2020 Jul 11. doi: 10.1002/hed.26359.
    PubMed     Abstract available


  246. TAE K, Kim KH
    Transoral robotic selective neck dissection for papillary thyroid carcinoma: Dissection of Levels III and IV.
    Head Neck. 2020 Jul 7. doi: 10.1002/hed.26379.
    PubMed     Abstract available


  247. HOLMES BJ, von Eyben R, Attardi LD, Kong CS, et al
    Pilot study of loss of the p53/p63 target gene PERP at the surgical margin as a potential predictor of local relapse in head and neck squamous cell carcinoma.
    Head Neck. 2020 Jul 7. doi: 10.1002/hed.26358.
    PubMed     Abstract available


  248. MUSORO JZ, Coens C, Singer S, Tribius S, et al
    Minimally important differences for interpreting European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 scores in patients with head and neck cancer.
    Head Neck. 2020 Jul 6. doi: 10.1002/hed.26363.
    PubMed     Abstract available


  249. FARQUHAR DR, Lenze NR, Masood MM, Divaris K, et al
    Access to preventive care services and stage at diagnosis in head and neck cancer.
    Head Neck. 2020 Jul 3. doi: 10.1002/hed.26326.
    PubMed     Abstract available


  250. LANDIN D, Ahrlund-Richter A, Mirzaie L, Mints M, et al
    Immune related proteins and tumor infiltrating CD8+ lymphocytes in hypopharyngeal cancer in relation to human papillomavirus (HPV) and clinical outcome.
    Head Neck. 2020 Jul 1. doi: 10.1002/hed.26364.
    PubMed     Abstract available


  251. GORDIN EA, Day A, Stankova L, Heitman E, et al
    Care in the time of coronavirus: Ethical considerations in head and neck oncology.
    Head Neck. 2020;42:1519-1525.
    PubMed     Abstract available


  252. GALLO O, Locatello LG
    Laser-assisted head and neck surgery in the COVID-19 pandemic: Controversial evidence and precautions.
    Head Neck. 2020;42:1533-1534.
    PubMed    


  253. MORRISON DR, Gentile C, McCammon S, Buczek E, et al
    Head and neck oncologic surgery in the COVID-19 pandemic: Our experience in a deep south tertiary care center.
    Head Neck. 2020;42:1471-1476.
    PubMed     Abstract available


  254. SHANTI RM, Stoopler ET, Weinstein GS, Newman JG, et al
    Considerations in the evaluation and management of oral potentially malignant disorders during the COVID-19 pandemic.
    Head Neck. 2020;42:1497-1502.
    PubMed     Abstract available


  255. TURRI-ZANONI M, Battaglia P, Karligkiotis A, Locatelli D, et al
    Managing care for patients with sinonasal and anterior skull base cancers during the COVID-19 pandemic.
    Head Neck. 2020;42:1503-1506.
    PubMed     Abstract available


  256. GIVI B, Moore MG, Bewley AF, Coffey CS, et al
    Advanced head and neck surgery training during the COVID-19 pandemic.
    Head Neck. 2020;42:1411-1417.
    PubMed     Abstract available


  257. HUANG VW, Imam SA, Nguyen SA
    Head and neck survivorship care in the times of the SARS-CoV-2 pandemic.
    Head Neck. 2020;42:1664-1667.
    PubMed     Abstract available


  258. BRODY RM, Albergotti WG, Shimunov D, Nicolli E, et al
    Changes in head and neck oncologic practice during the COVID-19 pandemic.
    Head Neck. 2020;42:1448-1453.
    PubMed     Abstract available


    June 2020
  259. FERRANDINO RM, Roof S, Garneau J, Haidar Y, et al
    Neutrophil-to-lymphocyte ratio as a prognostic indicator for overall and cancer-specific survival in squamous cell carcinoma of the head and neck.
    Head Neck. 2020 Jun 27. doi: 10.1002/hed.26329.
    PubMed     Abstract available


  260. LEON X, Neumann E, Gutierrez A, Garcia J, et al
    Weighted lymph node ratio: New tool in the assessment of postoperative staging of the neck dissection in HPV-negative head and neck squamous cell carcinoma patients.
    Head Neck. 2020 Jun 26. doi: 10.1002/hed.26340.
    PubMed     Abstract available


  261. WEINSTEIN GS, Cohen R, Lin A, O'Malley BW Jr, et al
    Penn Medicine Head and Neck Cancer Service Line COVID-19 management guidelines.
    Head Neck. 2020 Jun 25. doi: 10.1002/hed.26318.
    PubMed     Abstract available


  262. YEN CJ, Kiyota N, Hanai N, Takahashi S, et al
    Two-year follow-up of a randomized phase III clinical trial of nivolumab vs. the investigator's choice of therapy in the Asian population for recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141).
    Head Neck. 2020 Jun 24. doi: 10.1002/hed.26331.
    PubMed     Abstract available


  263. HOLCOMB AJ, Perryman M, Goodwin S, Penn J, et al
    Pathology protocol increases lymph node yield in neck dissection for oral cavity squamous cell carcinoma.
    Head Neck. 2020 Jun 24. doi: 10.1002/hed.26343.
    PubMed     Abstract available


  264. GRABOYES E, Cramer J, Balakrishnan K, Cognetti DM, et al
    COVID-19 pandemic and health care disparities in head and neck cancer: Scanning the horizon.
    Head Neck. 2020 Jun 20. doi: 10.1002/hed.26345.
    PubMed     Abstract available


  265. OH J, Liu A, Tran E, Berthelet E, et al
    Association between nutritional risk index and outcomes for head and neck cancer patients receiving concurrent chemo-radiotherapy.
    Head Neck. 2020 Jun 20. doi: 10.1002/hed.26315.
    PubMed     Abstract available


  266. VAN DER GEER SJ, van Rijn PV, Roodenburg JLN, Dijkstra PU, et al
    Prognostic factors associated with a restricted mouth opening (trismus) in patients with head and neck cancer: Systematic review.
    Head Neck. 2020 Jun 18. doi: 10.1002/hed.26327.
    PubMed     Abstract available


  267. ALTERIO D, Volpe S, Marvaso G, Turturici I, et al
    Head and neck cancer radiotherapy amid COVID-19 pandemic: Report from Milan, Italy.
    Head Neck. 2020 Jun 18. doi: 10.1002/hed.26319.
    PubMed     Abstract available



  268. Corrigendum to "Evaluation of oncologic outcomes in head and neck cancer patients > 80 years old based on adherence to NCCN guideline for postoperative adjuvant treatment" [Head and Neck, 2019:41(12):4128-4135].
    Head Neck. 2020 Jun 17. doi: 10.1002/hed.26309.
    PubMed    


  269. CHOI Y, Ahn KJ, Jang J, Shin NY, et al
    Prognostic value of computed tomography-based volumetric body composition analysis in patients with head and neck cancer: Feasibility study.
    Head Neck. 2020 Jun 16. doi: 10.1002/hed.26310.
    PubMed     Abstract available


  270. PANNU JS, Simpson MC, Donovan CL, Adjei Boakye E, et al
    Sociodemographic correlates of head and neck cancer survival among patients with metastatic disease.
    Head Neck. 2020 Jun 16. doi: 10.1002/hed.26284.
    PubMed     Abstract available


  271. HALL JA, Rusten M, Abughazaleh RD, Wuertz B, et al
    Effects of PPAR-gamma agonists on oral cancer cell lines: Potential horizons for chemopreventives and adjunctive therapies.
    Head Neck. 2020 Jun 9. doi: 10.1002/hed.26286.
    PubMed     Abstract available


  272. KEJNER AE, Li H, Li EY, Porterfield JZ, et al
    Reply to Letter to the Editor regarding "Treatment modality and outcomes in larynx cancer patients: A sex-based evaluation".
    Head Neck. 2020 Jun 8. doi: 10.1002/hed.26156.
    PubMed    


  273. HUANG GJ, Huang ZH
    Treatment modality and outcomes in larynx cancer patients.
    Head Neck. 2020 Jun 8. doi: 10.1002/hed.26157.
    PubMed    


  274. YAN F, Byun YJ, Nguyen SA, Stalcup ST, et al
    Predictive value of computed tomography in identifying extranodal extension in human papillomavirus-positive versus human papillomavirus-negative head and neck cancer.
    Head Neck. 2020 Jun 2. doi: 10.1002/hed.26281.
    PubMed     Abstract available


  275. KAWASHITA Y, Morimoto S, Tashiro K, Soutome S, et al
    Risk factors associated with the development of aspiration pneumonia in patients receiving radiotherapy for head and neck cancer: retrospective study.
    Head Neck. 2020 Jun 1. doi: 10.1002/hed.26314.
    PubMed     Abstract available


  276. FRIED J, Etter JL, Stenzel AE, Joseph JM, et al
    Physical inactivity and head and neck cancer mortality.
    Head Neck. 2020 Jun 1. doi: 10.1002/hed.26283.
    PubMed     Abstract available


  277. DAY AT, Dahlstrom KR, Lee R, Karam-Hage M, et al
    Impact of a tobacco treatment program on abstinence and survival rates among current smokers with head and neck squamous cell carcinoma.
    Head Neck. 2020 Jun 1. doi: 10.1002/hed.26268.
    PubMed     Abstract available


  278. GALLI J, Settimi S, Tricarico L, Almadori G, et al
    Clinical and surgical management of patients with head and neck cancer in a COVID-19 dedicated center in Italy.
    Head Neck. 2020 Jun 1. doi: 10.1002/hed.26263.
    PubMed     Abstract available


  279. KIONG KL, Guo T, Yao CMKL, Gross ND, et al
    Changing practice patterns in head and neck oncologic surgery in the early COVID-19 era.
    Head Neck. 2020;42:1179-1186.
    PubMed     Abstract available


  280. QUALLIOTINE JR, Orosco RK
    Self-removing passive drain to facilitate postoperative care via telehealth during the COVID-19 pandemic.
    Head Neck. 2020;42:1305-1307.
    PubMed     Abstract available


  281. MANIAKAS A, Jozaghi Y, Zafereo ME, Sturgis EM, et al
    Head and neck surgical oncology in the time of a pandemic: Subsite-specific triage guidelines during the COVID-19 pandemic.
    Head Neck. 2020;42:1194-1201.
    PubMed     Abstract available


  282. WU V, Noel CW, Forner D, Zhang ZJ, et al
    Considerations for head and neck oncology practices during the coronavirus disease 2019 (COVID-19) pandemic: Wuhan and Toronto experience.
    Head Neck. 2020;42:1202-1208.
    PubMed     Abstract available


  283. SINGH AG, Chaturvedi P
    Tobacco use and vaping in the COVID-19 era.
    Head Neck. 2020;42:1240-1242.
    PubMed     Abstract available


  284. RANASINGHE V, Mady LJ, Kim S, Ferris RL, et al
    Major head and neck reconstruction during the COVID-19 pandemic: The University of Pittsburgh approach.
    Head Neck. 2020;42:1243-1247.
    PubMed     Abstract available


  285. SHAH JP
    The impact of COVID-19 on Head and Neck surgery, education, and training.
    Head Neck. 2020;42:1344-1347.
    PubMed    


  286. BADDOUR K, Kudrick LD, Neopaney A, Sabik LM, et al
    Potential impact of the COVID-19 pandemic on financial toxicity in cancer survivors.
    Head Neck. 2020;42:1332-1338.
    PubMed     Abstract available


  287. PATEL RJ, Kejner A, McMullen C
    Early institutional head and neck oncologic and microvascular surgery practice patterns across the United States during the SARS-CoV-2 (COVID19) pandemic.
    Head Neck. 2020;42:1168-1172.
    PubMed     Abstract available


  288. TOPF MC, Shenson JA, Holsinger FC, Wald SH, et al
    Framework for prioritizing head and neck surgery during the COVID-19 pandemic.
    Head Neck. 2020;42:1159-1167.
    PubMed     Abstract available


  289. PRASAD A, Carey RM, Rajasekaran K
    Head and neck virtual medicine in a pandemic era: Lessons from COVID-19.
    Head Neck. 2020;42:1308-1309.
    PubMed     Abstract available


  290. CAI YC, Wang W, Li C, Zeng DF, et al
    Treating head and neck tumors during the SARS-CoV-2 epidemic, 2019 to 2020: Sichuan Cancer Hospital.
    Head Neck. 2020;42:1153-1158.
    PubMed     Abstract available


    May 2020
  291. MROUEH R, Tanskanen T, Haapaniemi A, Salo T, et al
    Familial cancer risk in family members and spouses of patients with early-onset head and neck cancer.
    Head Neck. 2020 May 30. doi: 10.1002/hed.26282.
    PubMed     Abstract available


  292. YAN F, Rauscher E, Hollinger A, Caputo MA, et al
    The role of head and neck cancer advocacy organizations during the COVID-19 pandemic.
    Head Neck. 2020 May 29. doi: 10.1002/hed.26287.
    PubMed     Abstract available


  293. PEI S, Chen L, Yang Y, Zhu X, et al
    Identification of genes associated with cancer stem cell characteristics in head and neck squamous cell carcinoma through co-expression network analysis.
    Head Neck. 2020 May 27. doi: 10.1002/hed.26266.
    PubMed     Abstract available


  294. PAGEDAR NA, Kendell N, Christensen AJ, Thomsen TA, et al
    Head and neck cancer survivorship from the patient perspective.
    Head Neck. 2020 May 23. doi: 10.1002/hed.26265.
    PubMed     Abstract available


  295. FOKI E, Gangl K, Kranebitter V, Niederberger-Leppin V, et al
    Early effects of cigarette smoke extract on human oral keratinocytes and carcinogenesis in head and neck squamous cell carcinoma.
    Head Neck. 2020 May 21. doi: 10.1002/hed.26247.
    PubMed     Abstract available


  296. LEE J, Shin IS, Kim WC, Yoon WS, et al
    Reirradiation with intensity-modulated radiation therapy for recurrent or secondary head and neck cancer: Meta-analysis and systematic review.
    Head Neck. 2020 May 21. doi: 10.1002/hed.26264.
    PubMed     Abstract available


  297. NILSEN ML, Clump DA 2nd, Kubik M, Losego K, et al
    Prevision of multidisciplinary head and neck cancer survivorship care during the 2019 novel coronavirus pandemic.
    Head Neck. 2020 May 18. doi: 10.1002/hed.26256.
    PubMed     Abstract available


  298. VERMA N, Patel S, Osborn V, McBride S, et al
    Prognostic significance of human papillomavirus and Epstein-Bar virus in nasopharyngeal carcinoma.
    Head Neck. 2020 May 16. doi: 10.1002/hed.26245.
    PubMed     Abstract available


  299. BOWMAN R, Crosby DL, Sharma A
    Surge after the surge: Anticipating the increased volume and needs of patients with head and neck cancer after the peak in COVID-19.
    Head Neck. 2020 May 16. doi: 10.1002/hed.26260.
    PubMed     Abstract available


  300. QIN T, Koneva LA, Liu Y, Zhang Y, et al
    Significant association between host transcriptome-derived HPV oncogene E6* influence score and carcinogenic pathways, tumor size, and survival in head and neck cancer.
    Head Neck. 2020 May 14. doi: 10.1002/hed.26244.
    PubMed     Abstract available


  301. CHANG CF, Ei-Sayed IH, George JR, Heaton CM, et al
    Modified technique of submandibular gland transfer followed by intensity modulated radiotherapy to reduce xerostomia in head and neck cancer patients.
    Head Neck. 2020 May 13. doi: 10.1002/hed.26249.
    PubMed     Abstract available


  302. PALERI V, Hardman J, Tikka T, Bradley P, et al
    Rapid implementation of an evidence-based remote triaging system for assessment of suspected head and neck cancer referrals and patients on follow up after treatment during the COVID-19 pandemic: A model for international collaboration.
    Head Neck. 2020 May 6. doi: 10.1002/hed.26219.
    PubMed     Abstract available


  303. KIM DH, Kim Y, Kim SW, Hwang SH, et al
    Use of narrowband imaging for the diagnosis and screening of laryngeal cancer: A systematic review and meta-analysis.
    Head Neck. 2020 May 4. doi: 10.1002/hed.26186.
    PubMed     Abstract available


  304. CIVANTOS FJ, Leibowitz JM, Arnold DJ, Stubbs VC, et al
    Ethical Surgical Triage of Head and Neck Cancer Patients during the COVID-19 Pandemic.
    Head Neck. 2020 May 1. doi: 10.1002/hed.26229.
    PubMed     Abstract available


  305. GUPTA A, Arora V, Nair D, Agrawal N, et al
    Status and strategies for the management of head and neck cancer during COVID-19 pandemic: Indian Scenario.
    Head Neck. 2020 May 1. doi: 10.1002/hed.26227.
    PubMed     Abstract available


  306. LEE AK, FRCSEd RHC, FRCSEd EHL, Cheng HK, et al
    Mitigation of Head and Neck Cancer Service Disruption During COVID-19 in Hong Kong Through Telehealth and Multi-institution Collaboration.
    Head Neck. 2020 May 1. doi: 10.1002/hed.26226.
    PubMed     Abstract available


    April 2020
  307. MASSA ST, Pipkorn P, Jackson RS, Zevallos JP, et al
    Access to a regular medical provider among head and neck cancer survivors.
    Head Neck. 2020 Apr 30. doi: 10.1002/hed.26182.
    PubMed     Abstract available


  308. KU PK, Holsinger FC, Chan JY, Yeung ZC, et al
    Management of Dysphagia in The Head and Neck Cancer Patient during COVID-19 Pandemic: A Practical Strategy.
    Head Neck. 2020 Apr 29. doi: 10.1002/hed.26224.
    PubMed     Abstract available


  309. PRASAD A, Brewster R, Newman JG, Rajasekaran K, et al
    Optimizing your telemedicine visit during the COVID-19 pandemic: Practice guidelines for patients with head and neck cancer.
    Head Neck. 2020 Apr 28. doi: 10.1002/hed.26197.
    PubMed     Abstract available


  310. SHARMA A, Crosby DL
    Special considerations for elderly patients with head and neck cancer during the COVID-19 pandemic.
    Head Neck. 2020 Apr 28. doi: 10.1002/hed.26216.
    PubMed     Abstract available


  311. SILVERMAN DA, Lin C, Tamaki A, Puram SV, et al
    Respiratory and pulmonary complications in head and neck cancer patients: Evidence-based review for the COVID-19 era.
    Head Neck. 2020 Apr 28. doi: 10.1002/hed.26217.
    PubMed     Abstract available


  312. CHOW VLY, Chan JYW, Ho VWY, Lee GCC, et al
    Conservation of personal protective equipment for head and neck cancer surgery during COVID-19 pandemic.
    Head Neck. 2020 Apr 28. doi: 10.1002/hed.26215.
    PubMed     Abstract available


  313. SINGH AG, Deodhar J, Chaturvedi P
    Navigating the impact of COVID-19 on palliative care for head and neck cancer.
    Head Neck. 2020 Apr 27. doi: 10.1002/hed.26211.
    PubMed     Abstract available


  314. YAN F, Nguyen SA
    Head and neck cancer: A high-risk population for COVID-19.
    Head Neck. 2020 Apr 27. doi: 10.1002/hed.26209.
    PubMed    


  315. NOEL CW, Stephens RF, Su JS, Xu W, et al
    Mapping the EORTC QLQ-C30 and QLQ-H&N35, onto EQ-5D-5L and HUI-3 indices in patients with head and neck cancer.
    Head Neck. 2020 Apr 25. doi: 10.1002/hed.26181.
    PubMed     Abstract available


  316. BHATTACHARJEE A, Patil VM, Dikshit R, Prabhash K, et al
    Should we wait or not? The preferable option for patients with stage IV oral cancer in COVID-19 pandemic.
    Head Neck. 2020 Apr 24. doi: 10.1002/hed.26196.
    PubMed     Abstract available


  317. SHUMAN AG, Campbell BH
    An Ethical Framework for Head and Neck Cancer Care Impacted by COVID-19.
    Head Neck. 2020 Apr 24. doi: 10.1002/hed.26193.
    PubMed     Abstract available


  318. WANG L, Cao J, Wang X, Lin E, et al
    Proton and photon radiosensitization effects of niraparib, a PARP-1/-2 inhibitor, on human head and neck cancer cells.
    Head Neck. 2020 Apr 23. doi: 10.1002/hed.26155.
    PubMed     Abstract available


  319. DAI LB, Yu Q, Zhou SH, Bao YY, et al
    Effect of combination of curcumin and GLUT-1 AS-ODN on radiosensitivity of laryngeal carcinoma through regulating autophagy.
    Head Neck. 2020 Apr 21. doi: 10.1002/hed.26180.
    PubMed     Abstract available


  320. KLIGERMAN MP, Vukkadala N, Tsang RKY, Sunwoo JB, et al
    Managing the Head and Neck Cancer Patient with Tracheostomy or Laryngectomy During the COVID-19 Pandemic.
    Head Neck. 2020 Apr 16. doi: 10.1002/hed.26171.
    PubMed    


  321. BOAKYE EA, Jenkins W, Sharma A
    Disproportionate impact of COVID-19 Pandemic on Head and Neck Cancer Survivors.
    Head Neck. 2020 Apr 16. doi: 10.1002/hed.26170.
    PubMed    


  322. CIVANTOS AM, Carey RM, Lichtenstein GR, Lukens JN, et al
    Care of Immunocompromised Patients with Head and Neck Cancer During the COVID-19 Pandemic: Two Challenging and Informative Clinical Cases.
    Head Neck. 2020 Apr 16. doi: 10.1002/hed.26165.
    PubMed     Abstract available


  323. RASSEKH CH, Jenks CM, Ochroch EA, Douglas JE, et al
    Management of the difficult airway in the COVID-19 pandemic: Illustrative complex head and neck cancer scenario.
    Head Neck. 2020 Apr 16. doi: 10.1002/hed.26175.
    PubMed     Abstract available


  324. LEE MY, Allen CT
    Mechanisms of resistance to T cell-based immunotherapy in head and neck cancer.
    Head Neck. 2020 Apr 10. doi: 10.1002/hed.26158.
    PubMed     Abstract available


    March 2020
  325. VENGALOOR THOMAS T, Packianathan S, Bhanat E, Albert A, et al
    Oligometastatic head and neck cancer: Comprehensive review.
    Head Neck. 2020 Mar 27. doi: 10.1002/hed.26144.
    PubMed     Abstract available


  326. FRANZ L, Tealdo G, Contro G, Bandolin L, et al
    Biological tumor markers (maspin, CD105, nm23-H1) and disease relapse in laryngeal cancer: cluster analysis.
    Head Neck. 2020 Mar 25. doi: 10.1002/hed.26152.
    PubMed     Abstract available


  327. PARK D, Kim HY, Kim HK, You JY, et al
    Institutional experience of 200 consecutive papillary thyroid carcinoma patients in transoral robotic thyroidectomy surgeries.
    Head Neck. 2020 Mar 25. doi: 10.1002/hed.26149.
    PubMed     Abstract available


  328. HE Y, Zhao Z, Wang Y, Chai J, et al
    Optimizing number of cycles of induction chemotherapy for patients with nasopharyngeal carcinoma: Retrospective survival analysis.
    Head Neck. 2020 Mar 23. doi: 10.1002/hed.26141.
    PubMed     Abstract available


  329. HUANG T, Su N, Zhang X, Ma S, et al
    Systemic chemotherapy and sequential locoregional radiotherapy in initially metastatic nasopharyngeal carcinoma: Retrospective analysis with 821 cases.
    Head Neck. 2020 Mar 10. doi: 10.1002/hed.26130.
    PubMed     Abstract available


  330. MEHRA R, Huang H, Seal B, Tse J, et al
    Real-world treatment patterns for patients with metastatic head and neck squamous cell carcinoma treated with immuno-oncology therapy.
    Head Neck. 2020 Mar 9. doi: 10.1002/hed.26126.
    PubMed     Abstract available


  331. PASALIC D, Betancourt-Cuellar SL, Taku N, Ludmir EB, et al
    Outcomes and toxicities following stereotactic ablative radiotherapy for pulmonary metastases in patients with primary head and neck cancer.
    Head Neck. 2020 Mar 4. doi: 10.1002/hed.26117.
    PubMed     Abstract available


  332. JACOMINA LE, Jacinto JKM, Co LBA, Yu KKL, et al
    The Role of postoperative external beam radiotherapy for differentiated thyroid carcinoma: A Systematic review and meta-analysis.
    Head Neck. 2020 Mar 4. doi: 10.1002/hed.26133.
    PubMed     Abstract available


  333. TSUKUURA R, Kageyama T, Sakai H, Fuse Y, et al
    Possible risk of iatrogenic lymphedema after harvest of posterior tibial artery perforator flap.
    Head Neck. 2020;42:585.
    PubMed    


    February 2020
  334. TOWNES TG, Navuluri S, Pytynia KB, Gunn GB, et al
    Assessing patient-reported symptom burden of long-term head and neck cancer survivors at annual surveillance in survivorship clinic.
    Head Neck. 2020 Feb 29. doi: 10.1002/hed.26119.
    PubMed     Abstract available


  335. KARSTEN RT, van der Molen L, Hamming-Vrieze O, van Son RJJH, et al
    Long-term swallowing, trismus, and speech outcomes after combined chemoradiotherapy and preventive rehabilitation for head and neck cancer; 10-year plus update.
    Head Neck. 2020 Feb 29. doi: 10.1002/hed.26120.
    PubMed     Abstract available


  336. LOFHEDE H, Wertsen M, Havstam C
    Palatal augmentation prostheses in individuals treated for head and neck cancer: Effects on speech and oral transport.
    Head Neck. 2020 Feb 27. doi: 10.1002/hed.26124.
    PubMed     Abstract available


  337. THIBOUW F, Duvillard C, Thibouw D, Bertaut A, et al
    Evaluation of the quality of the information received during head and neck cancer announcement: Prospective two-center study.
    Head Neck. 2020 Feb 24. doi: 10.1002/hed.26109.
    PubMed     Abstract available


  338. WAN Y, Liu H, Zhang M, Huang Z, et al
    Prognostic value of epithelial-mesenchymal transition-inducing transcription factors in head and neck squamous cell carcinoma: A meta-analysis.
    Head Neck. 2020 Feb 12. doi: 10.1002/hed.26104.
    PubMed     Abstract available


  339. TEXAKALIDIS P, Giannopoulos S, Tsouknidas I, Song S, et al
    Prevalence of carotid stenosis following radiotherapy for head and neck cancer: A systematic review and meta-analysis.
    Head Neck. 2020 Feb 12. doi: 10.1002/hed.26102.
    PubMed     Abstract available


  340. MALIK A, Nair S, Singh A, Lamba K, et al
    Soft tissue deposit in neck dissection specimen carries a poor prognosis in oral cancer: A matched pair analysis.
    Head Neck. 2020 Feb 11. doi: 10.1002/hed.26103.
    PubMed     Abstract available


  341. BAO X, Liu F, Chen Q, Chen L, et al
    Propensity score analysis exploring the impact of smoking and drinking on the prognosis of patients with oral cancer.
    Head Neck. 2020 Feb 7. doi: 10.1002/hed.26099.
    PubMed     Abstract available


  342. AYLWARD A, Park J, Abdelaziz S, Hunt JP, et al
    Individualized prediction of late-onset dysphagia in head and neck cancer survivors.
    Head Neck. 2020 Feb 7. doi: 10.1002/hed.26039.
    PubMed     Abstract available


  343. TWU CW, Wang WY, Tsou HH, Liu YC, et al
    Effects of Epstein-Barr virus viral load and different treatment modality for stage III nasopharyngeal carcinoma.
    Head Neck. 2020 Feb 3. doi: 10.1002/hed.26096.
    PubMed     Abstract available


  344. ILAPAKRUTY B, Rao VUS
    Is tailored management better than salvage in laryngeal squamous cell carcinomas.
    Head Neck. 2020;42:357.
    PubMed    


  345. MIMICA X, Hanson M, Cohen MA
    Reply to the letter of the editor: Is tailored management better than salvage in laryngeal squamous cell carcinomas?
    Head Neck. 2020;42:358-359.
    PubMed    


    January 2020
  346. RATURI V, Hojo H, Bhatt MLB, Suhel M, et al
    Prospective evaluation of XRCC-1 Arg194Trp polymorphism as bio-predictor for clinical outcome in locally advanced laryngeal cancer undergoing cisplatin-based chemoradiation.
    Head Neck. 2020 Jan 30. doi: 10.1002/hed.26083.
    PubMed     Abstract available


  347. SWIECICKI PL, Li P, Bellile E, Stucken C, et al
    Paired phase II trials evaluating cetuximab and radiotherapy for low risk HPV associated oropharyngeal cancer and locoregionally advanced squamous cell carcinoma of the head and neck in patients not eligible for cisplatin.
    Head Neck. 2020 Jan 27. doi: 10.1002/hed.26085.
    PubMed     Abstract available


  348. LIU YP, Xie YL, Zou X, You R, et al
    Techniques of endoscopic nasopharyngectomy for localized stage I nasopharyngeal carcinoma.
    Head Neck. 2020 Jan 24. doi: 10.1002/hed.26090.
    PubMed     Abstract available


  349. SOLDERA EB, Ortigara GB, Bonzanini LIL, Schulz RE, et al
    Clinical and sociodemographic factors associated with oral health-related quality of life in survivors of head and neck cancer.
    Head Neck. 2020 Jan 21. doi: 10.1002/hed.26063.
    PubMed     Abstract available


  350. AHN D, Lee GJ, Sohn JH, Jeon JH, et al
    Oncological impact of hypothyroidism and levothyroxine supplementation following hemithyroidectomy in patients with papillary thyroid carcinoma.
    Head Neck. 2020 Jan 13. doi: 10.1002/hed.26075.
    PubMed     Abstract available


  351. COGNETTI DM, Villaflor VM, Fakhry C, Miller MC, et al
    Survivorship support in head and neck cancer: American Head and Neck Society survey.
    Head Neck. 2020 Jan 10. doi: 10.1002/hed.26066.
    PubMed     Abstract available


  352. ROMAN BR, Lohia S, Mitra N, Wang MB, et al
    Perceived value drives use of routine asymptomatic surveillance PET/CT by physicians who treat head and neck cancer.
    Head Neck. 2020 Jan 10. doi: 10.1002/hed.26071.
    PubMed     Abstract available


  353. BAHL A, Bhatia K, Choudhary P, Singhla S, et al
    Palliative chemotherapy with or without cetuximab in recurrent or metastatic squamous cell carcinoma of the head and neck: Indian tertiary care retrospective analysis.
    Head Neck. 2020 Jan 8. doi: 10.1002/hed.26070.
    PubMed     Abstract available


  354. CHEE J, Liu X, Eu D, Loh T, et al
    Defining a cohort of oligometastatic nasopharyngeal carcinoma patients with improved clinical outcomes.
    Head Neck. 2020 Jan 7. doi: 10.1002/hed.26061.
    PubMed     Abstract available


  355. WALL LR, Ward EC, Cartmill B, Hill AJ, et al
    Prophylactic swallowing therapy for patients with head and neck cancer: A three-arm randomized parallel-group trial.
    Head Neck. 2020 Jan 6. doi: 10.1002/hed.26060.
    PubMed     Abstract available


  356. KOUDOUGOU C, Bertin H, Lecaplain B, Badran Z, et al
    Postimplantation radiation therapy in head and neck cancer patients: Literature review.
    Head Neck. 2020 Jan 3. doi: 10.1002/hed.26065.
    PubMed     Abstract available


  357. SULLIVAN CB, Al-Qurayshi Z, Pagedar NA
    Analysis of patients who decline treatment for squamous cell carcinoma of the head and neck: National perspective.
    Head Neck. 2020 Jan 2. doi: 10.1002/hed.26040.
    PubMed     Abstract available


  358. ILMARINEN T, Keski-Santti HT, Markkanen-Leppanen ML, Haapaniemi A, et al
    Reply to "Do not de-escalate oncology care in oropharyngeal cancer routinely".
    Head Neck. 2020;42:145-146.
    PubMed    


  359. SZTURZ P, Vermorken JB
    Do not de-escalate oncology care in oropharyngeal cancer routinely.
    Head Neck. 2020;42:143-144.
    PubMed    


    December 2019
  360. LEE YH, Goo-Yoshino S, Lew HL, Chi WC, et al
    Social participation in head and neck cancer survivors with swallowing disorder: World Health Organization Disability Assessment Schedule 2.0 study.
    Head Neck. 2019 Dec 30. doi: 10.1002/hed.26062.
    PubMed     Abstract available


  361. CHEN Q, Zou X, Ma Y, Liu F, et al
    Pseudomonas aeruginosa-mannose sensitive hemagglutinin injection therapy for the treatment of chyle fistula following neck dissection.
    Head Neck. 2019 Dec 28. doi: 10.1002/hed.26054.
    PubMed     Abstract available


  362. MEHDIZADEH OB, Dhar SI, Evangelista L, Nativ-Zeltzer N, et al
    Prevalence of profound laryngeal sensory neuropathy in head and neck cancer survivors with feeding tube-dependent oropharyngeal dysphagia.
    Head Neck. 2019 Dec 27. doi: 10.1002/hed.26059.
    PubMed     Abstract available


  363. SUN C, Wang Q, Guo Q, Chang Q, et al
    Analysis of patterns and risk factors regarding the onset of nodules in the contralateral thyroid lobe during follow-up ultrasonography among patients after unilateral lobectomy for the treatment of papillary thyroid carcinoma.
    Head Neck. 2019 Dec 24. doi: 10.1002/hed.26056.
    PubMed     Abstract available


  364. RUEGG P, Morand GB, Kudura K, Rupp NJ, et al
    Tumor cell viability in salvage neck dissections: Poor prognosis predicted by high postradiation nodal SUVmax , p16-negativity, and low nodal shrinkage.
    Head Neck. 2019 Dec 19. doi: 10.1002/hed.26045.
    PubMed     Abstract available


  365. MAKITIE AA, Almangush A, Youssef O, Metsala M, et al
    Exhaled breath analysis in the diagnosis of head and neck cancer.
    Head Neck. 2019 Dec 19. doi: 10.1002/hed.26043.
    PubMed     Abstract available


  366. SAITO Y, Favorov AV, Forman M, Ren S, et al
    Rational genomic optimization of DNA detection for human papillomavirus type 16 in head and neck squamous cell carcinoma.
    Head Neck. 2019 Dec 18. doi: 10.1002/hed.26041.
    PubMed     Abstract available


  367. TIAN S, Switchenko JM, Fei T, Press RH, et al
    Survival advantage of chemoradiotherapy in anaplastic thyroid carcinoma: Propensity score matched analysis with multiple subgroups.
    Head Neck. 2019 Dec 16. doi: 10.1002/hed.26042.
    PubMed     Abstract available


  368. YANG TH, Xirasagar S, Cheng YF, Wu CS, et al
    Association between pioglitazone use and head and neck cancer: Population-based case-control study.
    Head Neck. 2019 Dec 13. doi: 10.1002/hed.26046.
    PubMed     Abstract available


  369. NAGHAVI AO, Kim Y, Yang GQ, Ahmed KA, et al
    Alterations in genetic pathways following radiotherapy for head and neck cancer.
    Head Neck. 2019 Dec 13. doi: 10.1002/hed.26004.
    PubMed     Abstract available


  370. ROGERS SN, Alvear A, Anesi A, Babin E, et al
    Variations in concerns reported on the patient concerns inventory in patients with head and neck cancer from different health settings across the world.
    Head Neck. 2019 Dec 13. doi: 10.1002/hed.26027.
    PubMed     Abstract available


  371. DU C, Blanchard P, Even C, Boros A, et al
    Induction chemotherapy followed by radiotherapy for N3 head and neck squamous cell carcinoma.
    Head Neck. 2019 Dec 4. doi: 10.1002/hed.26021.
    PubMed     Abstract available


    November 2019
  372. WONG ECY, Hung JLC, Ng WT
    Potential pitfalls in incorporating plasma Epstein-Barr virus DNA in the management of nasopharyngeal carcinoma.
    Head Neck. 2019 Nov 28. doi: 10.1002/hed.26018.
    PubMed     Abstract available


  373. MARZILIANO A, Teckie S, Diefenbach MA
    Alcohol-related head and neck cancer: Summary of the literature.
    Head Neck. 2019 Nov 27. doi: 10.1002/hed.26023.
    PubMed     Abstract available


  374. PATEL JJ, Levy DA, Nguyen SA, Knochelmann HM, et al
    Impact of PD-L1 expression and human papillomavirus status in anti-PD1/PDL1 immunotherapy for head and neck squamous cell carcinoma-Systematic review and meta-analysis.
    Head Neck. 2019 Nov 24. doi: 10.1002/hed.26036.
    PubMed     Abstract available


  375. STEPHENS RF, Noel CW, Su JS, Xu W, et al
    Mapping the University of Washington Quality of life questionnaire onto EQ-5D and HUI-3 indices in patients with head and neck cancer.
    Head Neck. 2019 Nov 24. doi: 10.1002/hed.26031.
    PubMed     Abstract available


  376. AGHAJANZADEH S, Karlsson T, Tuomi L, Finizia C, et al
    The effect of jaw exercises on anxiety and depression in patients with head and neck cancer receiving radiotherapy: Prospective 2-year follow-up study.
    Head Neck. 2019 Nov 22. doi: 10.1002/hed.26012.
    PubMed     Abstract available


  377. COCA-PELAZ A, Rodrigo JP, Suarez C, Nixon IJ, et al
    The risk of second primary tumors in head and neck cancer: A systematic review.
    Head Neck. 2019 Nov 21. doi: 10.1002/hed.26016.
    PubMed     Abstract available


  378. VALERO C, Pardo L, Sansa A, Garcia Lorenzo J, et al
    Prognostic capacity of Systemic Inflammation Response Index (SIRI) in patients with head and neck squamous cell carcinoma.
    Head Neck. 2019 Nov 21. doi: 10.1002/hed.26010.
    PubMed     Abstract available


  379. PODEUR F, Pommier P, Crozes C, Monchet E, et al
    Management of unilateral head and neck carcinoma of unknown primary: Retrospective analysis of the impact of postoperative radiotherapy target volumes.
    Head Neck. 2019 Nov 18. doi: 10.1002/hed.26007.
    PubMed     Abstract available


  380. NEVES-SILVA R, Almeida LY, Silveira HA, Colturato CBN, et al
    SMARCB1 (INI-1) and NUT immunoexpression in a large series of head and neck carcinomas in a Brazilian reference center.
    Head Neck. 2019 Nov 15. doi: 10.1002/hed.26008.
    PubMed     Abstract available


  381. ZHANG Y, Xu S, Liu W, Wang X, et al
    Rational choice of neck dissection in clinically N0 patients with supraglottic cancer.
    Head Neck. 2019 Nov 14. doi: 10.1002/hed.26014.
    PubMed     Abstract available


  382. WANG L, Yang L, Han S, Zhu J, et al
    Patterns of protein expression in human head and neck cancer cell lines differ after proton vs photon radiotherapy.
    Head Neck. 2019 Nov 11. doi: 10.1002/hed.26005.
    PubMed     Abstract available


  383. BONOMO P, Talamonti C, Desideri I, Marrazzo L, et al
    Analysis of skin dose distribution for the prediction of severe radiation dermatitis in head and neck squamous cell carcinoma patients treated with concurrent chemo-radiotherapy.
    Head Neck. 2019 Nov 4. doi: 10.1002/hed.25997.
    PubMed     Abstract available


    October 2019
  384. WILSON TG, Hanna A, Recknagel J, Pruetz BL, et al
    Prognostic significance of MTOR expression in HPV positive and negative head and neck cancers treated by chemoradiation.
    Head Neck. 2019 Oct 27. doi: 10.1002/hed.25983.
    PubMed     Abstract available


  385. HORI Y, Kubota A, Yokose T, Furukawa M, et al
    Association between pathological invasion patterns and late lymph node metastases in patients with surgically treated clinical No early oral tongue carcinoma.
    Head Neck. 2019 Oct 24. doi: 10.1002/hed.25994.
    PubMed     Abstract available


  386. JANTHARAPATTANA K, Orapipatpong O
    Efficacy of EPA-enriched supplement compared with standard formula on body weight changes in malnourished patients with head and neck cancer undergone surgery: a randomized study.
    Head Neck. 2019 Oct 24. doi: 10.1002/hed.25987.
    PubMed     Abstract available


  387. GOU X, Duan B, Shi H, Qin L, et al
    The relations of dosimetric parameters with long-term outcomes and late toxicities in advanced T-stage nasopharyngeal carcinoma with IMRT.
    Head Neck. 2019 Oct 24. doi: 10.1002/hed.25986.
    PubMed     Abstract available


  388. PAIAR F, Cristaudo A, Gonnelli A, Giannini N, et al
    Radiation-induced nausea and vomiting in head and neck cancer: Is it something worth considering in the intensity modulated radiotherapy era? "A narrative review".
    Head Neck. 2019 Oct 21. doi: 10.1002/hed.25982.
    PubMed     Abstract available


  389. NG WT, Lee MC, Fung NT, Wong EC, et al
    Dose volume effects of re-irradiation for locally recurrent nasopharyngeal carcinoma.
    Head Neck. 2019 Oct 16. doi: 10.1002/hed.25988.
    PubMed     Abstract available


  390. DOOLEY BJ, Karassawa Zanoni D, Mcgill MR, Awad MI, et al
    Intraoperative and postanesthesia care unit fluid administration as risk factors for postoperative complications in patients with head and neck cancer undergoing free tissue transfer.
    Head Neck. 2019 Oct 8. doi: 10.1002/hed.25970.
    PubMed     Abstract available


  391. PARK H, Harries V, McGill MR, Ganly I, et al
    Isthmusectomy in selected patients with well-differentiated thyroid carcinoma.
    Head Neck. 2019 Oct 7. doi: 10.1002/hed.25968.
    PubMed     Abstract available


  392. AMINI A, Verma V, Li R, Vora N, et al
    Factors predicting for patient refusal of head and neck cancer therapy.
    Head Neck. 2019 Oct 4. doi: 10.1002/hed.25966.
    PubMed     Abstract available


  393. KAO HF, Lou PJ
    Immune checkpoint inhibitors for head and neck squamous cell carcinoma: Current landscape and future directions.
    Head Neck. 2019;41 Suppl 1:4-18.
    PubMed     Abstract available


  394. LOU PJ
    Preface for the special issue of "Immunotherapy for head and neck cancers: Current landscapes, emerging biomarkers, and future directions".
    Head Neck. 2019;41 Suppl 1:3.
    PubMed    


  395. CHEN TH, Chang PM, Yang MH
    Novel immune-modulating drugs for advanced head and neck cancer.
    Head Neck. 2019;41 Suppl 1:46-56.
    PubMed     Abstract available


  396. HSIEH JC, Wang HM, Wu MH, Chang KP, et al
    Review of emerging biomarkers in head and neck squamous cell carcinoma in the era of immunotherapy and targeted therapy.
    Head Neck. 2019;41 Suppl 1:19-45.
    PubMed     Abstract available


  397. NISHIO N, van Keulen S, van den Berg NS, Lu G, et al
    Probe-based fluorescence dosimetry of an antibody-dye conjugate to identify head and neck cancer as a first step to fluorescence-guided tissue preselection for pathological assessment.
    Head Neck. 2019 Oct 1. doi: 10.1002/hed.25964.
    PubMed     Abstract available


  398. ORLANDI E, Iacovelli NA, Cavallo A, Resteghini C, et al
    Could the extreme conformality achieved with proton therapy in paranasal sinuses cancers accidentally results in a high rate of leptomeningeal progression?
    Head Neck. 2019;41:3733-3735.
    PubMed    


    September 2019
  399. BALAGUER M, Pommee T, Farinas J, Pinquier J, et al
    Effects of oral and oropharyngeal cancer on speech intelligibility using acoustic analysis: Systematic review.
    Head Neck. 2019 Sep 30. doi: 10.1002/hed.25949.
    PubMed     Abstract available


  400. HAN JE, Yi SK, Wang S, Erman A, et al
    Neoadjuvant chemotherapy improves survival compared with concurrent chemoradiation alone in nasopharyngeal carcinoma patients with N3 disease.
    Head Neck. 2019 Sep 14. doi: 10.1002/hed.25955.
    PubMed     Abstract available


  401. WU L, Zhuo S, Zeng W, Liang S, et al
    Paranasal sinus invasion suggested T4 classification of patients of nasopharyngeal carcinoma: A two-center retrospective investigation.
    Head Neck. 2019 Sep 13. doi: 10.1002/hed.25953.
    PubMed     Abstract available


  402. RODEN D, Daniels K, Metkus J, Goldman R, et al
    Evaluation of oncologic outcomes in head and neck cancer patients >/=80 years old based on adherence to NCCN guideline for postoperative adjuvant treatment.
    Head Neck. 2019 Sep 12. doi: 10.1002/hed.25950.
    PubMed     Abstract available


  403. MOWERY AJ, Conlin MJ, Clayburgh DR
    Elevated incidence of head and neck cancer in solid organ transplant recipients.
    Head Neck. 2019 Sep 12. doi: 10.1002/hed.25937.
    PubMed     Abstract available


  404. GIRKAR F, Thiagarajan S, Malik A, Sawhney S, et al
    Factors predisposing to the development of orocutaneous fistula following surgery for oral cancer: Experience from a tertiary cancer center.
    Head Neck. 2019 Sep 9. doi: 10.1002/hed.25951.
    PubMed     Abstract available


  405. TAM S, Nurgalieva Z, Weber RS, Lewis CM, et al
    Adherence with National Comprehensive Cancer Network posttreatment surveillance guidelines in patients with head and neck cancer.
    Head Neck. 2019 Sep 9. doi: 10.1002/hed.25936.
    PubMed     Abstract available


  406. BRISSON RJ, Kochanny S, Arshad S, Dekker A, et al
    A pilot study of the pan-class I PI3K inhibitor buparlisib in combination with cetuximab in patients with recurrent or metastatic head and neck cancer.
    Head Neck. 2019 Sep 4. doi: 10.1002/hed.25910.
    PubMed     Abstract available


  407. MASKELL D, Buckley H, Sisson K, Roques T, et al
    In reply to McDowell et al.
    Head Neck. 2019;41:3470-3471.
    PubMed    


  408. MCDOWELL L, Corry J
    Comment on "Ipsilateral neck radiotherapy in N2b well-lateralized tonsil cancer-Approach with caution".
    Head Neck. 2019;41:3468-3469.
    PubMed    


    August 2019
  409. KARSTEN RT, Al-Mamgani A, Bril SI, Tjon-A-Joe S, et al
    Sarcopenia, a strong determinant for prolonged feeding tube dependency after chemoradiotherapy for head and neck cancer.
    Head Neck. 2019 Aug 31. doi: 10.1002/hed.25938.
    PubMed     Abstract available


  410. XU SY, Yao JJ, Zhou W, Chen L, et al
    Clinical characteristics and ultrasonographic features for predicting central lymph node metastasis in clinically node-negative papillary thyroid carcinoma without capsule invasion.
    Head Neck. 2019 Aug 29. doi: 10.1002/hed.25941.
    PubMed     Abstract available


  411. ELDRIDGE RC, Pugh SL, Trotti A, Hu K, et al
    Changing functional status within 6 months posttreatment is prognostic of overall survival in patients with head and neck cancer: NRG Oncology Study.
    Head Neck. 2019 Aug 22. doi: 10.1002/hed.25922.
    PubMed     Abstract available


  412. CHEN JH, Huang WY, Ho CL, Chao TY, et al
    Evaluation of oral tegafur-uracil as metronomic therapy following concurrent chemoradiotherapy in patients with non-distant metastatic TNM stage IV nasopharyngeal carcinoma.
    Head Neck. 2019 Aug 22. doi: 10.1002/hed.25904.
    PubMed     Abstract available


  413. MIMICA X, Hanson M, Patel SG, McGill M, et al
    Salvage surgery for recurrent larynx cancer.
    Head Neck. 2019 Aug 21. doi: 10.1002/hed.25925.
    PubMed     Abstract available


  414. CHO Y, Yoon HI, Lee IJ, Kim JW, et al
    Patterns of local recurrence after curative resection and reconstruction for oropharyngeal and oral cancers: Implications for postoperative radiotherapy target volumes.
    Head Neck. 2019 Aug 20. doi: 10.1002/hed.25928.
    PubMed     Abstract available


  415. TAN AL, Iyer NG, Putri N, Nadkarni N, et al
    Factors driving frequent attendance at emergency departments for patients with head and neck cancer.
    Head Neck. 2019 Aug 18. doi: 10.1002/hed.25916.
    PubMed     Abstract available


  416. SHAH M, Jomaa MK, Ferrarotto R, Yeung SJ, et al
    Serious immune-related adverse events in patients with head and neck cancer after checkpoint blockade: Systematic review.
    Head Neck. 2019 Aug 15. doi: 10.1002/hed.25911.
    PubMed     Abstract available


  417. GILL AS, Kinzinger M, Bewley AF, Farwell DG, et al
    Malnutrition evaluation in head and neck cancer patients: Practice patterns among otolaryngologists and radiation oncologists.
    Head Neck. 2019 Aug 12. doi: 10.1002/hed.25909.
    PubMed     Abstract available


  418. LIN DJ, Lam A, Warner L, Paleri V, et al
    Elective neck dissection in patients with radio-recurrent and radio-residual squamous cell carcinoma of the larynx undergoing salvage total laryngectomy: Systematic review and meta-analysis.
    Head Neck. 2019 Aug 10. doi: 10.1002/hed.25907.
    PubMed     Abstract available


  419. ALMADORI G, De Corso E, Visconti G, Almadori A, et al
    Impact of internal mammary artery perforator propeller flap in neck resurfacing and fistula closure after salvage larynx cancer surgery: Our experience.
    Head Neck. 2019 Aug 9. doi: 10.1002/hed.25903.
    PubMed     Abstract available


  420. LI H, Li EY, Kejner AE
    Treatment modality and outcomes in larynx cancer patients: A sex-based evaluation.
    Head Neck. 2019 Aug 7. doi: 10.1002/hed.25897.
    PubMed     Abstract available


  421. MANDAPATHIL M, Lennon P, Ganly I, Patel SG, et al
    Significance and management of incidentally diagnosed metastatic papillary thyroid carcinoma in cervical lymph nodes in neck dissection specimens.
    Head Neck. 2019 Aug 7. doi: 10.1002/hed.25905.
    PubMed     Abstract available


  422. MASCARELLA MA, Azzi JL, da Silva SD, Mlynarek A, et al
    Postoperative infection predicts poor survival in locoregionally advanced oral cancer.
    Head Neck. 2019 Aug 5. doi: 10.1002/hed.25885.
    PubMed     Abstract available


  423. MCGURK M
    Surgical consensus guidelines on sentinel node biopsy in patients with oral cancer.
    Head Neck. 2019 Aug 5. doi: 10.1002/hed.25898.
    PubMed    


  424. KWAN BYM, Khan NM, de Almeida JR, Goldstein D, et al
    Transoral robotic surgery for head and neck malignancies: Imaging features in presurgical workup.
    Head Neck. 2019 Aug 1. doi: 10.1002/hed.25887.
    PubMed     Abstract available


  425. LASSEN-RAMSHAD Y, Ozyar E, Alanyali S, Poortmans P, et al
    Reply to "Proper tumor classification and growth rate are key elements when considering indications and results of radiotherapy for head and neck paragangliomas".
    Head Neck. 2019;41:2837-2838.
    PubMed    


  426. ALBERTINI R, Mariani-Costantini R, Sanna M
    Proper tumor classification and growth rate are key elements when considering indications and results of radiotherapy for head and neck paragangliomas.
    Head Neck. 2019;41:2835-2836.
    PubMed    


    July 2019
  427. JAKOB M, Mattes LM, Kuffer S, Unger K, et al
    MicroRNA expression patterns in oral squamous cell carcinoma: hsa-mir-99b-3p and hsa-mir-100-5p as novel prognostic markers for oral cancer.
    Head Neck. 2019 Jul 29. doi: 10.1002/hed.25866.
    PubMed     Abstract available


  428. ORLANDI E, Bonomo P, Ferella L, D'Angelo E, et al
    Long-term outcome of re-irradiation for recurrent or second primary head and neck cancer: A multi-institutional study of AIRO-Head and Neck working group.
    Head Neck. 2019 Jul 29. doi: 10.1002/hed.25890.
    PubMed     Abstract available


  429. LE GUEVELOU J, Lebars S, Kammerer E, de Gabory L, et al
    Head and neck cancer during pregnancy.
    Head Neck. 2019 Jul 22. doi: 10.1002/hed.25877.
    PubMed     Abstract available


  430. MAKITIE AA, Almangush A, Rodrigo JP, Ferlito A, et al
    Hallmarks of cancer: Tumor budding as a sign of invasion and metastasis in head and neck cancer.
    Head Neck. 2019 Jul 22. doi: 10.1002/hed.25872.
    PubMed     Abstract available


  431. LU T, Xie X, Guo Q, Zhan S, et al
    Prognosis of nasopharyngeal carcinoma with insufficient radical dose to the primary site in the intensity-modulated radiotherapy era.
    Head Neck. 2019 Jul 16. doi: 10.1002/hed.25865.
    PubMed     Abstract available


  432. PAULI N, Mejersjo C, Fagerberg-Mohlin B, Finizia C, et al
    Temporomandibular disorder in head and neck cancer patients undergoing radiotherapy: Clinical findings and patient-reported symptoms.
    Head Neck. 2019 Jul 16. doi: 10.1002/hed.25878.
    PubMed     Abstract available


  433. RASSY E, Nicolai P, Pavlidis N
    Comprehensive management of HPV-related squamous cell carcinoma of the head and neck of unknown primary.
    Head Neck. 2019 Jul 13. doi: 10.1002/hed.25858.
    PubMed     Abstract available


  434. LI X, Zhou J, Chu C, You Q, et al
    Home enteral nutrition may prevent myelosuppression of patients with nasopharyngeal carcinoma treated by concurrent chemoradiotherapy.
    Head Neck. 2019 Jul 12. doi: 10.1002/hed.25861.
    PubMed     Abstract available


  435. PETRUZZI G, Zocchi J, Moretto S, Pichi B, et al
    Transoral robotic retropharyngeal lymph node dissection in a recurrent head and neck carcinoma.
    Head Neck. 2019 Jul 11. doi: 10.1002/hed.25874.
    PubMed     Abstract available


  436. ABOUYARED M, Katz AP, Ein L, Ketner J, et al
    Controversies in free tissue transfer for head and neck cancer: A review of the literature.
    Head Neck. 2019 Jul 9. doi: 10.1002/hed.25853.
    PubMed     Abstract available


  437. KIM SH, Lee WH, Seong D, An JH, et al
    The role of CIP2A as a therapeutic target of rapamycin in radioresistant head and neck cancer with TP53 mutation.
    Head Neck. 2019 Jul 3. doi: 10.1002/hed.25868.
    PubMed     Abstract available


  438. SU Z, Cao X, Zou G
    Brain and frontal-bone metastasis from nasopharyngeal carcinoma: Case report and literature review.
    Head Neck. 2019 Jul 2. doi: 10.1002/hed.25859.
    PubMed     Abstract available


    June 2019
  439. WANG JR, Nurgalieva Z, Fu S, Tam S, et al
    Utilization of rehabilitation services in patients with head and neck cancer in the United States: A SEER-Medicare analysis.
    Head Neck. 2019 Jun 25. doi: 10.1002/hed.25844.
    PubMed     Abstract available


  440. MOORE P, Grinsell D, Lyons B, Hewson I, et al
    Outcomes of dental and craniofacial osseointegrated implantation in head and neck cancer patients.
    Head Neck. 2019 Jun 19. doi: 10.1002/hed.25845.
    PubMed     Abstract available


  441. WATTERS AL, Cope S, Keller MN, Padilla M, et al
    Prevalence of trismus in patients with head and neck cancer: A systematic review with meta-analysis.
    Head Neck. 2019 Jun 19. doi: 10.1002/hed.25836.
    PubMed     Abstract available


  442. OH J, Prisman E, Olson R, Berthelet E, et al
    Primary organ preservation vs total laryngectomy for T4a larynx cancer.
    Head Neck. 2019 Jun 19. doi: 10.1002/hed.25838.
    PubMed     Abstract available


  443. HU Y, Lu T, Huang SH, Lin S, et al
    High-grade radiologic extra-nodal extension predicts distant metastasis in stage II nasopharyngeal carcinoma.
    Head Neck. 2019 Jun 17. doi: 10.1002/hed.25842.
    PubMed     Abstract available


  444. WANG KY, Yang KC, Su FY, Chen YC, et al
    Association between blood pressure and postoperative hematomas in the patients undergoing head and neck cancer reconstruction.
    Head Neck. 2019 Jun 7. doi: 10.1002/hed.25831.
    PubMed     Abstract available


  445. MIROSEVIC S, Thewes B, van Herpen C, Kaanders J, et al
    Prevalence and clinical and psychological correlates of high fear of cancer recurrence in patients newly diagnosed with head and neck cancer.
    Head Neck. 2019 Jun 7. doi: 10.1002/hed.25812.
    PubMed     Abstract available


  446. POWROZEK T, Brzozowska A, Mazurek M, Mlak R, et al
    Combined analysis of miRNA-181a with phase angle derived from bioelectrical impedance predicts radiotherapy-induced changes in body composition and survival of male patients with head and neck cancer.
    Head Neck. 2019 Jun 4. doi: 10.1002/hed.25830.
    PubMed     Abstract available


  447. VUONG HG, Ho ATN, Tran TTK, Capdevila J, et al
    Efficacy and toxicity of sorafenib in the treatment of advanced medullary thyroid carcinoma: A systematic review and meta-analysis.
    Head Neck. 2019 Jun 4. doi: 10.1002/hed.25832.
    PubMed     Abstract available


    May 2019
  448. CHEN JL, Shen CW, Wang CC, Huang YS, et al
    Impact of smoking cessation on clinical outcomes in patients with head and neck squamous cell carcinoma receiving curative chemoradiotherapy: A prospective study.
    Head Neck. 2019 May 22. doi: 10.1002/hed.25814.
    PubMed     Abstract available


  449. DELAHAUT G, Temam S, Ambroise J, Tao Y, et al
    Prognostic impact of tumor growth velocity in head and neck squamous cell carcinoma treated by radiotherapy: A pilot study.
    Head Neck. 2019 May 14. doi: 10.1002/hed.25789.
    PubMed     Abstract available


  450. JACOBI C, Gahleitner C, Bier H, Knopf A, et al
    Chemoradiation and local recurrence of head and neck squamous cell carcinoma and the risk of carotid artery blowout.
    Head Neck. 2019 May 9. doi: 10.1002/hed.25796.
    PubMed     Abstract available


    April 2019
  451. DANIELS KE, Luginbuhl AJ, Mardekian SK, Cognetti DM, et al
    Assessment of quality and consistency of monoclonal antibodies for CB1 and CB2 in head and neck squamous cell carcinoma.
    Head Neck. 2019 Apr 29. doi: 10.1002/hed.25794.
    PubMed     Abstract available


  452. VAN DE GOOR RMGE, Hardy JCA, van Hooren MRA, Kremer B, et al
    Detecting recurrent head and neck cancer using electronic nose technology: A feasibility study.
    Head Neck. 2019 Apr 23. doi: 10.1002/hed.25787.
    PubMed     Abstract available


  453. HO YY, Wu TY, Cheng HC, Yang CC, et al
    The significance of tumor budding in oral cancer survival and its relevance to the eighth edition of the American Joint Committee on Cancer staging system.
    Head Neck. 2019 Apr 23. doi: 10.1002/hed.25780.
    PubMed     Abstract available


  454. THAM T, Machado R, Herman SW, Kraus D, et al
    Personalized prognostication in head and neck cancer: A systematic review of nomograms according to the AJCC precision medicine core (PMC) criteria.
    Head Neck. 2019 Apr 23. doi: 10.1002/hed.25778.
    PubMed     Abstract available


  455. SONG YC, Hung KF, Liang KL, Chiang JH, et al
    Adjunctive Chinese herbal medicine therapy for nasopharyngeal carcinoma: Clinical evidence and experimental validation.
    Head Neck. 2019 Apr 15. doi: 10.1002/hed.25766.
    PubMed     Abstract available


  456. DURAN G, Aguin S, Cruz R, Barros F, et al
    Association of GSTP1 and ERCC1 polymorphisms with toxicity in locally advanced head and neck cancer platinum-based chemoradiotherapy treatment.
    Head Neck. 2019 Apr 11. doi: 10.1002/hed.25754.
    PubMed     Abstract available


  457. DE KORT WWB, Maas SLN, Van Es RJJ, Willems SM, et al
    Prognostic value of the nodal yield in head and neck squamous cell carcinoma: A systematic review.
    Head Neck. 2019 Apr 10. doi: 10.1002/hed.25764.
    PubMed     Abstract available


  458. MIYAGAWA Y, Araki K, Yamashita T, Tanaka S, et al
    Induction of cell fusion/apoptosis in anaplastic thyroid carcinoma in orthotopic mouse model by urokinase-specific oncolytic Sendai virus.
    Head Neck. 2019 Apr 10. doi: 10.1002/hed.25769.
    PubMed     Abstract available


  459. CHEN F, Yan L, Wang J, Lin L, et al
    Upregulated long noncoding RNA ENST00000470447.1 inhibits cell migration and invasion and predicts better disease-free survival of oral cancer.
    Head Neck. 2019 Apr 10. doi: 10.1002/hed.25765.
    PubMed     Abstract available


  460. PANDA S, Thakar A, Sikka K, Sharma SC, et al
    Role of sternomastoid muscle interposition in concomitant transoral oncologic resection and neck dissection.
    Head Neck. 2019 Apr 4. doi: 10.1002/hed.25753.
    PubMed     Abstract available


    March 2019
  461. YOUNG LK, Vimawala S, Ahmad N, Kushnir V, et al
    Review of inbound medical tourism and legal details of obtaining a visa for treatment of head and neck cancer.
    Head Neck. 2019 Mar 25. doi: 10.1002/hed.25743.
    PubMed     Abstract available


  462. COSTA EFD, Lopes-Aguiar L, Nogueira GS, Lima TRP, et al
    CASP9 c.-1339A>G and CASP3 c.-1191A>G polymorphisms alter susceptibility and clinical aspects of head and neck squamous cell carcinoma.
    Head Neck. 2019 Mar 23. doi: 10.1002/hed.25746.
    PubMed     Abstract available


  463. WANG HM, Wu MH, Chang PH, Lin HC, et al
    The change in circulating tumor cells before and during concurrent chemoradiotherapy is associated with survival in patients with locally advanced head and neck cancer.
    Head Neck. 2019 Mar 22. doi: 10.1002/hed.25744.
    PubMed     Abstract available


  464. MEANS C, Clayburgh DR, Maloney L, Sauer D, et al
    Tumor immune microenvironment characteristics of papillary thyroid carcinoma are associated with histopathological aggressiveness and BRAF mutation status.
    Head Neck. 2019 Mar 21. doi: 10.1002/hed.25740.
    PubMed     Abstract available


  465. SCHILLING C, Stoeckli SJ, Vigili MG, de Bree R, et al
    Surgical consensus guidelines on sentinel node biopsy (SNB) in patients with oral cancer.
    Head Neck. 2019 Mar 21. doi: 10.1002/hed.25739.
    PubMed     Abstract available


  466. KIM H, Shin JH, Hahn SY, Oh YL, et al
    Prediction of follicular thyroid carcinoma associated with distant metastasis in the preoperative and postoperative model.
    Head Neck. 2019 Mar 19. doi: 10.1002/hed.25721.
    PubMed     Abstract available


  467. HENRY M, Fuehrmann F, Hier M, Zeitouni A, et al
    Contextual and historical factors for increased levels of anxiety and depression in patients with head and neck cancer: A prospective longitudinal study.
    Head Neck. 2019 Mar 19. doi: 10.1002/hed.25725.
    PubMed     Abstract available


  468. MORSE RT, Ganju RG, TenNapel MJ, Neupane P, et al
    Weekly cisplatin chemotherapy dosing versus triweekly chemotherapy with concurrent radiation for head and neck squamous cell carcinoma.
    Head Neck. 2019 Mar 11. doi: 10.1002/hed.25717.
    PubMed     Abstract available


  469. JANG JY, Kim DS, Park HY, Shin SC, et al
    Preoperative serum VEGF-C but not VEGF-A level is correlated with lateral neck metastasis in papillary thyroid carcinoma.
    Head Neck. 2019 Mar 7. doi: 10.1002/hed.25729.
    PubMed     Abstract available


  470. BAI S, Zhang P, Zhang JC, Shen J, et al
    A gene signature associated with prognosis and immune processes in head and neck squamous cell carcinoma.
    Head Neck. 2019 Mar 6. doi: 10.1002/hed.25731.
    PubMed     Abstract available


  471. YASUMATSU R, Wakasaki T, Hashimoto K, Nakashima K, et al
    Monitoring the neutrophil-to-lymphocyte ratio may be useful for predicting the anticancer effect of nivolumab in recurrent or metastatic head and neck cancer.
    Head Neck. 2019 Mar 5. doi: 10.1002/hed.25737.
    PubMed     Abstract available


  472. MOHAMED A, Twardy B, Zordok MA, Ashraf K, et al
    Concurrent chemoradiotherapy with weekly versus triweekly cisplatin in locally advanced squamous cell carcinoma of the head and neck: A comparative analysis.
    Head Neck. 2019 Mar 5. doi: 10.1002/hed.25379.
    PubMed     Abstract available


  473. NAKANO K, Seto A, Sasaki T, Shimbashi W, et al
    Incidence and risk factors of interstitial lung disease of patients with head and neck cancer treated with cetuximab.
    Head Neck. 2019 Mar 4. doi: 10.1002/hed.25727.
    PubMed     Abstract available


  474. FADEN DL, Concha-Benavente F, Chakka AB, McMichael EL, et al
    Immunogenomic correlates of response to cetuximab monotherapy in head and neck squamous cell carcinoma.
    Head Neck. 2019 Mar 4. doi: 10.1002/hed.25726.
    PubMed     Abstract available


  475. VAN SCHAIK JE, Muller Kobold AC, van der Laan BFAM, van der Vegt B, et al
    Squamous cell carcinoma antigen concentration in fine needle aspiration samples: A new method to detect cervical lymph node metastases of head and neck squamous cell carcinoma.
    Head Neck. 2019 Mar 4. doi: 10.1002/hed.25733.
    PubMed     Abstract available


  476. MAEBAYASHI T, Ishibashi N, Aizawa T, Sakaguchi M, et al
    Effectiveness of chemoradiotherapy for radiation-induced bilateral external auditory canal cancer: A case report and literature review.
    Head Neck. 2019 Mar 4. doi: 10.1002/hed.25728.
    PubMed     Abstract available


  477. MORATIN J, Metzger K, Safaltin A, Herpel E, et al
    Upregulation of PD-L1 and PD-L2 in neck node metastases of head and neck squamous cell carcinoma.
    Head Neck. 2019 Mar 1. doi: 10.1002/hed.25713.
    PubMed     Abstract available


  478. FERRIS RL, Nikiforov YE, Randolph G
    Response to Letter to the Editor regarding follow-up for NIFTP.
    Head Neck. 2019;41:835.
    PubMed    


  479. ROSARIO PW, Mourao GF
    Follow-up of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP).
    Head Neck. 2019;41:833-834.
    PubMed    


    February 2019
  480. TU HF, Chen MY, Lai JC, Chen YL, et al
    Arecoline-regulated ataxia telangiectasia mutated expression level in oral cancer progression.
    Head Neck. 2019 Feb 28. doi: 10.1002/hed.25718.
    PubMed     Abstract available


  481. MIRZA AH, Thomas G, Ottensmeier CH, King EV, et al
    Importance of the immune system in head and neck cancer.
    Head Neck. 2019 Feb 28. doi: 10.1002/hed.25716.
    PubMed     Abstract available


  482. KAO LT, Hung SH, Kao PF, Liu JC, et al
    Inverse association between statin use and head and neck cancer: A population-based case-control study in Han population.
    Head Neck. 2019 Feb 26. doi: 10.1002/hed.25501.
    PubMed     Abstract available


  483. RODRIGUES-JUNIOR DM, Tan SS, Lim SK, de Souza Viana L, et al
    High expression of MLANA in the plasma of patients with head and neck squamous cell carcinoma as a predictor of tumor progression.
    Head Neck. 2019 Feb 25. doi: 10.1002/hed.25510.
    PubMed     Abstract available


  484. ROBBINS KT, Medina J, Ferlito A
    Adding clarity to the historical evolution of the selective neck dissection.
    Head Neck. 2019 Feb 23. doi: 10.1002/hed.25704.
    PubMed    


  485. STELZLE F, Oetter N, Goellner LT, Adler W, et al
    Speech intelligibility in patients with oral cancer: An objective baseline evaluation of pretreatment function and impairment.
    Head Neck. 2019 Feb 23. doi: 10.1002/hed.25527.
    PubMed     Abstract available


  486. SMEE R, Williams JR, Kotevski DP
    Surgery is not the only determinant of an outcome in patients with hypopharyngeal carcinoma.
    Head Neck. 2019 Feb 21. doi: 10.1002/hed.25496.
    PubMed     Abstract available


  487. BATES JE, De Leo AN, Morris CG, Amdur RJ, et al
    Oligometastatic squamous cell carcinoma of the head and neck treated with stereotactic body ablative radiotherapy: Single-institution outcomes.
    Head Neck. 2019 Feb 20. doi: 10.1002/hed.25695.
    PubMed     Abstract available


  488. WALD P, Grecula J, Walston S, Wei L, et al
    Intraoperative electron beam radiotherapy for locoregionally persistent or recurrent head and neck cancer.
    Head Neck. 2019 Feb 19. doi: 10.1002/hed.25673.
    PubMed     Abstract available


  489. TASSLER AB, Gooding WE, Ferris RL
    Hypopharyngeal cancer treatment: Does initial surgery confer survival benefit?
    Head Neck. 2019 Feb 19. doi: 10.1002/hed.25687.
    PubMed     Abstract available


  490. SHAHA AR
    Recent historic perspective on modified neck dissection.
    Head Neck. 2019 Feb 18. doi: 10.1002/hed.25700.
    PubMed    


  491. WANG B, Weng YJ, Wang SS, Zhao WX, et al
    Feasibility and safety of needle-assisted endoscopic thyroidectomy with lateral neck dissection for papillary thyroid carcinoma: a preliminary experience.
    Head Neck. 2019 Feb 18. doi: 10.1002/hed.25705.
    PubMed     Abstract available


  492. KHARIWALA SS, Rubin N, Stepanov I, Nollen N, et al
    "Cold turkey" or pharmacotherapy: Examination of tobacco cessation methods tried among smokers prior to developing head and neck cancer.
    Head Neck. 2019 Feb 15. doi: 10.1002/hed.25708.
    PubMed     Abstract available


  493. VAN DEN STEEN L, Van Gestel D, Vanderveken O, Vanderwegen J, et al
    Evolution of self-perceived swallowing function, tongue strength and swallow-related quality of life during radiotherapy in head and neck cancer patients.
    Head Neck. 2019 Feb 14. doi: 10.1002/hed.25684.
    PubMed     Abstract available


  494. KIM HK, Park D, Kim HY
    Robotic transoral thyroidectomy: Total thyroidectomy and ipsilateral central neck dissection with da Vinci Xi Surgical System.
    Head Neck. 2019 Feb 13. doi: 10.1002/hed.25661.
    PubMed     Abstract available


  495. COCA-PELAZ A, Halmos GB, Strojan P, de Bree R, et al
    The role of age in treatment-related adverse events in patients with head and neck cancer: A systematic review.
    Head Neck. 2019 Feb 9. doi: 10.1002/hed.25696.
    PubMed     Abstract available


  496. SUN W, Chen L, Huang JQ, Li J, et al
    Dynamic changes in chemosensitivity immune predictors in patients with hypopharyngeal cancer treated with induction chemotherapy.
    Head Neck. 2019 Feb 9. doi: 10.1002/hed.25699.
    PubMed     Abstract available


  497. AVKSHTOL V, Handorf EA, Ridge JA, Leachman BK, et al
    Examining adjuvant radiation dose in head and neck squamous cell carcinoma.
    Head Neck. 2019 Feb 9. doi: 10.1002/hed.25680.
    PubMed     Abstract available


  498. LIU J, Lu D, Deng D, Wang J, et al
    Free posterior tibial artery perforator flap for 2-stage tracheal reconstruction in patients after resection of well-differentiated thyroid carcinoma invading the trachea.
    Head Neck. 2019 Feb 6. doi: 10.1002/hed.25675.
    PubMed     Abstract available


  499. HUTCHISON AR, Cartmill B, Wall LR, Ward EC, et al
    Dysphagia optimized radiotherapy to reduce swallowing dysfunction severity in patients undergoing treatment for head and neck cancer: A systematized scoping review.
    Head Neck. 2019 Feb 5. doi: 10.1002/hed.25688.
    PubMed     Abstract available


  500. MUELLER SA, Riggauer J, Elicin O, Blaser D, et al
    Patients' preferences concerning follow-up after curative head and neck cancer treatment: A cross-sectional pilot study.
    Head Neck. 2019 Feb 5. doi: 10.1002/hed.25686.
    PubMed     Abstract available


  501. LI L, Sun Z, Huang X, Li X, et al
    Role of c-Met expression on prognosis of head and neck cancer: A literature review and meta-analysis.
    Head Neck. 2019 Feb 1. doi: 10.1002/hed.25655.
    PubMed     Abstract available


    January 2019
  502. STRIETH S, Ernst BP, Both I, Hirth D, et al
    Randomized controlled single-blinded clinical trial of functional voice outcome after vascular targeting KTP laser microsurgery of early laryngeal cancer.
    Head Neck. 2019 Jan 31. doi: 10.1002/hed.25474.
    PubMed     Abstract available


  503. BUSSU F, Tagliaferri L, Mattiucci G, Parrilla C, et al
    HDR interventional radiotherapy (brachytherapy) in the treatment of primary and recurrent head and neck malignancies.
    Head Neck. 2019 Jan 30. doi: 10.1002/hed.25646.
    PubMed     Abstract available


  504. LANG S, Schimansky S, Beynon R, Penfold C, et al
    Dietary behaviors and survival in people with head and neck cancer: Results from Head and Neck 5000.
    Head Neck. 2019 Jan 30. doi: 10.1002/hed.25660.
    PubMed     Abstract available


  505. ARBAB M, Margalit DN, Tishler RB, Rabinowits G, et al
    Outcomes following radiation for cutaneous squamous cell carcinoma of the head and neck: Associations between immune suppression and recurrence.
    Head Neck. 2019 Jan 29. doi: 10.1002/hed.25663.
    PubMed     Abstract available


  506. SWEGAL WC, Iwata AJ, Chang SS
    Developing a patient driven head and neck cancer care pathway.
    Head Neck. 2019 Jan 28. doi: 10.1002/hed.25590.
    PubMed    


  507. MENDEZ LC, Conrad T, Lee J, Smith B, et al
    Prospective evaluation of pretreatment and intratreatment FDG PET-CT SUV stability in primary head and neck cancer.
    Head Neck. 2019 Jan 28. doi: 10.1002/hed.25624.
    PubMed     Abstract available


  508. DEN TOOM IJ, Janssen LM, van Es RJJ, Karagozoglu KH, et al
    Depth of invasion in patients with early stage oral cancer staged by sentinel node biopsy.
    Head Neck. 2019 Jan 28. doi: 10.1002/hed.25665.
    PubMed     Abstract available


  509. RILEY CA, Marino MJ, Hsieh MC, Wu EL, et al
    Detection of laryngeal carcinoma in the U.S. elderly population with gastroesophageal reflux disease.
    Head Neck. 2019 Jan 25. doi: 10.1002/hed.25600.
    PubMed     Abstract available


  510. KLIGERMAN MP, Sethi RKV, Kozin ED, Gray ST, et al
    Morbidity and mortality among patients with head and neck cancer in the emergency department: A national perspective.
    Head Neck. 2019 Jan 24. doi: 10.1002/hed.25534.
    PubMed     Abstract available


  511. MENNINI FS, Marcellusi A, Fabiano G, Platini F, et al
    Rationale and budget impact of bimonthly use of Cetuximab in patients with recurrent and/or metastatic head and neck cancer.
    Head Neck. 2019 Jan 24. doi: 10.1002/hed.25481.
    PubMed     Abstract available


  512. BUTTERWORTH CJ
    Primary vs secondary zygomatic implant placement in patients with head and neck cancer-A 10-year prospective study.
    Head Neck. 2019 Jan 21. doi: 10.1002/hed.25645.
    PubMed     Abstract available


  513. SOOD A, Wykes J, Roshan D, Wang LY, et al
    A critical analysis of the prognostic performance of the 8th edition American Joint Committee on Cancer staging for metastatic cutaneous squamous cell carcinoma of the head and neck.
    Head Neck. 2019 Jan 19. doi: 10.1002/hed.25599.
    PubMed     Abstract available


  514. MIRABILE A, Miceli R, Calderone RG, Locati L, et al
    Prognostic factors in recurrent or metastatic squamous cell carcinoma of the head and neck.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25636.
    PubMed     Abstract available


  515. KRAAIJENGA SA, Hamming-Vrieze O, Verheijen S, Lamers E, et al
    Radiation dose to the masseter and medial pterygoid muscle in relation to trismus after chemoradiotherapy for advanced head and neck cancer.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25573.
    PubMed     Abstract available


  516. HUANG HI, Chen CH, Wang SH, Wang LH, et al
    Effects of APE1 Asp148Glu polymorphisms on OPMD malignant transformation, and on susceptibility to and overall survival of oral cancer in Taiwan.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25576.
    PubMed     Abstract available


  517. FAGAN JJ, Otiti J, Aswani J, Konney A, et al
    African head and neck fellowships: A model for a sustainable impact on head and neck cancer care in developing countries.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25615.
    PubMed     Abstract available


  518. PAVON MA, Arroyo-Solera I, Leon X, Tellez-Gabriel M, et al
    The combined use of EFS, GPX2, and SPRR1A expression could distinguish favorable from poor clinical outcome among epithelial-like head and neck carcinoma subtypes.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25623.
    PubMed     Abstract available


  519. CABEZAS-CAMARERO S, Garcia-Barberan V, Saiz-Pardo Sanz M, Cabrera-Martin MN, et al
    Durable intracranial and extracranial response to nivolumab with appearance of secondary resistance in a heavily pretreated patient with head and neck cancer.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25635.
    PubMed     Abstract available


  520. SU WW, Su CW, Chang DC, Chuang SL, et al
    Impact of varying anatomic sites on advanced stage and survival of oral cancer: A 9-year prospective cohort of 27 717 cases.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25579.
    PubMed     Abstract available


  521. BUGTER O, van Iwaarden DLP, Dronkers EAC, de Herdt MJ, et al
    Survival of patients with head and neck cancer with metachronous multiple primary tumors is surprisingly favorable.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25595.
    PubMed     Abstract available


  522. MEHTA V, Ow TJ, Kim S, Tharakan T, et al
    Significant racial differences in the incidence and behavior of the follicular variant of papillary thyroid carcinoma.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25596.
    PubMed     Abstract available


  523. SINGER S, Amdal CD, Hammerlid E, Tomaszewska IM, et al
    International validation of the revised European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ-HN43: Phase IV.
    Head Neck. 2019 Jan 12. doi: 10.1002/hed.25609.
    PubMed     Abstract available


  524. LEE JW, Ban MJ, Park JH, Lee SM, et al
    Visceral adipose tissue volume and CT-attenuation as prognostic factors in patients with head and neck cancer.
    Head Neck. 2019 Jan 12. doi: 10.1002/hed.25605.
    PubMed     Abstract available


  525. BECKHAM TH, Leeman J, Jillian Tsai C, Riaz N, et al
    Treatment modalities and outcomes of Fanconi anemia patients with head and neck squamous cell carcinoma: A series of 9 cases and review of the literature.
    Head Neck. 2019 Jan 11. doi: 10.1002/hed.25577.
    PubMed     Abstract available


  526. CHAN JW, Yeh I, El-Sayed IH, Algazi AP, et al
    Ultraviolet light-related DNA damage mutation signature distinguishes cutaneous from mucosal or other origin for head and neck squamous cell carcinoma of unknown primary site.
    Head Neck. 2019 Jan 11. doi: 10.1002/hed.25613.
    PubMed     Abstract available


  527. VAN DAELE DJ, Langmore SE, Krisciunas GP, Lazarus CL, et al
    The impact of time after radiation treatment on dysphagia in patients with head and neck cancer enrolled in a swallowing therapy program.
    Head Neck. 2019 Jan 10. doi: 10.1002/hed.25344.
    PubMed     Abstract available


  528. TESHIMA M, Otsuki N, Shinomiya H, Morita N, et al
    Impact of retropharyngeal lymph node dissection in the surgical treatment of hypopharyngeal cancer.
    Head Neck. 2019 Jan 8. doi: 10.1002/hed.25608.
    PubMed     Abstract available


  529. XIANG ZZ, Liu F, Yan RN, Zeng YY, et al
    The prognostic value of volumetric reduction of the target lesions after induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma.
    Head Neck. 2019 Jan 8. doi: 10.1002/hed.25620.
    PubMed     Abstract available


  530. IWATA AJ, Olden HA, Kippen KE, Swegal WC, et al
    A flexible model for patient engagement: Achieving quality outcomes and building a research agenda for head and neck cancer.
    Head Neck. 2019 Jan 8. doi: 10.1002/hed.25584.
    PubMed     Abstract available


  531. WHITE JM, Panchal NH, Wehler CJ, Bestgen SC, et al
    Department of Veterans Affairs Consensus: Preradiation dental treatment guidelines for patients with head and neck cancer.
    Head Neck. 2019 Jan 8. doi: 10.1002/hed.25519.
    PubMed     Abstract available


  532. INGARFIELD K, McMahon AD, Douglas CM, Savage SA, et al
    Determinants of long-term survival in a population-based cohort study of patients with head and neck cancer from Scotland.
    Head Neck. 2019 Jan 8. doi: 10.1002/hed.25630.
    PubMed     Abstract available


  533. MONTES DE OCA MK, Nye A, Porter C, Collins J, et al
    Head and neck cancer PEG site metastases: Association with PEG placement method.
    Head Neck. 2019 Jan 7. doi: 10.1002/hed.25564.
    PubMed     Abstract available


  534. DENARO AN, Merlano MC
    Unexpected response with palliative conventional therapy in head and neck squamous cell carcinoma after anti-programmed death-1 progression.
    Head Neck. 2019 Jan 5. doi: 10.1002/hed.25418.
    PubMed     Abstract available


  535. MAYFIELD JD, Mercado CE, Kaye FJ, Mendenhall WM, et al
    Cetuximab-associated pulmonary toxicity in concurrent chemoradiation for the treatment of a squamous cell carcinoma of the head and neck.
    Head Neck. 2019 Jan 5. doi: 10.1002/hed.25528.
    PubMed     Abstract available


    December 2018
  536. LIN CS, Chen YW, Liu SC, Tsao CC, et al
    Treatment outcomes with whole-field versus split-field intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma.
    Head Neck. 2018 Dec 31. doi: 10.1002/hed.25328.
    PubMed     Abstract available


  537. GILL A, Givi BB, Moore MG
    AHNS Series - Do you know your guidelines?: Assessment and management of malnutrition in patients with head and neck cancer: A review of the NCCN Clinical Practice Guidelines In Oncology (NCCN Guidelines((R)) ).
    Head Neck. 2018 Dec 31. doi: 10.1002/hed.24866.
    PubMed     Abstract available


  538. YANG L, Huang Y, Zhou L, Dai Y, et al
    High pretreatment neutrophil-to-lymphocyte ratio as a predictor of poor survival prognosis in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
    Head Neck. 2018 Dec 30. doi: 10.1002/hed.25583.
    PubMed     Abstract available


  539. RAMOS-GARCIA P, Gonzalez-Moles MA, Ayen A, Gonzalez-Ruiz L, et al
    Prognostic and clinicopathological significance of CTTN/cortactin alterations in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
    Head Neck. 2018 Dec 30. doi: 10.1002/hed.25632.
    PubMed     Abstract available


  540. TIAN YM, Liu MZ, Zeng L, Bai L, et al
    Long-term outcome and pattern of failure for patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.
    Head Neck. 2018 Dec 28. doi: 10.1002/hed.25545.
    PubMed     Abstract available


  541. BUGTER O, van de Ven SEM, Hardillo JA, Bruno MJ, et al
    Early detection of esophageal second primary tumors using Lugol chromoendoscopy in patients with head and neck cancer: A systematic review and meta-analysis.
    Head Neck. 2018 Dec 28. doi: 10.1002/hed.25548.
    PubMed     Abstract available


  542. MIRZA AH, Aylin P, Middleton S, King EV, et al
    Impact of social deprivation on the outcome of major head and neck cancer surgery in England: A national analysis.
    Head Neck. 2018 Dec 28. doi: 10.1002/hed.25461.
    PubMed     Abstract available


  543. ALVES-PAIVA RM, Gutierrez-Rodrigues F, Pereira-Martins DA, Figueiredo DLA, et al
    Short telomere length in peripheral blood leukocytes in head and neck cancer: Findings in a Brazilian cohort.
    Head Neck. 2018 Dec 27. doi: 10.1002/hed.25472.
    PubMed     Abstract available


  544. HOLLOWS R, Wei W, Cazier JB, Mehanna H, et al
    Association between loss of Y chromosome and poor prognosis in male head and neck squamous cell carcinoma.
    Head Neck. 2018 Dec 23. doi: 10.1002/hed.25537.
    PubMed     Abstract available


  545. CAO C, Wei Q, Tang X, Jia Y, et al
    PD-1 and PD-L1 in locoregionally advanced nasopharyngeal carcinoma: A substudy of a randomized phase III trial.
    Head Neck. 2018 Dec 23. doi: 10.1002/hed.25601.
    PubMed     Abstract available


  546. TANDON S, Gairola M, Ahlawat P, Karimi AM, et al
    Failure patterns of head and neck squamous cell carcinoma treated with radical radiotherapy by intensity modulated radiotherapy technique using focal volume and dosimetric method.
    Head Neck. 2018 Dec 23. doi: 10.1002/hed.25586.
    PubMed     Abstract available


  547. FATTOUH M, Chang GY, Ow TJ, Shifteh K, et al
    Association between pretreatment obesity, sarcopenia, and survival in patients with head and neck cancer.
    Head Neck. 2018 Dec 23. doi: 10.1002/hed.25420.
    PubMed     Abstract available


  548. DI MAIO P, Iocca O, De Virgilio A, Ferreli F, et al
    Role of palatine tonsillectomy in the diagnostic workup of head and neck squamous cell carcinoma of unknown primary origin: A systematic review and meta-analysis.
    Head Neck. 2018 Dec 21. doi: 10.1002/hed.25522.
    PubMed     Abstract available


  549. KWON DI, Miles BA
    Hypopharyngeal carcinoma: Do you know your guidelines?
    Head Neck. 2018 Dec 20. doi: 10.1002/hed.24752.
    PubMed     Abstract available


  550. VAN DER GEER SJ, van Rijn PV, Kamstra JI, Langendijk JA, et al
    Prevalence and prediction of trismus in patients with head and neck cancer: A cross-sectional study.
    Head Neck. 2018 Dec 18. doi: 10.1002/hed.25369.
    PubMed     Abstract available


  551. WANG L, Han S, Zhu J, Wang X, et al
    Proton versus photon radiation-induced cell death in head and neck cancer cells.
    Head Neck. 2018 Dec 18. doi: 10.1002/hed.25357.
    PubMed     Abstract available


  552. KABARRITI R, Baliga S, Ohri N, Guha C, et al
    Radiation therapy for patients with newly diagnosed metastatic head and neck squamous cell carcinoma.
    Head Neck. 2018 Dec 16. doi: 10.1002/hed.25476.
    PubMed     Abstract available


  553. IBRAHIM MY, Nunez MI, Harun N, Lee JJ, et al
    PI3-kinase pathway biomarkers in oral cancer and tumor immune cells.
    Head Neck. 2018 Dec 16. doi: 10.1002/hed.25350.
    PubMed     Abstract available


  554. WANG K, Moon DH, Amdur RJ, Dagan R, et al
    Shoulder symptoms and quality of life impact of limited neck dissection after de-intensified chemoradiotherapy: Secondary analysis of two prospective trials.
    Head Neck. 2018 Dec 15. doi: 10.1002/hed.25535.
    PubMed     Abstract available


  555. EGYUD M, Sridhar P, Devaiah A, Yamada E, et al
    Plasma circulating tumor DNA as a potential tool for disease monitoring in head and neck cancer.
    Head Neck. 2018 Dec 15. doi: 10.1002/hed.25563.
    PubMed     Abstract available


  556. PLASCHKE CC, Johannesen HH, Hansen RH, Hendel HW, et al
    The DAHANCA 32 study: Electrochemotherapy for recurrent mucosal head and neck cancer.
    Head Neck. 2018 Dec 15. doi: 10.1002/hed.25454.
    PubMed     Abstract available


  557. SLAVIK M, Shatokhina T, Sana J, Ahmad P, et al
    Expression of CD44, EGFR, p16, and their mutual combinations in patients with head and neck cancer: Impact on outcomes of intensity-modulated radiation therapy.
    Head Neck. 2018 Dec 15. doi: 10.1002/hed.25533.
    PubMed     Abstract available


  558. KUBOKI A, Kanaya H, Nakayama T, Konno W, et al
    Prognostic value of C-reactive protein/albumin ratio for patients with hypopharyngeal and laryngeal cancer undergoing invasive surgery involving laryngectomy.
    Head Neck. 2018 Dec 15. doi: 10.1002/hed.25565.
    PubMed     Abstract available


  559. LEE YA, Li S, Chen Y, Li Q, et al
    Tobacco smoking, alcohol drinking, betel quid chewing, and the risk of head and neck cancer in an East Asian population.
    Head Neck. 2018 Dec 15. doi: 10.1002/hed.25383.
    PubMed     Abstract available


  560. WANG Y, Xie D, Wang Z, Zhang X, et al
    Kinetics of indocyanine green: Optimizing tumor to normal tissue fluorescence in image-guided oral cancer surgery applications.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25541.
    PubMed     Abstract available


  561. ODENTHAL J, Friedl P, Takes RP
    Compatibility of CO2 laser surgery and fluorescence detection in head and neck cancer cells.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25547.
    PubMed     Abstract available


  562. KARABULUT B
    AHNS series: Do you know our guidelines? Review of current knowledge on laryngeal cancer.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25491.
    PubMed    


  563. PAGEDAR NA, Davis AB, Sperry SM, Charlton ME, et al
    Population analysis of socioeconomic status and otolaryngologist distribution on head and neck cancer outcomes.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25521.
    PubMed     Abstract available


  564. PAKKANEN PP, Aaltonen LM, Sorsa TA, Tervahartiala TI, et al
    Serum matrix metalloproteinase 8 and tissue inhibitor of metalloproteinase 1: Potential markers for malignant transformation of recurrent respiratory papillomatosis and for prognosis of laryngeal cancer.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25459.
    PubMed     Abstract available


  565. RUUSKANEN M, Irjala H, Minn H, Vahlberg T, et al
    Epstein-Barr virus and human papillomaviruses as favorable prognostic factors in nasopharyngeal carcinoma: A nationwide study in Finland.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25450.
    PubMed     Abstract available


  566. ARRESE LC, Schieve HJ, Graham JM, Stephens JA, et al
    Relationship between oral intake, patient perceived swallowing impairment, and objective videofluoroscopic measures of swallowing in patients with head and neck cancer.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25542.
    PubMed     Abstract available


  567. GUEZENNEC C, Robin P, Orlhac F, Bourhis D, et al
    Prognostic value of textural indices extracted from pretherapeutic 18-F FDG-PET/CT in head and neck squamous cell carcinoma.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25433.
    PubMed     Abstract available


  568. SCHIMANSKY S, Lang S, Beynon R, Penfold C, et al
    Association between comorbidity and survival in head and neck cancer: Results from Head and Neck 5000.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25543.
    PubMed     Abstract available


  569. ZHU Y, Liu H, Xie N, Liu X, et al
    Impact of tumor budding in head and neck squamous cell carcinoma: A meta-analysis.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25462.
    PubMed     Abstract available


  570. TAMAKI A
    HED-17-0417-AHNS series: Do you know your guidelines? A review of current knowledge on laryngeal cancer.
    Head Neck. 2018 Dec 14. doi: 10.1002/hed.25448.
    PubMed    


  571. GAO W, Wong TS, Lv KX, Zhang MJ, et al
    Detection of Epstein-Barr virus (EBV)-encoded microRNAs in plasma of patients with nasopharyngeal carcinoma.
    Head Neck. 2018 Dec 13. doi: 10.1002/hed.25544.
    PubMed     Abstract available


  572. TUMATI V, Hoang L, Sumer BD, Truelson JM, et al
    Association between treatment delays and oncologic outcome in patients treated with surgery and radiotherapy for head and neck cancer.
    Head Neck. 2018 Dec 13. doi: 10.1002/hed.25457.
    PubMed     Abstract available


  573. SHAHID N, Iqbal A, Siddiqui AJ, Shoaib M, et al
    Plasma metabolite profiling and chemometric analyses of tobacco snuff dippers and patients with oral cancer: Relationship between metabolic signatures.
    Head Neck. 2018 Dec 13. doi: 10.1002/hed.25511.
    PubMed     Abstract available


  574. RODNER E, Bocklitz T, von Eggeling F, Ernst G, et al
    Fully convolutional networks in multimodal nonlinear microscopy images for automated detection of head and neck carcinoma: A pilot study.
    Head Neck. 2018 Dec 12. doi: 10.1002/hed.25489.
    PubMed     Abstract available


  575. KIM TH, Lee IJ, Kim JH, Lee CG, et al
    High-dose versus standard-dose radiation therapy for cervical esophageal cancer: A retrospective single-institution study.
    Head Neck. 2018 Dec 12. doi: 10.1002/hed.25483.
    PubMed     Abstract available


  576. QUATRE R, Jacquet T, Atallah I, Tillement O, et al
    Evaluation of the theranostic properties of gadolinium-based nanoparticles for head and neck cancer.
    Head Neck. 2018 Dec 12. doi: 10.1002/hed.25460.
    PubMed     Abstract available


  577. PANTVAIDYA G, Sivasanker M, Ranganathan P, Pai P, et al
    Prospective cross-sectional study assessing prevalence and factors affecting trismus after multimodal treatment for oral cancers.
    Head Neck. 2018 Dec 12. doi: 10.1002/hed.25464.
    PubMed     Abstract available


  578. LADANYI A, Kapuvari B, Papp E, Toth E, et al
    Local immune parameters as potential predictive markers in head and neck squamous cell carcinoma patients receiving induction chemotherapy and cetuximab.
    Head Neck. 2018 Dec 12. doi: 10.1002/hed.25546.
    PubMed     Abstract available


  579. ARROYO-SOLERA I, Pavon MA, Leon X, Lopez M, et al
    Effect of serpinE1 overexpression on the primary tumor and lymph node, and lung metastases in head and neck squamous cell carcinoma.
    Head Neck. 2018 Dec 12. doi: 10.1002/hed.25437.
    PubMed     Abstract available


  580. MIYAMARU S, Minoda R, Kodama N
    Long-term changes in vocal function after supracricoid partial laryngectomy with cricohyoidoepiglottopexy for laryngeal cancer.
    Head Neck. 2018 Dec 12. doi: 10.1002/hed.25487.
    PubMed     Abstract available


  581. LUMLEY CJ, Kaffenberger TM, Desale S, Tefera E, et al
    Post-diagnosis aspirin use and survival in veterans with head and neck cancer.
    Head Neck. 2018 Dec 11. doi: 10.1002/hed.25518.
    PubMed     Abstract available


  582. FANG FM, Huang TL, Lin YH, Chien CY, et al
    Concurrent chemoradiotherapy by simultaneously integrated boost volumetric-modulated arc therapy for nasopharyngeal carcinoma-toxicity/quality of life and survival.
    Head Neck. 2018 Dec 10. doi: 10.1002/hed.25551.
    PubMed     Abstract available


  583. KUWABARA H, Toriihara A, Yuasa-Nakagawa K, Toda K, et al
    Prognostic value of metabolic tumor burden calculated using dual-time-point 18F-fluorodeoxyglucose positron emission tomography/CT in patients with oropharyngeal or hypopharyngeal cancer.
    Head Neck. 2018 Dec 10. doi: 10.1002/hed.25490.
    PubMed     Abstract available


  584. YANG CY, Lin CK, Hsieh CC, Tsao CH, et al
    Anti-oral cancer effects of triptolide by downregulation of DcR3 in vitro, in vivo, and in preclinical patient-derived tumor xenograft model.
    Head Neck. 2018 Dec 10. doi: 10.1002/hed.25554.
    PubMed     Abstract available


  585. LEE JH, Chun YS, Chung YS
    Extent of lateral neck dissection for papillary thyroid microcarcinomas.
    Head Neck. 2018 Dec 10. doi: 10.1002/hed.25570.
    PubMed     Abstract available


  586. RYU HJ, Kim EK, Cho BC, Yoon SO, et al
    Characterization of head and neck squamous cell carcinoma arising in young patients: Particular focus on molecular alteration and tumor immunity.
    Head Neck. 2018 Dec 10. doi: 10.1002/hed.25507.
    PubMed     Abstract available


  587. MCSPADDEN R, Zender C, Eskander A
    AHNS series: Do you know your guidelines? Guideline recommendations for recurrent and persistent head and neck cancer after primary treatment.
    Head Neck. 2018 Dec 10. doi: 10.1002/hed.25443.
    PubMed     Abstract available


  588. CHOI JB, Lee SG, Kim MJ, Kim TH, et al
    Oncologic outcomes in patients with 1-cm to 4-cm differentiated thyroid carcinoma according to extent of thyroidectomy.
    Head Neck. 2018 Dec 10. doi: 10.1002/hed.25356.
    PubMed     Abstract available


  589. OKAZAKI E, Kawabe J, Oishi M, Hosono M, et al
    Prognostic significance of pretreatment 18F-fluorodeoxyglucose positron emission tomography evaluation using metabolic tumor volume of the primary tumor and lymph nodes in advanced hypopharyngeal cancer.
    Head Neck. 2018 Dec 7. doi: 10.1002/hed.25429.
    PubMed     Abstract available


  590. HUTCHESON KA, Nurgalieva Z, Zhao H, Gunn GB, et al
    Two-year prevalence of dysphagia and related outcomes in head and neck cancer survivors: An updated SEER-Medicare analysis.
    Head Neck. 2018 Dec 7. doi: 10.1002/hed.25412.
    PubMed     Abstract available


  591. ROTMAN A, Kerr SJ, Giddings CEB
    Elective neck dissection in metastatic cutaneous squamous cell carcinoma to the parotid gland: A systematic review and meta-analysis.
    Head Neck. 2018 Dec 7. doi: 10.1002/hed.25561.
    PubMed     Abstract available


  592. DRIESSEN CML, Leijendeckers J, Snik A, van der Graaf WTA, et al
    Ototoxicity in locally advanced head and neck cancer patients treated with induction chemotherapy followed by intermediate or high-dose cisplatin-based chemoradiotherapy.
    Head Neck. 2018 Dec 7. doi: 10.1002/hed.25434.
    PubMed     Abstract available


  593. VILASECA I, Nogues-Sabate A, Aviles-Jurado FX, Berenguer J, et al
    Factors of local recurrence and organ preservation with transoral laser microsurgery in laryngeal carcinomas; CHAID decision-tree analysis.
    Head Neck. 2018 Dec 6. doi: 10.1002/hed.25422.
    PubMed     Abstract available


  594. VON DER GRUN J, Kohn J, Loutfi-Krauss B, Blanck O, et al
    Second infield re-irradiation with a resulting cumulative equivalent dose (EQD2max ) of >180 Gy for patients with recurrent head and neck cancer.
    Head Neck. 2018 Dec 6. doi: 10.1002/hed.25428.
    PubMed     Abstract available


    November 2018
  595. PAGEDAR NA, Fowlkes JW, Sheffield AM
    Operative technique: Lateral neck dissection.
    Head Neck. 2018 Nov 26. doi: 10.1002/hed.25348.
    PubMed    


  596. WONG ET, Dmytriw AA, Yu E, Waldron J, et al
    (18) F-FDG PET/CT for locoregional surveillance following definitive treatment of head and neck cancer: A meta-analysis of reported studies.
    Head Neck. 2018 Nov 20. doi: 10.1002/hed.25513.
    PubMed     Abstract available


  597. BOSSI P, Miceli R, Benasso M, Corvo R, et al
    Impact of treatment expertise on the outcome of patients with head and neck cancer treated within 6 randomized trials.
    Head Neck. 2018 Nov 17. doi: 10.1002/hed.25389.
    PubMed     Abstract available


  598. PARK JC, Gourin CG, Kiess AP, Mehra R, et al
    Pattern of planned systemic therapy usage in newly diagnosed, nonmetastatic squamous cell carcinoma of the head and neck in a commercially insured population in the United States.
    Head Neck. 2018 Nov 13. doi: 10.1002/hed.25333.
    PubMed     Abstract available


  599. TRUONG AT, Truong DT, Rahlfs TF
    TRS score: A proposed mnemonic for airway assessment and management in patients with head and neck cancers.
    Head Neck. 2018 Nov 2. doi: 10.1002/hed.25502.
    PubMed    


    October 2018
  600. ANSCHUETZ L, Visini M, Shelan M, Elicin O, et al
    Risk analysis for tracheostomy dependency in curatively treated laryngeal cancer with organ preservation.
    Head Neck. 2018 Oct 11. doi: 10.1002/hed.25373.
    PubMed     Abstract available


  601. LEON X, Pardo L, Sansa A, Fernandez A, et al
    Prognostic role of extracapsular spread in planned neck dissection after chemoradiotherapy.
    Head Neck. 2018 Oct 11. doi: 10.1002/hed.25390.
    PubMed     Abstract available


  602. ZHANG N, Fielding R, Soong I, Chan KK, et al
    Illness perceptions as predictors of psychological distress among head and neck cancer survivors: a longitudinal study.
    Head Neck. 2018 Oct 11. doi: 10.1002/hed.25343.
    PubMed     Abstract available


  603. KILIC S, Kilic SS, Hsueh WD, Eloy JA, et al
    Radiotherapy modality as a predictor of survival in hypopharyngeal cancer.
    Head Neck. 2018 Oct 10. doi: 10.1002/hed.25360.
    PubMed     Abstract available


  604. SON HJ, Kim JK, Jung YD, Jang GH, et al
    Comparison of outcomes between hemithyroidectomy alone and hemithyroidectomy with elective unilateral central neck dissection in patients with papillary thyroid microcarcinoma.
    Head Neck. 2018 Oct 10. doi: 10.1002/hed.25354.
    PubMed     Abstract available


  605. KOGASHIWA Y, Inoue H, Kuba K, Araki R, et al
    Prognostic role of epiregulin/amphiregulin expression in recurrent/metastatic head and neck cancer treated with cetuximab.
    Head Neck. 2018 Oct 10. doi: 10.1002/hed.25353.
    PubMed     Abstract available


  606. HAMILTON SN, Tran E, Berthelet E, Wu J, et al
    Early (90-day) mortality after radical radiotherapy for head and neck squamous cell carcinoma: A population-based analysis.
    Head Neck. 2018 Oct 8. doi: 10.1002/hed.25352.
    PubMed     Abstract available


    September 2018
  607. SCRIMGER RA, Seikaly H, Vos LJ, Harris J, et al
    Combination of submandibular salivary gland transfer and intensity-modulated radiotherapy to reduce dryness of mouth (xerostomia) in patients with head and neck cancer.
    Head Neck. 2018 Sep 3. doi: 10.1002/hed.25339.
    PubMed     Abstract available


    August 2018
  608. DOMINGUES CSDC, Serambeque BP, Laranjo Candido MS, Marto CMM, et al
    Epithelial-mesenchymal transition and microRNAs: Challenges and future perspectives in oral cancer.
    Head Neck. 2018 Aug 18. doi: 10.1002/hed.25381.
    PubMed     Abstract available


  609. TAKENAKA Y, Oya R, Kitamiura T, Ashida N, et al
    Platelet count and platelet-lymphocyte ratio as prognostic markers for head and neck squamous cell carcinoma: A meta-analysis.
    Head Neck. 2018 Aug 13. doi: 10.1002/hed.25366.
    PubMed     Abstract available


  610. KARATAS OF
    Antiproliferative potential of miR-33a in laryngeal cancer Hep-2 cells via targeting PIM1.
    Head Neck. 2018 Aug 13. doi: 10.1002/hed.25361.
    PubMed     Abstract available


    July 2018
  611. HONG YT, Hong KH
    Identification of lymphatic channels in the tracheoesophageal groove during central neck dissection for thyroid cancer.
    Head Neck. 2018 Jul 26. doi: 10.1002/hed.25125.
    PubMed     Abstract available


    June 2018
  612. MARIONI G, Cappellesso R, Ottaviano G, Fasanaro E, et al
    Nuclear nonmetastatic protein 23-H1 expression and epithelial-mesenchymal transition in laryngeal carcinoma: A pilot investigation.
    Head Neck. 2018 Jun 28. doi: 10.1002/hed.25188.
    PubMed     Abstract available


  613. LEBO NL, Griffiths R, Hall S, Dimitroulakos J, et al
    Effect of statin use on oncologic outcomes in head and neck squamous cell carcinoma.
    Head Neck. 2018 Jun 22. doi: 10.1002/hed.25152.
    PubMed     Abstract available


  614. OOFT ML, van Ipenburg J, van de Loo RJM, de Jong R, et al
    Differences in cancer gene copy number alterations between Epstein-Barr virus-positive and Epstein-Barr virus-negative nasopharyngeal carcinoma.
    Head Neck. 2018 Jun 21. doi: 10.1002/hed.25195.
    PubMed     Abstract available


    May 2018
  615. THAM T, Bardash Y, Herman SW, Costantino PD, et al
    Neutrophil-to-lymphocyte ratio as a prognostic indicator in head and neck cancer: A systematic review and meta-analysis.
    Head Neck. 2018 May 14. doi: 10.1002/hed.25324.
    PubMed     Abstract available


  616. WU JS, Tsai YC, Jian JJ, Chen HH, et al
    Survival without adjuvant chemotherapy for selected patients with stage II and III nasopharyngeal carcinoma after concurrent chemoradiotherapy alone.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25205.
    PubMed     Abstract available


  617. LANDEEN KC, Spanos WC, Gromer L
    Topical superoxide dismutase in posttreatment fibrosis in patients with head and neck cancer.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25119.
    PubMed     Abstract available


  618. ANDERSON NJ, Jackson JE, Smith JG, Wada M, et al
    Pretreatment risk stratification of feeding tube use in patients treated with intensity-modulated radiotherapy for head and neck cancer.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25316.
    PubMed     Abstract available


  619. TRIVEDI NP
    Oral cancer involving masticator space (T4b): Review of literature and future directions.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25211.
    PubMed     Abstract available


  620. SUCCO G, Crosetti E, Bertolin A, Piazza C, et al
    Treatment for T3 to T4a laryngeal cancer by open partial horizontal laryngectomies: Prognostic impact of different pathologic tumor subcategories.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25176.
    PubMed     Abstract available


  621. ALAHMAD YM, Aljaber M, Saleh AI, Yalcin HC, et al
    Effect of cell-phone radiofrequency on angiogenesis and cell invasion in human head and neck cancer cells.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25210.
    PubMed     Abstract available


  622. SONG JSA, Moolman N, Burrell S, Rajaraman M, et al
    Use of radioiodine-131 scan to measure influence of surgical discipline, practice, and volume on residual thyroid tissue after total thyroidectomy for differentiated thyroid carcinoma.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25204.
    PubMed     Abstract available


  623. MULCAHY CF, Mohamed ASR, Kanwar A, Hutcheson KA, et al
    Age-adjusted comorbidity and survival in locally advanced laryngeal cancer.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25200.
    PubMed     Abstract available


  624. ONO T, Azuma K, Kawahara A, Sasada T, et al
    Prognostic stratification of patients with nasopharyngeal carcinoma based on tumor immune microenvironment.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25189.
    PubMed     Abstract available


    April 2018
  625. NAIR D, Mair M, Singhvi H, Mishra A, et al
    Perineural invasion: Independent prognostic factor in oral cancer that warrants adjuvant treatment.
    Head Neck. 2018 Apr 29. doi: 10.1002/hed.25170.
    PubMed     Abstract available


  626. HO JC, Phan J
    Reirradiation of head and neck cancer using modern highly conformal techniques.
    Head Neck. 2018 Apr 23. doi: 10.1002/hed.25180.
    PubMed     Abstract available


  627. BERNSTEIN LJ, Pond GR, Gan HK, Tirona K, et al
    Pretreatment neurocognitive function and self-reported symptoms in patients with newly diagnosed head and neck cancer compared with noncancer cohort.
    Head Neck. 2018 Apr 17. doi: 10.1002/hed.25198.
    PubMed     Abstract available


  628. FAN CY, Jen YM, Su YC, Chao HL, et al
    Association between nasopharyngeal carcinoma and risk of optic neuropathy: A population-based cohort study.
    Head Neck. 2018 Apr 16. doi: 10.1002/hed.25177.
    PubMed     Abstract available


    March 2018
  629. SHINGLER E, Robles LA, Perry R, Penfold C, et al
    Systematic review evaluating randomized controlled trials of smoking and alcohol cessation interventions in people with head and neck cancer and oral dysplasia.
    Head Neck. 2018 Mar 30. doi: 10.1002/hed.25138.
    PubMed     Abstract available


  630. HAQUE SU, Niu L, Kuhnell D, Hendershot J, et al
    Differential expression and prognostic value of long non-coding RNA in HPV-negative head and neck squamous cell carcinoma.
    Head Neck. 2018 Mar 25. doi: 10.1002/hed.25136.
    PubMed     Abstract available


  631. HEGDE JV, Demanes DJ, Veruttipong D, Chin RK, et al
    Head and neck cancer reirradiation with interstitial high-dose-rate brachytherapy.
    Head Neck. 2018 Mar 23. doi: 10.1002/hed.25137.
    PubMed     Abstract available


  632. KIM HK, Lee I, Lee J, Chang HS, et al
    BRAF(wild) papillary thyroid carcinoma has two distinct mRNA expression patterns with different clinical behaviors.
    Head Neck. 2018 Mar 23. doi: 10.1002/hed.25151.
    PubMed     Abstract available


  633. RHOTEN BA, Murphy BA, Dietrich MS, Ridner SH, et al
    Depressive symptoms, social anxiety, and perceived neck function in patients with head and neck cancer.
    Head Neck. 2018 Mar 23. doi: 10.1002/hed.25129.
    PubMed     Abstract available


  634. LUCIONI M, Lionello M, Salis G, Bertolin A, et al
    Bocca's hemipharyngo-total laryngectomy for hypopharyngeal carcinoma to avoid reconstruction with a pedicled flap.
    Head Neck. 2018 Mar 23. doi: 10.1002/hed.25124.
    PubMed     Abstract available


  635. CONDELLO V, Macerola E, Ugolini C, De Napoli L, et al
    Analysis of circulating tumor DNA does not improve the clinical management of patients with locally advanced and metastatic papillary thyroid carcinoma.
    Head Neck. 2018 Mar 22. doi: 10.1002/hed.25155.
    PubMed     Abstract available


  636. MCEWEN SE, Dunphy C, Rios JN, Davis AM, et al
    Evaluation of a rehabilitation planning consult for survivors of head and neck cancer.
    Head Neck. 2018 Mar 22. doi: 10.1002/hed.25113.
    PubMed     Abstract available


  637. PAYNE K, Spruce R, Beggs A, Sharma N, et al
    Circulating tumor DNA as a biomarker and liquid biopsy in head and neck squamous cell carcinoma.
    Head Neck. 2018 Mar 15. doi: 10.1002/hed.25140.
    PubMed     Abstract available


  638. WANG CI, Yu CJ, Huang Y, Yi JS, et al
    Association of overexpressed karyopherin alpha 2 with poor survival and its contribution to interleukin-1beta-induced matrix metalloproteinase expression in oral cancer.
    Head Neck. 2018 Mar 15. doi: 10.1002/hed.25145.
    PubMed     Abstract available


  639. KIM H, Vargo JA, Beriwal S, Clump DA, et al
    Cost-effectiveness analysis of salvage therapies in locoregional previously irradiated head and neck cancer.
    Head Neck. 2018 Mar 14. doi: 10.1002/hed.25142.
    PubMed     Abstract available


  640. SUZUKI S, Yasunaga H, Matsui H, Fushimi K, et al
    Postoperative mechanical bowel obstruction after pharyngolaryngectomy for hypopharyngeal cancer: Retrospective analysis using a Japanese inpatient database.
    Head Neck. 2018 Mar 14. doi: 10.1002/hed.25139.
    PubMed     Abstract available


  641. YU F, Lu Y, Petersson F, Wang DY, et al
    Presence of lytic Epstein-Barr virus infection in nasopharyngeal carcinoma.
    Head Neck. 2018 Mar 9. doi: 10.1002/hed.25131.
    PubMed     Abstract available


  642. DAHER T, Tur MK, Brobeil A, Etschmann B, et al
    Combined human papillomavirus typing and TP53 mutation analysis in distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma.
    Head Neck. 2018 Mar 9. doi: 10.1002/hed.25041.
    PubMed     Abstract available


  643. WANG X, Li Y, Gao Y, Ouyang D, et al
    Second primary squamous cell carcinoma in patients with nasopharyngeal carcinoma after radiotherapy predictors and prognostic factors.
    Head Neck. 2018 Mar 9. doi: 10.1002/hed.25130.
    PubMed     Abstract available


  644. MIZUSHIMA T, Ohnishi S, Shimizu Y, Hatanaka Y, et al
    Rapid detection of superficial head and neck squamous cell carcinoma by topically spraying fluorescent probe targeting dipeptidyl peptidase-IV.
    Head Neck. 2018 Mar 6. doi: 10.1002/hed.25126.
    PubMed     Abstract available


  645. VUONG HG, Odate T, Duong UNP, Mochizuki K, et al
    Prognostic importance of solid variant papillary thyroid carcinoma: A systematic review and meta-analysis.
    Head Neck. 2018 Mar 6. doi: 10.1002/hed.25123.
    PubMed     Abstract available


  646. LU J, Chen XM, Huang HR, Zhao FP, et al
    Detailed analysis of inflammatory cell infiltration and the prognostic impact on nasopharyngeal carcinoma.
    Head Neck. 2018 Mar 1. doi: 10.1002/hed.25104.
    PubMed     Abstract available


    February 2018
  647. PENFOLD CM, Thomas SJ, Waylen A, Ness AR, et al
    Change in alcohol and tobacco consumption after a diagnosis of head and neck cancer: Findings from head and neck 5000.
    Head Neck. 2018 Feb 27. doi: 10.1002/hed.25116.
    PubMed     Abstract available


  648. HAMSTRA DA, Lee KC, Eisbruch A, Sunkara P, et al
    Double-blind placebo-controlled multicenter phase II trial to evaluate D-methionine in preventing/reducing oral mucositis induced by radiation and chemotherapy for head and neck cancer.
    Head Neck. 2018 Feb 23. doi: 10.1002/hed.25115.
    PubMed     Abstract available


  649. DANILOVIC DLS, de Mello ES, Frazzato EST, Wakamatsu A, et al
    Oncogenic mutations in KEAP1 disturbing inhibitory Nrf2-Keap1 interaction: Activation of antioxidative pathway in papillary thyroid carcinoma.
    Head Neck. 2018 Feb 22. doi: 10.1002/hed.25105.
    PubMed     Abstract available


  650. MORISADA M, Chamberlin M, Allen C
    Exploring the rationale for combining ionizing radiation and immune checkpoint blockade in head and neck cancer.
    Head Neck. 2018 Feb 20. doi: 10.1002/hed.25101.
    PubMed     Abstract available


  651. OSBORN VW, Givi B, Rineer J, Roden D, et al
    Patterns of care and outcomes of adjuvant therapy for high-risk head and neck cancer after surgery.
    Head Neck. 2018 Feb 16. doi: 10.1002/hed.25103.
    PubMed     Abstract available


  652. CHAN SL, Ng LS, Goh X, Siow CH, et al
    Time course and clinical characterization of cisplatin-induced ototoxicity after treatment for nasopharyngeal carcinoma in a South East Asian population.
    Head Neck. 2018 Feb 16. doi: 10.1002/hed.25112.
    PubMed     Abstract available


  653. GINGERICH MA, Smith JD, Michmerhuizen NL, Ludwig M, et al
    Comprehensive review of genetic factors contributing to head and neck squamous cell carcinoma development in low-risk, nontraditional patients.
    Head Neck. 2018 Feb 10. doi: 10.1002/hed.25057.
    PubMed     Abstract available


  654. YOSHIDA EJ, Luu M, David JM, Kim S, et al
    Postoperative chemoradiotherapy in patients with head and neck cancer aged 70 or older with positive margins or extranodal extension and the influence of nodal classification.
    Head Neck. 2018 Feb 8. doi: 10.1002/hed.25100.
    PubMed     Abstract available


  655. KIRKE DN, Qureshi MM, Kamran SC, Ezzat W, et al
    Role of adjuvant chemoradiotherapy in T4N0 stage IV head and neck cancer: A National Cancer Database analysis.
    Head Neck. 2018 Feb 8. doi: 10.1002/hed.25087.
    PubMed     Abstract available


  656. MURTHY SP, Balasubramanian D, Subramaniam N, Nair G, et al
    Prevalence of adverse pathological features in 1 to 4 cm low-risk differentiated thyroid carcinoma.
    Head Neck. 2018 Feb 8. doi: 10.1002/hed.25099.
    PubMed     Abstract available


  657. HALL SF, Griffiths RJ
    Evaluation of treatment outcomes in patients with supraglottic laryngeal cancer in Ontario, Canada: A population-based study.
    Head Neck. 2018 Feb 7. doi: 10.1002/hed.25073.
    PubMed     Abstract available


  658. BACK LJJ, Aro K, Tapiovaara L, Vikatmaa P, et al
    Sacrifice and extracranial reconstruction of the common or internal carotid artery in advanced head and neck carcinoma: Review and meta-analysis.
    Head Neck. 2018 Feb 5. doi: 10.1002/hed.25093.
    PubMed     Abstract available


  659. GUTTMANN DM, Kobie J, Grover S, Lin A, et al
    National disparities in treatment package time for resected locally advanced head and neck cancer and impact on overall survival.
    Head Neck. 2018 Feb 2. doi: 10.1002/hed.25091.
    PubMed     Abstract available


  660. TALMI YP, Takes RP, Alon EE, Nixon IJ, et al
    Prognostic value of lymph node ratio in head and neck squamous cell carcinoma.
    Head Neck. 2018 Feb 2. doi: 10.1002/hed.25080.
    PubMed     Abstract available


  661. LIN PJ, Twu CW, Liu YC, Lin TY, et al
    Comparison the clinical outcomes with altered versus conventional fractionated radiotherapy plus concurrent chemotherapy for advanced nasopharyngeal carcinoma.
    Head Neck. 2018 Feb 1. doi: 10.1002/hed.25084.
    PubMed     Abstract available


  662. TIRELLI G, Bergamini PR, Scardoni A, Gatto A, et al
    Intraoperative monitoring of marginal mandibular nerve during neck dissection.
    Head Neck. 2018 Feb 1. doi: 10.1002/hed.25078.
    PubMed     Abstract available


    January 2018
  663. VALLS-MATEUS M, Nogues-Sabate A, Blanch JL, Bernal-Sprekelsen M, et al
    Narrow band imaging for head and neck malignancies: Lessons learned from mistakes.
    Head Neck. 2018 Jan 31. doi: 10.1002/hed.25088.
    PubMed     Abstract available


  664. NAKAYAMA M, Gosho M, Hirose Y, Nishimura B, et al
    Modified combination of platelet count and neutrophil "to" lymphocyte ratio as a prognostic factor in patients with advanced head and neck cancer.
    Head Neck. 2018 Jan 31. doi: 10.1002/hed.25085.
    PubMed     Abstract available


  665. ZENGA J, Pipkorn P, Graboyes EM, Martin EJ, et al
    Oncologic outcomes of extended neck dissections in human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Head Neck. 2018 Jan 29. doi: 10.1002/hed.25060.
    PubMed     Abstract available


  666. AEBERHARD C, Mayer C, Meyer S, Mueller SA, et al
    Effect of preoperative immunonutrition on postoperative short-term outcomes of patients with head and neck squamous cell carcinoma.
    Head Neck. 2018 Jan 24. doi: 10.1002/hed.25072.
    PubMed     Abstract available


  667. VASAN K, Low TH, Gupta R, Ashford B, et al
    Lymph node ratio as a prognostic factor in metastatic cutaneous head and neck squamous cell carcinoma.
    Head Neck. 2018 Jan 23. doi: 10.1002/hed.25066.
    PubMed     Abstract available


  668. LAM JKS, Sundaresan P, Gebski V, Veness MJ, et al
    Immunocompromised patients with metastatic cutaneous nodal squamous cell carcinoma of the head and neck: Poor outcome unrelated to the index lesion.
    Head Neck. 2018 Jan 23. doi: 10.1002/hed.25069.
    PubMed     Abstract available


  669. BAUMEISTER P, Baumuller K, Harreus U, Reiter M, et al
    Evaluation of margins in head and neck squamous cell carcinoma from the surgeon's perspective.
    Head Neck. 2018 Jan 22. doi: 10.1002/hed.25061.
    PubMed     Abstract available


  670. MASCARELLA MA, Mannard E, Daniela Silva Wurzba S, Zeitouni A, et al
    Neutrophil-to-lymphocyte ratio in head and neck cancer prognosis: A systematic review and meta-analysis.
    Head Neck. 2018 Jan 22. doi: 10.1002/hed.25075.
    PubMed     Abstract available


  671. ESKANDER A, Strigenz D, Seim N, Ozer E, et al
    Submental artery island flap with simultaneous level I neck dissection.
    Head Neck. 2018 Jan 13. doi: 10.1002/hed.25044.
    PubMed     Abstract available


  672. REN Y, Deschler DG, Sajed D, Durand ML, et al
    Case of late-onset, relapsing surgical site infection related to a venous coupler placed during free flap reconstruction for major head and neck cancer.
    Head Neck. 2018 Jan 12. doi: 10.1002/hed.25043.
    PubMed     Abstract available


  673. SATHASIVAM HP, Davies GR, Boyd NM
    Predictive factors for osteoradionecrosis of the jaws: A retrospective study.
    Head Neck. 2018;40:46-54.
    PubMed     Abstract available


  674. CHENG SJ, Ko HH, Lee JJ, Kok SH, et al
    Comparison of long-term outcomes between pull-through resection and mandibular lip-split surgery for T4a tongue/floor of mouth cancers.
    Head Neck. 2018;40:144-153.
    PubMed     Abstract available


  675. MAYROVITZ HN, Ryan S, Hartman JM
    Usability of advanced pneumatic compression to treat cancer-related head and neck lymphedema: A feasibility study.
    Head Neck. 2018;40:137-143.
    PubMed     Abstract available


  676. GROSELJ A, Bosnjak M, Strojan P, Krzan M, et al
    Efficiency of electrochemotherapy with reduced bleomycin dose in the treatment of nonmelanoma head and neck skin cancer: Preliminary results.
    Head Neck. 2018;40:120-125.
    PubMed     Abstract available


  677. KANG JH, Jung DW, Pak KJ, Kim IJ, et al
    Prognostic implication of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with recurrent papillary thyroid cancer.
    Head Neck. 2018;40:94-102.
    PubMed     Abstract available


  678. OKER N, Verillaud B, Wassef M, Froelich S, et al
    Ethmoidal adenocarcinoma treated by exclusive endoscopic approach: Focus on learning curve and modification of management.
    Head Neck. 2018;40:126-136.
    PubMed     Abstract available


  679. WONG EHC, Tetter N, Tzankov A, Muller L, et al
    CASTLE tumor of the parotid: First documented case, literature review, and genetic analysis of the cancer.
    Head Neck. 2018;40:E1-E4.
    PubMed     Abstract available


  680. PARK I, Her N, Choe JH, Kim JS, et al
    Management of chyle leakage after thyroidectomy, cervical lymph node dissection, in patients with thyroid cancer.
    Head Neck. 2018;40:7-15.
    PubMed     Abstract available


  681. MCCLELLAN J, Achim V, Clayburgh D
    Small bowel obstruction after transoral robotic surgery.
    Head Neck. 2018;40:E9-E12.
    PubMed     Abstract available


  682. SO YK, Oh D, Choi N, Baek CH, et al
    Efficacy of postoperative neck irradiation for regional control in patients with pN0 oral tongue cancer: Propensity analysis.
    Head Neck. 2018;40:163-169.
    PubMed     Abstract available


  683. ARO K, Tarkkanen J, Saat R, Saarilahti K, et al
    Submandibular gland cancer: Specific features and treatment considerations.
    Head Neck. 2018;40:154-162.
    PubMed     Abstract available


  684. MATTAVELLI D, Schreiber A, Villaret AB, Accorona R, et al
    Complications and donor site morbidity of 3-layer reconstruction with iliotibial tract of the anterior skull base: Retrospective analysis of 186 patients.
    Head Neck. 2018;40:63-69.
    PubMed     Abstract available


  685. LANSU J, Klop WM, Heemsbergen W, Navran A, et al
    Local control in sinonasal malignant melanoma: Comparing conventional to hypofractionated radiotherapy.
    Head Neck. 2018;40:86-93.
    PubMed     Abstract available


  686. HONG MH, Kim CG, Koh YW, Choi EC, et al
    Efficacy and safety of vinorelbine plus cisplatin chemotherapy for patients with recurrent and/or metastatic salivary gland cancer of the head and neck.
    Head Neck. 2018;40:55-62.
    PubMed     Abstract available


  687. MEYER A, Gross N, Teng M
    AHNS Series: Do you know your guidelines? Perioperative antithrombotic management in head and neck surgery.
    Head Neck. 2018;40:182-191.
    PubMed     Abstract available


  688. PENA I, Clayman GL, Grubbs EG, Bergeron JM Jr, et al
    Management of the lateral neck compartment in patients with sporadic medullary thyroid cancer.
    Head Neck. 2018;40:79-85.
    PubMed     Abstract available


    December 2017
  689. AVINCSAL MO, Shinomiya H, Teshima M, Kubo M, et al
    Impact of alcohol dehydrogenase-aldehyde dehydrogenase polymorphism on clinical outcome in patients with hypopharyngeal cancer.
    Head Neck. 2017 Dec 29. doi: 10.1002/hed.25050.
    PubMed     Abstract available


  690. DEJACO D, Steinbichler T, Schartinger VH, Fischer N, et al
    Prognostic value of tumor volume in patients with head and neck squamous cell carcinoma treated with primary surgery.
    Head Neck. 2017 Dec 22. doi: 10.1002/hed.25040.
    PubMed     Abstract available


  691. SON HJ, Roh JL, Choi SH, Nam SY, et al
    Nutritional and hematologic markers as predictors of risk of surgical site infection in patients with head and neck cancer undergoing major oncologic surgery.
    Head Neck. 2017 Dec 5. doi: 10.1002/hed.25031.
    PubMed     Abstract available


  692. SANABRIA A, Kowalski LP, Shah JP, Nixon IJ, et al
    Growing incidence of thyroid carcinoma in recent years: Factors underlying overdiagnosis.
    Head Neck. 2017 Dec 5. doi: 10.1002/hed.25029.
    PubMed     Abstract available


    November 2017
  693. FULCHER CD, Haigentz M Jr, Ow TJ
    AHNS Series: Do you know your guidelines? Principles of treatment for locally advanced or unresectable head and neck squamous cell carcinoma.
    Head Neck. 2017 Nov 24. doi: 10.1002/hed.25025.
    PubMed     Abstract available


  694. ESKANDER A, Ghanem T, Agrawal A
    AHNS Series: Do you know your guidelines? Guideline recommendations for head and neck cancer of unknown primary site.
    Head Neck. 2017 Nov 21. doi: 10.1002/hed.25026.
    PubMed     Abstract available


  695. CAO C, Hu Q, Chen X
    Intensity-modulated radiotherapy for elderly patients with nasopharyngeal carcinoma.
    Head Neck. 2017 Nov 20. doi: 10.1002/hed.25016.
    PubMed     Abstract available


  696. WONG DJY, Donaldson C, Lai LT, Coleman A, et al
    Safety and effectiveness of endovascular embolization or stent-graft reconstruction for treatment of acute carotid blowout syndrome in patients with head and neck cancer: Case series and systematic review of observational studies.
    Head Neck. 2017 Nov 20. doi: 10.1002/hed.25018.
    PubMed     Abstract available


  697. LECHELT LA, Rieger JM, Cowan K, Debenham BJ, et al
    Top 10 research priorities in head and neck cancer: Results of an Alberta priority setting partnership of patients, caregivers, family members, and clinicians.
    Head Neck. 2017 Nov 17. doi: 10.1002/hed.24998.
    PubMed     Abstract available


  698. MAYS AC, Bartels HG, Wistermayer PR, Rohlfing ML, et al
    Potential for health care cost savings with preoperative gastrostomy tube placement in the head and neck cancer population.
    Head Neck. 2017 Nov 13. doi: 10.1002/hed.24992.
    PubMed     Abstract available


  699. LEONG YH, Soon YY, Lee KM, Wong LC, et al
    Long-term outcomes after reirradiation in nasopharyngeal carcinoma with intensity-modulated radiotherapy: A meta-analysis.
    Head Neck. 2017 Nov 11. doi: 10.1002/hed.24993.
    PubMed     Abstract available


  700. DAVIDI ES, Dreifuss T, Motiei M, Shai E, et al
    Cisplatin-conjugated gold nanoparticles as a theranostic agent for head and neck cancer.
    Head Neck. 2017 Nov 11. doi: 10.1002/hed.24935.
    PubMed     Abstract available


  701. KAMSTRA JI, van Leeuwen M, Roodenburg JLN, Dijkstra PU, et al
    Exercise therapy for trismus secondary to head and neck cancer: A systematic review.
    Head Neck. 2017;39:2352-2362.
    PubMed     Abstract available


    October 2017
  702. CHAN JYW, Wong STS, Wei WI
    Stage II recurrent nasopharyngeal carcinoma: Prognostic significance of retropharyngeal nodal metastasis, parapharyngeal invasion, and carotid encasement.
    Head Neck. 2017 Oct 30. doi: 10.1002/hed.24976.
    PubMed     Abstract available


  703. TAMAKI A, Miles BA, Lango M, Kowalski L, et al
    AHNS Series: Do you know your guidelines? Review of current knowledge on laryngeal cancer.
    Head Neck. 2017 Oct 27. doi: 10.1002/hed.24862.
    PubMed     Abstract available


  704. TAKENAKA Y, Oya R, Kitamiura T, Ashida N, et al
    Prognostic role of neutrophil-to-lymphocyte ratio in head and neck cancer: A meta-analysis.
    Head Neck. 2017 Oct 27. doi: 10.1002/hed.24986.
    PubMed     Abstract available


  705. PENG S, Wu C, Sun W, Liu D, et al
    Snail-mediated cancer stem cell-like phenotype in human CNE2 nasopharyngeal carcinoma cell.
    Head Neck. 2017 Oct 12. doi: 10.1002/hed.24982.
    PubMed     Abstract available


  706. HUANG WB, Wong STS, Chan JYW
    Role of surgery in the treatment of osteoradionecrosis and its complications after radiotherapy for nasopharyngeal carcinoma.
    Head Neck. 2017 Oct 9. doi: 10.1002/hed.24973.
    PubMed     Abstract available


  707. LIU JC
    Head and Neck Cancer, Multimodality Management, 2nd ed, Editor: Jacques Bernier Jeffrey C. Liu Springer, Switzerland, 2016, USD $329, 878 pages.
    Head Neck. 2017 Oct 5. doi: 10.1002/hed.24920.
    PubMed    


    September 2017
  708. FAN CY, Chao HL, Lin CS, Huang WY, et al
    Risk of depressive disorder among patients with head and neck cancer: A nationwide population-based study.
    Head Neck. 2017 Sep 30. doi: 10.1002/hed.24961.
    PubMed     Abstract available


  709. LECHIEN JR, Nassri A, Kindt N, Brown DN, et al
    Role of macrophage migration inhibitory factor in head and neck cancer and novel therapeutic targets: A systematic review.
    Head Neck. 2017 Sep 30. doi: 10.1002/hed.24939.
    PubMed     Abstract available


  710. ONG HS, Gokavarapu S, Al-Qamachi L, Yin MY, et al
    Justification of routine venous thromboembolism prophylaxis in head and neck cancer reconstructive surgery.
    Head Neck. 2017 Sep 30. doi: 10.1002/hed.24914.
    PubMed     Abstract available


  711. BURNS CL, Kularatna S, Ward EC, Hill AJ, et al
    Cost analysis of a speech pathology synchronous telepractice service for patients with head and neck cancer.
    Head Neck. 2017 Sep 30. doi: 10.1002/hed.24916.
    PubMed     Abstract available


  712. LOMBARDI D, Paderno A, Giordano D, Barbieri D, et al
    Therapeutic lateral neck dissection in well-differentiated thyroid cancer: Analysis on factors predicting distribution of positive nodes and prognosis.
    Head Neck. 2017 Sep 30. doi: 10.1002/hed.24936.
    PubMed     Abstract available


  713. AVILES-JURADO FX, Flores JC, Guma J, Ceperuelo-Mallafre V, et al
    Prognostic relevance of insulin resistance on disease-free survival in head and neck squamous cell carcinomas: Preliminary results.
    Head Neck. 2017 Sep 30. doi: 10.1002/hed.24919.
    PubMed     Abstract available


  714. QIU J, Lv B, Fu M, Wang X, et al
    18 F-Fluoromisonidazole positron emission tomography/CT-guided volumetric-modulated arc therapy-based dose escalation for hypoxic subvolume in nasopharyngeal carcinomas: A feasibility study.
    Head Neck. 2017 Sep 30. doi: 10.1002/hed.24925.
    PubMed     Abstract available


  715. LIU H, Zhang Y, Zhang T, Li F, et al
    Correlation between the pathology and clinical presentations in patients with adenoid cystic carcinoma of the external auditory canal.
    Head Neck. 2017 Sep 30. doi: 10.1002/hed.24915.
    PubMed     Abstract available


  716. KAWAKITA D, Lee YA, Li Q, Chen Y, et al
    Impact of oral hygiene on head and neck cancer risk in a Chinese population.
    Head Neck. 2017 Sep 27. doi: 10.1002/hed.24929.
    PubMed     Abstract available


  717. LUCIONI M, D'Ascanio L, De Nardi E, Lionello M, et al
    Management of paratracheal lymph nodes in laryngeal cancer with subglottic involvement.
    Head Neck. 2017 Sep 27. doi: 10.1002/hed.24905.
    PubMed     Abstract available


  718. CHENG SJ, Chang CF, Ko HH, Lee JJ, et al
    Hypermethylated ZNF582 and PAX1 genes in mouth rinse samples as biomarkers for oral dysplasia and oral cancer detection.
    Head Neck. 2017 Sep 27. doi: 10.1002/hed.24958.
    PubMed     Abstract available


  719. ITO M, Kodaira T, Tachibana H, Tomita N, et al
    Clinical results of definitive chemoradiotherapy for cervical esophageal cancer: Comparison of failure pattern and toxicities between intensity-modulated radiotherapy and 3-dimensional conformal radiotherapy.
    Head Neck. 2017 Sep 27. doi: 10.1002/hed.24909.
    PubMed     Abstract available


  720. ZHANG H, Kim S, Chen Z, Nannapaneni S, et al
    Prognostic biomarkers in patients with human immunodeficiency virus-positive disease with head and neck squamous cell carcinoma.
    Head Neck. 2017 Sep 25. doi: 10.1002/hed.24911.
    PubMed     Abstract available


  721. DA FONSECA FL, Yamanaka PK, Mazoti L, Arakawa-Sugueno L, et al
    Correlation among ocular surface disease, xerostomia, and nasal symptoms in patients with differentiated thyroid carcinoma subjected to radioiodine therapy: A prospective comparative study.
    Head Neck. 2017 Sep 25. doi: 10.1002/hed.24895.
    PubMed     Abstract available


    August 2017
  722. BERWOUTS D, Madani I, Duprez F, Olteanu AL, et al
    Long-term outcome of 18 F-fluorodeoxyglucose-positron emission tomography-guided dose painting for head and neck cancer: Matched case-control study.
    Head Neck. 2017 Aug 21. doi: 10.1002/hed.24892.
    PubMed     Abstract available


  723. DE BREE R, Wolf GT, de Keizer B, Nixon IJ, et al
    Response assessment after induction chemotherapy for head and neck squamous cell carcinoma: From physical examination to modern imaging techniques and beyond.
    Head Neck. 2017 Aug 17. doi: 10.1002/hed.24883.
    PubMed     Abstract available


  724. KAWADA T, Takahashi H, Sakakura K, Ida S, et al
    Circulating tumor cells in patients with head and neck squamous cell carcinoma: Feasibility of detection and quantitation.
    Head Neck. 2017 Aug 17. doi: 10.1002/hed.24893.
    PubMed     Abstract available


  725. FANELLI MF, Oliveira TB, Braun AC, Corassa M, et al
    Evaluation of incidence, significance, and prognostic role of circulating tumor microemboli and transforming growth factor-beta receptor I in head and neck cancer.
    Head Neck. 2017 Aug 17. doi: 10.1002/hed.24899.
    PubMed     Abstract available


  726. LACCOURREYE O, Bonfils P, Malinvaud D, Menard M, et al
    Survival and laryngeal preservation tradeoff in advanced laryngeal cancer: From the otorhinolaryngology patient to the managing physician.
    Head Neck. 2017 Aug 8. doi: 10.1002/hed.24833.
    PubMed     Abstract available


  727. KRAAIJENGA SAC, Molen LV, Stuiver MM, Takes RP, et al
    Efficacy of a novel swallowing exercise program for chronic dysphagia in long-term head and neck cancer survivors.
    Head Neck. 2017 Aug 2. doi: 10.1002/hed.24710.
    PubMed     Abstract available


  728. ASTRUP GL, Rustoen T, Hofso K, Gran JM, et al
    Symptom burden and patient characteristics: Association with quality of life in patients with head and neck cancer undergoing radiotherapy.
    Head Neck. 2017 Aug 2. doi: 10.1002/hed.24875.
    PubMed     Abstract available


    July 2017
  729. GREEN R, Macmillan MT, Tikka T, Bruce L, et al
    Analysis of the incidence and factors predictive of outcome in patients with head and neck cancer with pulmonary nodules.
    Head Neck. 2017 Jul 25. doi: 10.1002/hed.24885.
    PubMed     Abstract available


  730. KO HC, Chen S, Wieland AM, Yu M, et al
    Clinical outcomes for patients presenting with N3 head and neck squamous cell carcinoma: Analysis of the National Cancer Database.
    Head Neck. 2017 Jul 24. doi: 10.1002/hed.24881.
    PubMed     Abstract available


  731. MALIK A, Sahu A, Singh SP, Deshmukh A, et al
    In vivo Raman spectroscopy-assisted early identification of potential second primary/recurrences in oral cancers: An exploratory study.
    Head Neck. 2017 Jul 24. doi: 10.1002/hed.24884.
    PubMed     Abstract available


  732. MARINA M, Ceda GP, Corcione L, Sgargi P, et al
    Size of thyroid carcinoma by histotype and variants: A population-based study in a mildly iodine-deficient area.
    Head Neck. 2017 Jul 24. doi: 10.1002/hed.24877.
    PubMed     Abstract available


  733. CZERWONKA L, Bissada E, Goldstein DP, Wood RE, et al
    High-resolution cone-beam computed tomography for assessment of bone invasion in oral cancer: Comparison with conventional computed tomography.
    Head Neck. 2017 Jul 12. doi: 10.1002/hed.24858.
    PubMed     Abstract available


  734. CHENG CT, Lin CY, Hung-Chun Cheng S, Lin YP, et al
    Survival benefit of surgical approach for advanced oropharyngeal and hypopharyngeal cancer: A retrospective analysis.
    Head Neck. 2017 Jul 10. doi: 10.1002/hed.24869.
    PubMed     Abstract available


  735. CHANG PH, Yeh KY, Wang CH, Chen EY, et al
    Impact of the pretreatment Glasgow prognostic score on treatment tolerance, toxicities, and survival in patients with advanced head and neck cancer undergoing concurrent chemoradiotherapy.
    Head Neck. 2017 Jul 7. doi: 10.1002/hed.24853.
    PubMed     Abstract available


  736. FLETCHER KT, Gal TJ, Ebelhar AJ, Valentino J, et al
    Prognostic indicators and survival in salvage surgery for laryngeal cancer.
    Head Neck. 2017 Jul 6. doi: 10.1002/hed.24860.
    PubMed     Abstract available


  737. SHAH-BECKER S, Pennock M, Sinoway L, Goldenberg D, et al
    Baroreceptor reflex failure: Review of the literature and the potential impact on patients with head and neck cancer.
    Head Neck. 2017 Jul 4. doi: 10.1002/hed.24857.
    PubMed     Abstract available


    June 2017
  738. DUPREZ F, Berwouts D, De Neve W, Bonte K, et al
    Distant metastases in head and neck cancer.
    Head Neck. 2017 Jun 26. doi: 10.1002/hed.24687.
    PubMed     Abstract available


  739. REID PA, Wilson P, Li Y, Marcu LG, et al
    Current understanding of cancer stem cells: Review of their radiobiology and role in head and neck cancers.
    Head Neck. 2017 Jun 23. doi: 10.1002/hed.24848.
    PubMed     Abstract available


  740. MASSA ST, Cass LM, Osazuwa-Peters N, Christopher KM, et al
    Decreased cancer-independent life expectancy in the head and neck cancer population.
    Head Neck. 2017 Jun 22. doi: 10.1002/hed.24850.
    PubMed     Abstract available


  741. VILASECA I, Valls-Mateus M, Nogues A, Lehrer E, et al
    Usefulness of office examination with narrow band imaging for the diagnosis of head and neck squamous cell carcinoma and follow-up of premalignant lesions.
    Head Neck. 2017 Jun 22. doi: 10.1002/hed.24849.
    PubMed     Abstract available


  742. TING Y, Chee J, Charn TC, Loh KS, et al
    Prognostic significance of cystic lymph nodal metastasis in nasopharyngeal carcinoma.
    Head Neck. 2017 Jun 22. doi: 10.1002/hed.24844.
    PubMed     Abstract available


  743. BARBER B, Harris J, Shillington C, Rychlik S, et al
    Efficacy of a high-observation protocol in major head and neck cancer surgery: A prospective study.
    Head Neck. 2017 Jun 20. doi: 10.1002/hed.24599.
    PubMed     Abstract available


  744. ESKANDER A, Mifsud M, Irish J, Gullane P, et al
    Overview of surgery for laryngeal and hypopharyngeal cancer in Ontario, 2003-2010.
    Head Neck. 2017 Jun 7. doi: 10.1002/hed.24787.
    PubMed     Abstract available


  745. TAMJID B, Phan P, John T, Mitchell P, et al
    Outcomes for patients with synchronous and metachronous primary lung cancer after diagnosis of head and neck cancer.
    Head Neck. 2017 Jun 7. doi: 10.1002/hed.24751.
    PubMed     Abstract available


  746. MOHANTI BK, Thakar A, Kaur J, Bahadur S, et al
    Postoperative radiotherapy dose requirement in standard combined-modality practice for head and neck squamous cell carcinoma: Analysis of salient surgical and radiotherapy parameters in 2 cohorts.
    Head Neck. 2017 Jun 6. doi: 10.1002/hed.24836.
    PubMed     Abstract available


  747. SAITO Y, Omura G, Yasuhara K, Rikitake R, et al
    Prognostic value of lymphovascular invasion of the primary tumor in hypopharyngeal carcinoma after total laryngopharyngectomy.
    Head Neck. 2017 Jun 5. doi: 10.1002/hed.24705.
    PubMed     Abstract available


  748. D'SOUZA W, Pradhan S, Saranath D
    Multiple single nucleotide polymorphism analysis and association of specific genotypes in FHIT, SAMD4A, and ANKRD17 in Indian patients with oral cancer.
    Head Neck. 2017 Jun 5. doi: 10.1002/hed.24798.
    PubMed     Abstract available


    May 2017
  749. MEZI S, Chiappetta C, Carletti R, Nardini A, et al
    Clinical significance of epithelial-to-mesenchymal transition in laryngeal carcinoma: its role in the different subsites.
    Head Neck. 2017 May 31. doi: 10.1002/hed.24838.
    PubMed     Abstract available


  750. MARUCCI L, Farneti A, Di Ridolfi P, Pinnaro P, et al
    Double-blind randomized phase III study comparing a mixture of natural agents versus placebo in the prevention of acute mucositis during chemoradiotherapy for head and neck cancer.
    Head Neck. 2017 May 31. doi: 10.1002/hed.24832.
    PubMed     Abstract available


  751. MIFSUD M, Eskander A, Irish J, Gullane P, et al
    Evolving trends in head and neck cancer epidemiology: Ontario, Canada 1993-2010.
    Head Neck. 2017 May 30. doi: 10.1002/hed.24829.
    PubMed     Abstract available


  752. HONDA K, Asato R, Tsuji J, Miyazaki M, et al
    Oncologic safety of cervical nerve preservation in neck dissection for head and neck cancer.
    Head Neck. 2017 May 30. doi: 10.1002/hed.24826.
    PubMed     Abstract available


  753. ZAIRIS S, Margalit DN, Royce TJ, Powlis WD, et al
    Prospective analysis of radiation oncology image and plan-driven peer review for head and neck cancer.
    Head Neck. 2017 May 17. doi: 10.1002/hed.24800.
    PubMed     Abstract available


  754. LEE JH, Hwang Y, Song RY, Yi JW, et al
    Relationship between iodine levels and papillary thyroid carcinoma: A systematic review and meta-analysis.
    Head Neck. 2017 May 17. doi: 10.1002/hed.24797.
    PubMed     Abstract available


  755. SEKINE T, Barbosa FG, Delso G, Burger IA, et al
    Local resectability assessment of head and neck cancer: Positron emission tomography/MRI versus positron emission tomography/CT.
    Head Neck. 2017 May 13. doi: 10.1002/hed.24783.
    PubMed     Abstract available


  756. ERKAN S, Savundra JM, Wood B, Acharya AN, et al
    Clinical perineural invasion of the trigeminal and facial nerves in cutaneous head and neck squamous cell carcinoma: Outcomes and prognostic implications of multimodality and salvage treatment.
    Head Neck. 2017 May 5. doi: 10.1002/hed.24607.
    PubMed     Abstract available


  757. WEISS BG, Ihler F, Wolff HA, Schneider S, et al
    Transoral laser microsurgery for treatment for hypopharyngeal cancer in 211 patients.
    Head Neck. 2017 May 5. doi: 10.1002/hed.24814.
    PubMed     Abstract available


  758. HINSON AM, Massoll NA, Jolly LA, Stack BC Jr, et al
    Structural alterations in tumor-draining lymph nodes before papillary thyroid carcinoma metastasis.
    Head Neck. 2017 May 3. doi: 10.1002/hed.24807.
    PubMed     Abstract available


  759. LIN CS, de Oliveira Santos AB, Silva EL, de Matos LL, et al
    Tumor volume as an independent predictive factor of worse survival in patients with oral cavity squamous cell carcinoma.
    Head Neck. 2017;39:960-964.
    PubMed     Abstract available


  760. SOSA A, Heineman N, Thomas K, Tang K, et al
    Improving patient health engagement with mobile texting: A pilot study in the head and neck postoperative setting.
    Head Neck. 2017;39:988-995.
    PubMed     Abstract available


  761. LIKHTEROV I, Reis LL, Urken ML
    Central compartment management in patients with papillary thyroid cancer presenting with metastatic disease to the lateral neck: Anatomic pathways of lymphatic spread.
    Head Neck. 2017;39:853-859.
    PubMed     Abstract available


  762. AMIT M, Na'ara S, Trejo-Leider L, Ramer N, et al
    Defining the surgical margins of adenoid cystic carcinoma and their impact on outcome: An international collaborative study.
    Head Neck. 2017;39:1008-1014.
    PubMed     Abstract available


  763. ZHANG D, Li F, Wu CW, Liu X, et al
    Percutaneous probe stimulation for intraoperative neuromonitoring in total endoscopic thyroidectomy: A preliminary experience.
    Head Neck. 2017;39:1001-1007.
    PubMed     Abstract available


  764. SOWDER JC, Cannon RB, Buchmann LO, Hunt JP, et al
    Treatment-related determinants of survival in early-stage (T1-2N0M0) oral cavity cancer: A population-based study.
    Head Neck. 2017;39:876-880.
    PubMed     Abstract available


  765. BROCKHOFF HC 2ND, Kim RY, Braun TM, Skouteris C, et al
    Correlating the depth of invasion at specific anatomic locations with the risk for regional metastatic disease to lymph nodes in the neck for oral squamous cell carcinoma.
    Head Neck. 2017;39:974-979.
    PubMed     Abstract available


  766. BROWN TJ, Sher DJ, Nedzi LA, Hughes RS, et al
    Cutaneous adnexal adenocarcinoma with exquisite sensitivity to trastuzumab.
    Head Neck. 2017;39:E69-E71.
    PubMed     Abstract available


  767. LOPEZ F, Triantafyllou A, Snyderman CH, Hunt JL, et al
    Nasal juvenile angiofibroma: Current perspectives with emphasis on management.
    Head Neck. 2017;39:1033-1045.
    PubMed     Abstract available


  768. WELLER MA, Ward MC, Berriochoa C, Reddy CA, et al
    Predictors of distant metastasis in human papillomavirus-associated oropharyngeal cancer.
    Head Neck. 2017;39:940-946.
    PubMed     Abstract available


  769. MORISOD B, Venara-Vulpe II, Alzuphar S, Monnier Y, et al
    Minimizing adjuvant treatment after transoral robotic surgery through surgical margin revision and exclusion of radiographic extracapsular extension: A Prospective observational cohort study.
    Head Neck. 2017;39:965-973.
    PubMed     Abstract available


  770. KANG SY, Old MO, Teknos TN
    Lateral arm free tissue transfer for parotid reconstruction: A pictorial essay.
    Head Neck. 2017;39:1015-1019.
    PubMed     Abstract available


  771. CHOU WC, Chang KP, Lu CH, Chen MF, et al
    Complementary role of the Memorial Sloan Kettering Cancer Center nomogram to the American Joint Committee on Cancer system for the prediction of relapse of major salivary gland carcinoma after surgery.
    Head Neck. 2017;39:860-867.
    PubMed     Abstract available


  772. LANSAAT L, van den Boer C, Muller SH, van der Noort V, et al
    Ex vivo humidifying capacity and patient acceptability of stoma cloths in laryngectomized individuals.
    Head Neck. 2017;39:921-931.
    PubMed     Abstract available


    April 2017
  773. AGRAWAL N, Evasovich MR, Kandil E, Noureldine SI, et al
    Indications and extent of central neck dissection for papillary thyroid cancer: An American Head and Neck Society Consensus Statement.
    Head Neck. 2017 Apr 27. doi: 10.1002/hed.24715.
    PubMed     Abstract available


  774. CHANG PH, Yeh KY, Wang CH, Chen EY, et al
    Impact of metformin on patients with advanced head and neck cancer undergoing concurrent chemoradiotherapy.
    Head Neck. 2017 Apr 27. doi: 10.1002/hed.24793.
    PubMed     Abstract available


  775. LIU SY, Feng IJ, Wu YW, Chen CY, et al
    Implication for second primary cancer from visible oral and oropharyngeal premalignant lesions in betel-nut chewing related oral cancer.
    Head Neck. 2017 Apr 6. doi: 10.1002/hed.24777.
    PubMed     Abstract available


  776. FUJIWARA RJ, Judson BL, Yarbrough WG, Husain Z, et al
    Treatment delays in oral cavity squamous cell carcinoma and association with survival.
    Head Neck. 2017;39:639-646.
    PubMed     Abstract available


  777. GARCIA-OLMO DC, Contreras JD, Picazo MG, Lopez-Torres J, et al
    Potential clinical significance of perioperative levels of mRNA in plasma from patients with cancer of the larynx or hypopharynx.
    Head Neck. 2017;39:647-655.
    PubMed     Abstract available


  778. VAN LOON Y, Stiggelbout AM, Hakkesteegt MM, Langeveld TP, et al
    Utility approach to decision-making in extended T1 and limited T2 glottic carcinoma.
    Head Neck. 2017;39:779-785.
    PubMed     Abstract available


  779. KIL WJ, Camphausen K
    Cyclical hypofractionated radiotherapy also known as "QUAD Shot" alone using intensity-modulated radiotherapy for squamous cell carcinoma of the parotid gland in an 85-year-old patient with multiple comorbidities.
    Head Neck. 2017;39:E55-E60.
    PubMed     Abstract available


  780. LEE JH, Chung YS, Lee YD
    A variation in recurrence patterns of papillary thyroid cancer with disease progression: A long-term follow-up study.
    Head Neck. 2017;39:767-771.
    PubMed     Abstract available


  781. DUEK I, Amit M, Sviri GE, Gil Z, et al
    Combined endoscopic transcervical-transoral robotic approach for resection of parapharyngeal space tumors.
    Head Neck. 2017;39:786-790.
    PubMed     Abstract available


  782. ZHOU L, Luo W
    Vascular endothelial growth factor-targeted paclitaxel-loaded liposome microbubbles and inhibition of human epidermoid-2 cell proliferation.
    Head Neck. 2017;39:656-661.
    PubMed     Abstract available


  783. OSORIO M, Moubayed SP, Su H, Urken ML, et al
    Systematic review of site distribution of bone metastases in differentiated thyroid cancer.
    Head Neck. 2017;39:812-818.
    PubMed     Abstract available


  784. TURRI-ZANONI M, Salzano G, Lambertoni A, Giovannardi M, et al
    Prognostic value of pretreatment peripheral blood markers in paranasal sinus cancer: Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio.
    Head Neck. 2017;39:730-736.
    PubMed     Abstract available


  785. ALMADORI G, Lauriola L, Coli A, Bussu F, et al
    Minichromosome maintenance protein 7 and geminin expression: Prognostic value in laryngeal squamous cell carcinoma in patients treated with radiotherapy and cetuximab.
    Head Neck. 2017;39:684-693.
    PubMed     Abstract available


  786. FERNANDEZ-RIERA R, Hung SY, Wu JC, Tsao CK, et al
    Free profunda femoris artery perforator flap as a first-line choice of reconstruction for partial glossectomy defects.
    Head Neck. 2017;39:737-743.
    PubMed     Abstract available


  787. TURRI-ZANONI M, Battaglia P, Karligkiotis A, Lepera D, et al
    Transnasal endoscopic partial maxillectomy: Operative nuances and proposal for a comprehensive classification system based on 1378 cases.
    Head Neck. 2017;39:754-766.
    PubMed     Abstract available


  788. QUINLAN-DAVIDSON SR, Morrison WH, Myers JN, Gunn GB, et al
    Recurrent oral cavity cancer: Patterns of failure after salvage multimodality therapy.
    Head Neck. 2017;39:633-638.
    PubMed     Abstract available


  789. LUKSIC I, Suton P
    Predictive markers for delayed lymph node metastases and survival in early-stage oral squamous cell carcinoma.
    Head Neck. 2017;39:694-701.
    PubMed     Abstract available


  790. KOTO M, Hasegawa A, Takagi R, Ikawa H, et al
    Definitive carbon-ion radiotherapy for locally advanced parotid gland carcinomas.
    Head Neck. 2017;39:724-729.
    PubMed     Abstract available


  791. TESSEROLI MA, Zasso FB, Hepp H, Priante AV, et al
    Parotidectomy under sedation and locoregional anesthesia with monitoring of brain activity.
    Head Neck. 2017;39:744-747.
    PubMed     Abstract available


  792. JARROM D, Paleri V, Kerawala C, Roques T, et al
    Mucosal melanoma of the upper airways tract mucosal melanoma: A systematic review with meta-analyses of treatment.
    Head Neck. 2017;39:819-825.
    PubMed     Abstract available


  793. STUANI VT, Rubira CM, Sant'Ana AC, Santos PS, et al
    Salivary biomarkers as tools for oral squamous cell carcinoma diagnosis: A systematic review.
    Head Neck. 2017;39:797-811.
    PubMed     Abstract available


    March 2017
  794. TIGHE DF, Thomas AJ, Sassoon I, Kinsman R, et al
    Developing a risk stratification tool for audit of outcome after surgery for head and neck squamous cell carcinoma.
    Head Neck. 2017 Mar 29. doi: 10.1002/hed.24769.
    PubMed     Abstract available


  795. RIDDER M, Klop M, Hamming-Vrieze O, Boer J, et al
    Unknown primary head and neck squamous cell carcinoma in the era of fluorodeoxyglucose-positron emission tomography/CT and intensity-modulated radiotherapy.
    Head Neck. 2017 Mar 28. doi: 10.1002/hed.24762.
    PubMed     Abstract available


  796. REYES-GIBBY CC, Melkonian SC, Hanna EY, Yeung SJ, et al
    Cohort study of oncologic emergencies in patients with head and neck cancer.
    Head Neck. 2017 Mar 27. doi: 10.1002/hed.24748.
    PubMed     Abstract available


  797. WANG YY, Chen YK, Hsu YL, Chiu WC, et al
    Synthetic beta-nitrostyrene derivative CYT-Rx20 as inhibitor of oral cancer cell proliferation and tumor growth through glutathione suppression and reactive oxygen species induction.
    Head Neck. 2017 Mar 27. doi: 10.1002/hed.24664.
    PubMed     Abstract available


  798. GAMA RR, Song Y, Zhang Q, Brown MC, et al
    Body mass index and prognosis in patients with head and neck cancer.
    Head Neck. 2017 Mar 21. doi: 10.1002/hed.24760.
    PubMed     Abstract available


  799. WU WJ, Shao X, Huang MW, Lv XM, et al
    Postoperative iodine-125 interstitial brachytherapy for the early stages of minor salivary gland carcinomas of the lip and buccal mucosa with positive or close margins.
    Head Neck. 2017;39:572-577.
    PubMed     Abstract available


  800. GROSHEVA M, Shabli S, Volk GF, Sommer B, et al
    Sensation loss after superficial parotidectomy: A prospective controlled multicenter trial.
    Head Neck. 2017;39:520-526.
    PubMed     Abstract available


  801. CHONG LS, Eviston TJ, Ashford B, Ebrahami A, et al
    Single innervated segmented vastus lateralis for midfacial reanimation during radical parotidectomy.
    Head Neck. 2017;39:602-604.
    PubMed     Abstract available


  802. SIDDIQUI F, Smith RV, Yom SS, Beitler JJ, et al
    ACR appropriateness criteria((R)) nasal cavity and paranasal sinus cancers.
    Head Neck. 2017;39:407-418.
    PubMed     Abstract available


  803. BERGER MH, Kerr DA, Rangel Filho AE, Sargi ZB, et al
    Case of parotid mucoepidermoid carcinoma: Expanding the spectrum of von Hippel-Lindau-related neoplasms.
    Head Neck. 2017;39:E51-E54.
    PubMed     Abstract available


  804. THORPE LM, Schrock AB, Erlich RL, Miller VA, et al
    Significant and durable clinical benefit from trastuzumab in 2 patients with HER2-amplified salivary gland cancer and a review of the literature.
    Head Neck. 2017;39:E40-E44.
    PubMed     Abstract available


  805. BOEVE K, Schepman KP, Vegt BV, Schuuring E, et al
    Lymphatic drainage patterns of oral maxillary tumors: Approachable locations of sentinel lymph nodes mainly at the cervical neck level.
    Head Neck. 2017;39:486-491.
    PubMed     Abstract available


  806. MANTSOPOULOS K, Scherl C, Iro H
    Investigation of arguments against properly indicated extracapsular dissection in the parotid gland.
    Head Neck. 2017;39:498-502.
    PubMed     Abstract available


  807. IWAKI S, Maeda T, Saito M, Otsuki N, et al
    Role of immediate recurrent laryngeal nerve reconstruction in surgery for thyroid cancers with fixed vocal cords.
    Head Neck. 2017;39:427-431.
    PubMed     Abstract available


  808. NISHIO N, Fujii M, Hayashi Y, Hiramatsu M, et al
    Preoperative surgical simulation and validation of the line of resection in anterolateral craniofacial resection of advanced sinonasal sinus carcinoma.
    Head Neck. 2017;39:512-519.
    PubMed     Abstract available


  809. LING S, Bhatt AD, Brown NV, Nguyen P, et al
    Correlative study of dose to thyroid and incidence of subsequent dysfunction after head and neck radiation.
    Head Neck. 2017;39:548-554.
    PubMed     Abstract available


  810. GAO LL, Basta M, Kanchwala SK, Serletti JM, et al
    Cost-effectiveness of microsurgical reconstruction for head and neck defects after oncologic resection.
    Head Neck. 2017;39:541-547.
    PubMed     Abstract available


  811. HERNANDEZ-PRERA JC, Kwan R, Tripodi J, Chiosea S, et al
    Reappraising hyalinizing clear cell carcinoma: A population-based study with molecular confirmation.
    Head Neck. 2017;39:503-511.
    PubMed     Abstract available


  812. LOMBARDI D, Mattavelli D, Redaelli De Zinis LO, Accorona R, et al
    Primary Ewing's sarcoma of the sinonasal tract in adults: A challenging disease.
    Head Neck. 2017;39:E45-E50.
    PubMed     Abstract available


  813. SIVARS L, Landin D, Haeggblom L, Tertipis N, et al
    Human papillomavirus DNA detection in fine-needle aspirates as indicator of human papillomavirus-positive oropharyngeal squamous cell carcinoma: A prospective study.
    Head Neck. 2017;39:419-426.
    PubMed     Abstract available


  814. BURGESS M, Leung M, Chellapah A, Clark JR, et al
    Osseointegrated implants into a variety of composite free flaps: A comparative analysis.
    Head Neck. 2017;39:443-447.
    PubMed     Abstract available


  815. FAGAN JJ, Zafereo M, Aswani J, Netterville JL, et al
    Head and neck surgical subspecialty training in Africa: Sustainable models to improve cancer care in developing countries.
    Head Neck. 2017;39:605-611.
    PubMed     Abstract available


  816. MATTHEIS S, Hasskamp P, Holtmann L, Schafer C, et al
    Flex Robotic System in transoral robotic surgery: The first 40 patients.
    Head Neck. 2017;39:471-475.
    PubMed     Abstract available


  817. VAN WEERT S, Reinhard R, Bloemena E, Buter J, et al
    Differences in patterns of survival in metastatic adenoid cystic carcinoma of the head and neck.
    Head Neck. 2017;39:456-463.
    PubMed     Abstract available


  818. YU Y, Mabray M, Silveira W, Shen PY, et al
    Earlier and more specific detection of persistent neck disease with diffusion-weighted MRI versus subsequent PET/CT after definitive chemoradiation for oropharyngeal squamous cell carcinoma.
    Head Neck. 2017;39:432-438.
    PubMed     Abstract available


  819. JUNG JH, Lee SW, Son SH, Kim CY, et al
    Clinical impact of (18) F-FDG positron emission tomography/CT on adenoid cystic carcinoma of the head and neck.
    Head Neck. 2017;39:447-455.
    PubMed     Abstract available


    February 2017
  820. GOOI Z, Richmon J, Agrawal N, Blair E, et al
    AHNS Series - Do you know your guidelines? Principles of treatment for nasopharyngeal cancer: A review of the National Comprehensive Cancer Network guidelines.
    Head Neck. 2017;39:201-205.
    PubMed     Abstract available


  821. KADLETZ L, Grasl S, Grasl MC, Perisanidis C, et al
    Extracapsular dissection versus superficial parotidectomy in benign parotid gland tumors: The Vienna Medical School experience.
    Head Neck. 2017;39:356-360.
    PubMed     Abstract available


  822. FRISCH T
    Versatility of the facial artery myomucosal island flap in neopharyngeal reconstruction.
    Head Neck. 2017;39:E29-E33.
    PubMed     Abstract available


  823. MCDOWELL LJ, Jacobson MC, Levin W
    High-dose intravenous steroid regimen for radiation-induced hypoglossal nerve palsy.
    Head Neck. 2017;39:E23-E28.
    PubMed     Abstract available


  824. MEHTA V, Flores JM, Thompson RW, Nathan CA, et al
    Primary payer status, individual patient characteristics, and hospital-level factors affecting length of stay and total cost of hospitalization in total laryngectomy.
    Head Neck. 2017;39:311-319.
    PubMed     Abstract available


  825. GAVRIEL H, Eviatar E, Abu Eta R
    Hyperbaric oxygen therapy for maxillary bone radiation-induced injury: A 15-year single-center experience.
    Head Neck. 2017;39:275-278.
    PubMed     Abstract available


  826. WEAVER AN, Cooper TS, Wei S, Carroll WR, et al
    DNA-PkCS expression in oropharyngeal squamous cell carcinoma: Correlations with human papillomavirus status and recurrence after transoral robotic surgery.
    Head Neck. 2017;39:206-214.
    PubMed     Abstract available


    January 2017
  827. CANNON RB, Sowder JC, Buchmann LO, Hunt JP, et al
    Increasing use of nonsurgical therapy in advanced-stage oral cavity cancer: A population-based study.
    Head Neck. 2017;39:82-91.
    PubMed     Abstract available


  828. HOFSTEDE TM, Jacob RF, Montgomery P, Wesley P, et al
    Surgical preparation of nasal defects to enhance the implant-retained facial prostheses: A case report.
    Head Neck. 2017;39:E4-E11.
    PubMed     Abstract available


  829. BOON E, van der Graaf WT, Gelderblom H, Tesselaar ME, et al
    Impact of chemotherapy on the outcome of osteosarcoma of the head and neck in adults.
    Head Neck. 2017;39:140-146.
    PubMed     Abstract available


  830. KATZ O, Nachalon Y, Hilly O, Shpitzer T, et al
    Radiotherapy in early-stage tongue squamous cell carcinoma with minor adverse features.
    Head Neck. 2017;39:147-150.
    PubMed     Abstract available


  831. BEECH NM, Porceddu S, Batstone MD
    Radiotherapy-associated dental extractions and osteoradionecrosis.
    Head Neck. 2017;39:128-132.
    PubMed     Abstract available


  832. PRPIC M, Kust D, Kruljac I, Kirigin LS, et al
    Prediction of radioactive iodine remnant ablation failure in patients with differentiated thyroid cancer: A cohort study of 740 patients.
    Head Neck. 2017;39:109-115.
    PubMed     Abstract available


  833. ORBACH D, Mosseri V, Gallego S, Kelsey A, et al
    Nonparameningeal head and neck rhabdomyosarcoma in children and adolescents: Lessons from the consecutive International Society of Pediatric Oncology Malignant Mesenchymal Tumor studies.
    Head Neck. 2017;39:24-31.
    PubMed     Abstract available


  834. ANSARIN M, Cattaneo A, De Benedetto L, Zorzi S, et al
    Retrospective analysis of factors influencing oncologic outcome in 590 patients with early-intermediate glottic cancer treated by transoral laser microsurgery.
    Head Neck. 2017;39:71-81.
    PubMed     Abstract available


  835. KNOPF A, Bas M, Hofauer B, Mansour N, et al
    Clinicopathological characteristics of head and neck Merkel cell carcinomas.
    Head Neck. 2017;39:92-97.
    PubMed     Abstract available


  836. RACKLEY TP, Namelo WC, Palaniappan N, Cole N, et al
    Unilateral radiotherapy for surgically resected lateralized squamous cell carcinoma of the tonsil.
    Head Neck. 2017;39:17-23.
    PubMed     Abstract available


  837. MERMOD M, Bongiovanni M, Petrova TV, Dubikovskaya EA, et al
    Correlation between podoplanin expression and extracapsular spread in squamous cell carcinoma of the oral cavity using subjective immunoreactivity scores and semiquantitative image analysis.
    Head Neck. 2017;39:98-108.
    PubMed     Abstract available


  838. LAARA E, Korpi JT, Pitkanen H, Alho OP, et al
    Competing risks analysis of cause-specific mortality in patients with oral squamous cell carcinoma.
    Head Neck. 2017;39:56-62.
    PubMed     Abstract available


  839. BAUMEISTER P, Rauch J, Jacobi C, Kisser U, et al
    Impact of comorbidity and anemia in patients with oropharyngeal cancer primarily treated with surgery in the human papillomavirus era.
    Head Neck. 2017;39:7-16.
    PubMed     Abstract available


  840. STROM T, Naghavi AO, Messina JL, Kim S, et al
    Improved local and regional control with radiotherapy for Merkel cell carcinoma of the head and neck.
    Head Neck. 2017;39:48-55.
    PubMed     Abstract available


  841. RAGUIN T, Schneegans O, Rodier JF, Volkmar PP, et al
    Value of fine-needle aspiration in evaluating large thyroid nodules.
    Head Neck. 2017;39:32-36.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: